,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,Interferon signaling,50 of 168,1.1217728325625533e-39,1.0107173221388604e-36,0,0,18.126800613611703,1625.718577725998,IFITM3;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;JAK2;B2M;JAK1;GBP5;DDX58;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;IRF9;SP100;IFI6;USP18;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;PTPN1;STAT1;STAT2;MX1;EIF2AK2;ISG15;PML;PSMB8;ISG20;HLA-DRA;XAF1;PTPN2
1,BioPlanet_2019,Immune system,107 of 998,1.1876832306524718e-38,5.350512954089385e-36,0,0,5.642400435329728,492.72955246466574,IFITM3;UBE2D3;RNF19B;UBE2L6;IFI35;IFI30;IFIT1;UBE2Z;IFIT3;IFIT2;ICAM1;HERC5;MT2A;DHX58;MAP3K8;FBXO6;TRIM21;B2M;PDIA3;GBP5;TAP2;HLA-B;TAP1;HLA-C;HLA-A;HLA-F;RBX1;HLA-E;PSME1;PSME2;TXNIP;RBCK1;IL6ST;CFB;CD274;UBA6;TXN;HSP90B1;SOCS3;SOCS1;UBB;UBC;TNFRSF14;LYN;HSPA5;EIF2AK2;ISG15;NFKB1;NFKB2;ISG20;NFKBIA;CYLD;HLA-DRA;CALR;XAF1;LGMN;CDKN1A;CD40;YWHAB;ADAR;CTSS;IFIH1;CTSO;CTSL;PPP2R5E;CASP4;JAK2;JAK1;DTX3L;RIPK2;DDX58;PPP2R5B;TAPBP;PSMA3;PSMA4;OAS1;PSMA2;IRF1;OAS3;IRF2;IRF7;IRF9;BIRC3;SP100;C1R;NLRC5;IFI6;TANK;USP18;PSMB10;PSMB2;PSMB3;GBP2;GBP1;GBP4;GBP3;PTPN1;CD74;ERAP2;STAT1;STAT2;MX1;STAT3;PSMB8;PML;PSMB9;PTPN2
2,BioPlanet_2019,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",59 of 280,2.3653056611383525e-37,7.10380133561885e-35,0,0,11.590273531450002,977.462718521696,IFITM3;YWHAB;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;MAP3K8;JAK2;B2M;JAK1;GBP5;RIPK2;DDX58;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;RBX1;OAS1;IRF1;OAS3;IRF2;IRF7;IL6ST;IRF9;SP100;IFI6;USP18;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;LYN;PTPN1;STAT1;STAT2;STAT3;MX1;EIF2AK2;ISG15;PSMB8;NFKB1;PML;NFKB2;ISG20;HLA-DRA;XAF1;PTPN2
3,BioPlanet_2019,Interferon alpha/beta signaling,31 of 64,8.577937367434843e-33,1.9321803920146985e-30,0,0,38.73805855161788,2860.2677299894267,IFITM3;IFI6;ADAR;IFI35;IFIT1;USP18;IFIT3;IFIT2;SOCS3;SOCS1;GBP2;JAK1;PTPN1;STAT1;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;ISG20;OAS1;IRF1;OAS3;IRF2;IRF7;XAF1;IRF9
4,BioPlanet_2019,Interferon-gamma signaling pathway,33 of 97,1.1492735923801215e-28,2.0709910134689792e-26,0,0,21.319448138297872,1371.5494406647174,CEBPB;SP100;IFI30;ICAM1;SOCS3;MT2A;SOCS1;JAK2;GBP2;B2M;GBP1;GBP4;JAK1;GBP3;GBP5;PTPN1;STAT1;STAT3;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;HLA-DRA;CALM3;IRF9;PTPN2
5,BioPlanet_2019,Type II interferon signaling (interferon-gamma),21 of 50,5.83913656358238e-21,8.768436739646208e-19,0,0,29.247961081699813,1362.6538498581467,CXCL9;STAT1;STAT2;HLA-B;IFI6;TAP1;EIF2AK2;ISG15;ICAM1;IFIT2;PSMB9;SOCS3;CXCL10;SOCS1;OAS1;IRF1;IRF2;JAK2;GBP1;IRF9;JAK1
6,BioPlanet_2019,T cell receptor regulation of apoptosis,61 of 603,1.2649498868661295e-20,1.628171211523404e-18,0,0,4.826497303434572,221.1340310875604,IFITM3;CDKN1A;CXCL9;TNFAIP8;BTG1;CXCL8;PDCD5;BZW1;ETS2;CHCHD2;NAMPT;CASP4;MAP3K8;JUNB;IER2;IER3;EIF5A;DUSP5;SERPINB1;HSP90AA1;HLA-B;SHISA5;TAP1;TNFRSF1A;PPA1;NCL;IRF1;PSME1;S100A6;IRF7;PSME2;LAP3;PTMA;ATF3;BIRC3;CEBPD;MAX;EPAS1;HSP90B1;RELB;STOM;PMAIP1;GBP1;GBP3;MCL1;HSPA8;GADD45B;HSPA5;STAT1;MX1;CFLAR;SOD2;PSMB8;NFKB1;PSMB9;NFKBIA;CXCL10;CXCL11;BCL3;NUCB1;FAS
7,BioPlanet_2019,Interleukin-2 signaling pathway,72 of 847,7.228428523108093e-20,7.511344944930004e-18,0,0,4.035578175286281,177.86278192922626,IFITM3;BTG1;CXCL8;CSF1;YWHAB;CTSZ;IFIT1;LITAF;CTSS;ETS2;ICAM1;ZFP36;MT2A;CTSO;NAMPT;TNFSF10;FLOT1;JAK2;TRIM21;IER3;JAK1;PDIA3;DUSP5;HSP90AA1;WARS;BTN3A1;TAP1;TRAFD1;BTN3A3;BTN3A2;ATP1B1;KARS;TMX1;IRF1;TOP1;IL6ST;VAMP5;IRF9;LY6E;BIRC3;MT1E;SP100;USP15;CREM;TXN;SAMHD1;SLC9A3R1;SOCS3;GNG10;SOCS1;UBC;CTNNA1;PMAIP1;TNFRSF14;NDUFV2;GBP1;ZNF267;S100A11;LYN;APOBEC3G;STAT1;MX1;STAT3;IFI44;CFLAR;NMI;NFKB1;GADD45G;EHD1;BCL6;FAS;CD68
8,BioPlanet_2019,Antigen processing: cross presentation,24 of 79,7.503008269075475e-20,7.511344944930004e-18,0,0,17.711444296830518,779.948206972679,PDIA3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;CALR;B2M
9,BioPlanet_2019,Antigen processing and presentation,24 of 81,1.4538568890649852e-19,1.3099250570475517e-17,0,0,17.088232062410725,741.2003025141818,PDIA3;CD74;HSPA8;HSP90AA1;HSPA5;HLA-B;TAP2;HLA-C;TAP1;HLA-A;IFI30;HLA-F;CTSS;PSMB8;HLA-E;TAPBP;PSMB9;CTSL;PSME1;PSME2;HLA-DRA;CALR;B2M;LGMN
10,BioPlanet_2019,"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",38 of 255,8.141900332406063e-19,6.668956544998057e-17,0,0,7.260690748724047,302.42296745764224,UBA6;UBE2D3;RNF19B;UBE2L6;UBE2Z;CTSS;PSMB10;SOCS3;SOCS1;PSMB2;UBB;PSMB3;UBC;FBXO6;B2M;TRIM21;PDIA3;HSPA5;DTX3L;ERAP2;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;PSMB9;RBX1;TAPBP;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1;CALR
11,BioPlanet_2019,Thymic stromal lymphopoietin (TSLP) pathway,24 of 90,2.2495123355801963e-18,1.6890088452981302e-16,0,0,14.751186183336497,599.4265202888622,CD274;CD40;CXCL9;CXCL8;CD82;CSF1;PDCD5;CXCL3;CXCL2;PSMB10;PSMB8;ICAM1;PSMB9;CXCL10;PSMA4;PSMB2;PSMA2;LAMP3;IRF1;IRF2;BCL3;PSME1;PSME2;IDO1
12,BioPlanet_2019,Adaptive immune system,57 of 606,7.658454824982922e-18,5.307898305622779e-16,0,0,4.4109387635080495,173.83827885545395,CDKN1A;CD40;YWHAB;UBE2D3;RNF19B;UBE2L6;IFI30;UBE2Z;CTSS;ICAM1;CTSO;CTSL;PPP2R5E;MAP3K8;FBXO6;TRIM21;B2M;PDIA3;DTX3L;RIPK2;TAP2;HLA-B;PPP2R5B;TAP1;HLA-C;HLA-A;HLA-F;RBX1;HLA-E;TAPBP;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1;CD274;UBA6;PSMB10;SOCS3;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;LYN;CD74;ERAP2;HSPA5;PSMB8;NFKB1;PSMB9;NFKBIA;HLA-DRA;CALR;LGMN
13,BioPlanet_2019,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",26 of 135,4.987007093230083e-16,3.209495279285932e-14,0,0,9.695305137230012,341.6094764661059,CD40;TNFAIP8;CXCL8;CSF1;IFIT5;TAPBPL;CXCL3;CXCL2;CX3CL1;ICAM1;RND1;RELB;UBD;TNFSF10;PMAIP1;RIPK2;CFLAR;SOD2;NFKB2;NFKBIA;CXCL10;CXCL11;IRF1;OPTN;PTPN2;BIRC3
14,BioPlanet_2019,Proteasome degradation,18 of 63,1.0908995884697547e-14,6.552670194741661e-13,0,0,16.042886597938143,515.765787495599,UBE2D3;HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
15,BioPlanet_2019,Oncostatin M,35 of 311,1.26008648894377e-13,7.0958620408646036e-12,0,0,5.208217205499814,154.69668534817814,CDKN1A;CXCL8;CEBPD;EPAS1;C1R;SECTM1;CXCL3;HIF1A;CXCL2;ETS2;ICAM1;SOCS3;MT2A;SOCS1;NAMPT;CASP4;TIMP1;B2M;JUNB;IER3;IL13RA1;TGM2;LYN;SERPINB1;HSPA5;STAT1;STAT3;SOD2;BTC;OAS1;IRF1;LCN2;IL6ST;ATF3;MT1E
16,BioPlanet_2019,RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways,18 of 76,3.9036280501361764e-13,2.0689228665721728e-11,0,0,12.438748666903662,355.39619303418067,DDX58;UBE2D3;NLRC5;UBE2L6;ISG15;TANK;NFKB1;NFKB2;HERC5;IFIH1;NFKBIA;CYLD;UBB;IRF1;DHX58;IRF2;UBC;IRF7
17,BioPlanet_2019,Apoptosis,30 of 242,6.009409551922697e-13,3.008043336823527e-11,0,0,5.769575970321911,162.35748160991955,YWHAB;ENDOD1;PSMB10;CASP7;PSMB2;UBB;PSMB3;UBC;CASP4;TNFSF10;PMAIP1;MCL1;HIST1H1C;CFLAR;PSMB8;NFKB1;PSMB9;TNFRSF1A;NFKBIA;PSMA3;PSMA4;PSMA2;IRF1;IRF2;PSME1;NMT1;IRF7;PSME2;FAS;BIRC3
18,BioPlanet_2019,Destabilization of mRNA by AUF1 (hnRNP D0),15 of 66,6.841076812428071e-11,3.2441106357882596e-09,0,0,11.720106075216972,274.3148357972075,HSPA8;APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
19,BioPlanet_2019,Endosomal/vacuolar pathway,7 of 9,2.104512087893445e-10,9.480826955959973e-09,0,0,137.56552419354838,3065.202995404981,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
20,BioPlanet_2019,Degradation of beta-catenin by the destruction complex,15 of 73,3.153937125517007e-10,1.3531892143289634e-08,0,0,10.301900791407576,225.37673756990344,PPP2R5B;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
21,BioPlanet_2019,mRNA stability regulation by proteins that bind AU-rich elements,16 of 86,3.8661426223401866e-10,1.5833611376038675e-08,0,0,9.117981812848342,197.61943279623068,HSPA8;YWHAB;PSMB10;PSMB8;PSMB9;ZFP36;PSMA3;PSMA4;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
22,BioPlanet_2019,Interleukin-5 regulation of apoptosis,20 of 144,5.962322161089381e-10,2.3356748987571884e-08,0,0,6.469311427235691,137.41070357093136,DUSP5;CXCL8;MAX;MT1X;SOD2;HIF1A;CXCL2;NFKB1;ICAM1;NFKB2;RELB;SOCS1;CASP4;IRF2;QSOX1;IER2;IER3;IDO1;NFE2L2;BIRC3
23,BioPlanet_2019,Activation of NF-kappaB in B cells,14 of 68,1.2023234360156036e-09,4.5137225660419126e-08,0,0,10.308339013860486,211.7230776302009,PSMB10;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
24,BioPlanet_2019,Cyclin A-Cdk2-associated events at S phase entry,14 of 72,2.659075371104123e-09,9.317735282827615e-08,0,0,9.595444608983852,189.4648113377832,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
25,BioPlanet_2019,Innate immune system,29 of 319,2.688802634334272e-09,9.317735282827615e-08,0,0,4.05210970464135,79.9650212018337,C1R;UBE2D3;NLRC5;UBE2L6;TXN;TANK;CTSS;HSP90B1;HERC5;IFIH1;UBB;CTSL;DHX58;UBC;CASP4;RIPK2;DDX58;ISG15;NFKB1;NFKB2;NFKBIA;CYLD;IRF1;IRF2;IRF7;TXNIP;CFB;LGMN;BIRC3
26,BioPlanet_2019,HIV factor interactions with host,18 of 128,3.534297617281557e-09,1.1794082048780309e-07,0,0,6.541068416119963,127.29410536305024,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M;PPIA
27,BioPlanet_2019,Negative regulators of RIG-I/MDA5 signaling,10 of 33,5.0990094249477925e-09,1.6407883899564145e-07,0,0,17.174353999470853,327.9308858349268,HERC5;IFIH1;CYLD;UBB;DDX58;UBE2D3;UBC;NLRC5;UBE2L6;ISG15
28,BioPlanet_2019,Interleukin-12-mediated signaling events,13 of 65,6.872500031153722e-09,2.135214664851553e-07,0,0,9.92091836734694,186.47098127419304,GADD45B;RIPK2;STAT1;STAT3;HLA-A;NFKB1;RELB;GADD45G;NFKB2;SOCS1;HLA-DRA;JAK2;B2M
29,BioPlanet_2019,Apoptosis regulation,14 of 78,7.935227690524477e-09,2.383213383054185e-07,0,0,8.693187627811861,162.14493391237255,CDKN1A;POMP;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
30,BioPlanet_2019,FSH regulation of apoptosis,25 of 263,1.3963125207399337e-08,4.058314778021549e-07,0,0,4.232226363348687,76.54762603063145,IFITM3;CREM;MT1X;IFI35;CX3CL1;CASP4;PMAIP1;ACP2;TIMP1;GBP1;IER3;PTPN1;STAT1;ITGA3;PPP2R5B;RAB27A;ISG15;CFLAR;RANGAP1;VGF;BCL3;S100A6;ACPP;ANGPTL1;PLA1A
31,BioPlanet_2019,Interferon gamma signaling regulation,7 of 14,1.7981913127174047e-08,5.063032414869942e-07,0,0,39.29435483870968,700.7715715938344,PTPN1;SOCS3;SOCS1;STAT1;JAK2;PTPN2;JAK1
32,BioPlanet_2019,Interleukin-4 regulation of apoptosis,25 of 267,1.889325651004388e-08,5.158431550166526e-07,0,0,4.16140772502507,74.00839246264206,CDKN1A;CEBPB;NNMT;CXCL8;IFI6;CREM;RNF19B;UBE2L6;LITAF;CXCL2;CTSL;TNFSF10;GBP2;IL13RA1;TMOD1;HSPA8;RSAD2;GADD45B;RIPK2;STAT1;DENND4A;MX1;ARID5B;BCL6;FKBP5
33,BioPlanet_2019,Interleukin-6 signaling pathway,13 of 71,2.1193446993765308e-08,5.616263453347807e-07,0,0,8.891871921182267,157.11558719477577,CEBPB;CEBPD;STAT1;STAT3;HSP90B1;SOCS3;IRF1;TIMP1;JAK2;IL6ST;JUNB;JAK1;MCL1
34,BioPlanet_2019,Downstream signaling events Of B cell receptor (BCR),15 of 98,2.2260193283375413e-08,5.730409756663214e-07,0,0,7.189660280466127,126.68516314413806,CDKN1A;NFKB1;PSMB10;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
35,BioPlanet_2019,HIF-1 degradation in normoxia,14 of 88,3.9616702745643707e-08,9.915180326062494e-07,0,0,7.514563643398,128.07833561513814,HSP90AA1;TXN;HIF1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;ID1;PSME1;PSME2
36,BioPlanet_2019,Ubiquitin-mediated degradation of phosphorylated Cdc25A,12 of 64,5.625817221189012e-08,1.3417354465950445e-06,0,0,9.139119536268211,152.56219687899866,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
37,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,16 of 120,5.6588176437970806e-08,1.3417354465950445e-06,0,0,6.126362344021482,102.23346191301728,CXCL8;C1R;HLA-B;CXCL3;SOD2;CXCL2;NFKB1;ICAM1;NFKBIA;MT2A;ZFP36;NAMPT;ID1;ALDH1A1;ACPP;BIRC3
38,BioPlanet_2019,Erythropoietin-mediated neuroprotection through NF-kB,6 of 11,1.0195661933707103e-07,2.35545933391541e-06,0,0,47.06317907444668,757.6568676222387,NFKBIA;CDKN1A;JAK2;SOD2;HIF1A;NFKB1
39,BioPlanet_2019,Antiviral mechanism by interferon-stimulated genes,12 of 70,1.5894001368035228e-07,3.5801238081499344e-06,0,0,8.191165109909404,128.2305517242972,HERC5;UBB;DDX58;STAT1;UBC;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;JAK1
40,BioPlanet_2019,RIG-I-like receptor signaling pathway,12 of 71,1.869565719933281e-07,4.1084846674631365e-06,0,0,8.051917567054437,124.74344302892491,IFIH1;NFKBIA;CXCL10;CYLD;CXCL8;DDX58;DHX58;IRF7;ISG15;TMEM173;TANK;NFKB1
41,BioPlanet_2019,TNF-alpha signaling pathway,14 of 101,2.3440051856599894e-07,5.028449219713453e-06,0,0,6.387419787038996,97.51184874641112,HSP90AA1;STAT1;TXN;CFLAR;TANK;NFKB1;NFKB2;TNFRSF1A;NFKBIA;CYLD;CASP7;MAP3K8;GLUL;BIRC3
42,BioPlanet_2019,Prolactin regulation of apoptosis,15 of 118,2.780439738211884e-07,5.825991172392808e-06,0,0,5.787641254177941,87.36726074658816,HSP90AA1;CEBPB;HSPA5;FNDC3A;RBX1;MYL12B;SOCS3;PSMA4;BCL6;FTH1;IRF1;BCL3;GBP1;IER3;GBP3
43,BioPlanet_2019,DNA replication pre-Initiation,13 of 88,2.967361788372434e-07,6.076347662099007e-06,0,0,6.870367346938775,103.26452312782772,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
44,BioPlanet_2019,TGF-beta regulation of extracellular matrix,36 of 565,3.605688959125913e-07,7.219390560383216e-06,0,0,2.764085604530385,41.006820814650354,CSF1;CEBPD;C1R;INPP1;CREM;PLOD2;IFIT1;SAT1;IFIT3;ETS2;SDCBP;CTSL;CREG1;TNFSF10;STOM;GBP2;JUNB;SKIL;S100A11;ATG3;TNFRSF12A;DENND4A;TAP1;LMO7;BTN3A2;ATP1B1;TNFRSF1A;ELF3;PPA1;RBP1;LCN2;ATF3;CFB;PFKP;IRF9;IDO1
45,BioPlanet_2019,HIV infection,19 of 200,7.743141121691384e-07,1.5166456849225949e-05,0,0,4.189352084379709,58.949580617638176,APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;NMT1;PSME2;B2M;PPIA
46,BioPlanet_2019,S phase,14 of 112,8.529739314519451e-07,1.635169174974899e-05,0,0,5.667250949459539,79.19720723674351,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
47,BioPlanet_2019,APC/C-mediated degradation of cell cycle proteins,12 of 82,9.417028523815653e-07,1.767654729157896e-05,0,0,6.782775676462031,94.11491976590314,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
48,BioPlanet_2019,Protein processing in the endoplasmic reticulum,17 of 166,1.0378813810680095e-06,1.9084308660046465e-05,0,0,4.542160355732317,62.58338000720804,PDIA3;HSPA8;HSP90AA1;HSPA5;UBE2D3;DERL1;EIF2AK2;PDIA6;RBX1;HSP90B1;DNAJA1;LMAN2;FBXO6;CALR;P4HB;SIL1;NFE2L2
49,BioPlanet_2019,Signaling by the B cell receptor (BCR),16 of 151,1.3665326086057576e-06,2.4624917607075752e-05,0,0,4.712023728040156,63.62755886719389,LYN;CDKN1A;NFKB1;PSMB10;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
50,BioPlanet_2019,Autodegradation of Cdh1 by Cdh1-APC/C,10 of 58,1.6359587659524391e-06,2.8901938198493094e-05,0,0,8.218813387423936,109.50156455622717,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
51,BioPlanet_2019,Interferon alpha signaling regulation,7 of 25,1.980388264755593e-06,3.4314035125861343e-05,0,0,15.272513440860216,200.5619704025362,SOCS3;PTPN1;SOCS1;STAT1;STAT2;USP18;JAK1
52,BioPlanet_2019,Interleukin-4 signaling pathway,13 of 104,2.09738077106246e-06,3.565547310806182e-05,0,0,5.6577259475218655,73.97375540898948,CEBPB;STAT1;STAT3;PARP14;NFKB1;NFKBIA;SOCS3;SOCS1;BCL6;HLA-DRA;JAK2;IL13RA1;JAK1
53,BioPlanet_2019,Prolactin activation of MAPK signaling,11 of 75,2.615492330175227e-06,4.329398481465619e-05,0,0,6.788713160569106,87.26251411380383,NFKBIA;SOCS3;PTPN1;SOCS1;STAT1;IRF1;STAT3;JAK2;PPIA;NFKB1;JAK1
54,BioPlanet_2019,Licensing factor removal from origins,10 of 61,2.642807064157703e-06,4.329398481465619e-05,0,0,7.7341606013602195,99.33499816746078,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
55,BioPlanet_2019,Toll receptor cascades,16 of 159,2.7097165765520525e-06,4.359740420488213e-05,0,0,4.446576011257736,56.99917501230773,RIPK2;UBE2D3;EIF2AK2;UBE2L6;UBE2Z;NFKB1;CTSS;HSP90B1;NFKB2;NFKBIA;UBB;CTSL;UBC;IRF7;MAP3K8;LGMN
56,BioPlanet_2019,Toll-like receptor signaling pathway regulation,15 of 142,3.028362915620933e-06,4.697009153563286e-05,0,0,4.6881050729314575,59.5740407212786,CD40;CXCL9;CXCL8;STAT1;TRAFD1;NFKB1;NFKB2;NFKBIA;CXCL10;CYLD;CXCL11;SOCS1;IRF7;MAP3K8;RBCK1
57,BioPlanet_2019,Allograft rejection,8 of 37,3.0757329640425517e-06,4.697009153563286e-05,0,0,10.849460118425636,137.70099329328949,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
58,BioPlanet_2019,Interleukin-23-mediated signaling events,8 of 37,3.0757329640425517e-06,4.697009153563286e-05,0,0,10.849460118425636,137.70099329328949,NFKBIA;SOCS3;CXCL9;ITGA3;STAT1;STAT3;JAK2;NFKB1
59,BioPlanet_2019,Signaling by interleukins,13 of 109,3.576336420321688e-06,5.370465191183068e-05,0,0,5.361670918367347,67.24163519906556,LYN;YWHAB;RIPK2;STAT1;STAT3;NFKB1;RBX1;NFKB2;SOCS3;MAP3K8;IL6ST;JAK2;JAK1
60,BioPlanet_2019,Chemokine signaling pathway,17 of 189,6.163690488412314e-06,9.10407398370409e-05,0,0,3.9301009665996745,47.14877225799976,LYN;CXCL9;CXCL8;STAT1;STAT2;STAT3;CXCL3;CXCL2;NFKB1;CX3CL1;CXCL16;NFKBIA;CXCL10;GNG10;CXCL11;GNG5;JAK2
61,BioPlanet_2019,Adipogenesis,14 of 133,6.715544295075083e-06,9.759202273972016e-05,0,0,4.662095513051846,55.530619079469474,CDKN1A;CEBPB;GADD45B;CEBPD;EPAS1;STAT1;STAT2;STAT3;HIF1A;SOCS3;SOCS1;NAMPT;FAS;IL6ST
62,BioPlanet_2019,Cell cycle checkpoints,13 of 117,7.888805694935925e-06,0.000112517798440652,0,0,4.947193877551021,58.12985360650464,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
63,BioPlanet_2019,Mitotic G1-G1/S phases,14 of 135,7.992385238847645e-06,0.000112517798440652,0,0,4.584562862309656,53.80911203360554,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
64,BioPlanet_2019,Disease,37 of 674,8.201853348591652e-06,0.00011369030564740122,0,0,2.350812890359181,27.530723347375854,CDKN1A;CXCL8;YWHAB;PSMB10;HSP90B1;PSMB2;UBB;PSMB3;UBC;B2M;HSP90AA1;ATP6V1G1;APOBEC3G;HSPA5;STAT1;H3F3A;STAT3;PPP2R5B;EIF2AK2;RAB27A;HLA-A;RANGAP1;PDIA6;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;SPCS1;PSMA2;PSME1;NMT1;PSME2;CALR;PPIA;ATF3;ITM2B
65,BioPlanet_2019,NOD signaling pathway,11 of 85,9.087231932165837e-06,0.0001240544844072942,0,0,5.8682981762250055,68.12296219664069,NFKBIA;CYLD;CASP7;HSP90AA1;CXCL8;RIPK2;CASP4;CXCL2;NFKB1;BIRC3;HSP90B1
66,BioPlanet_2019,Type 1 diabetes mellitus,8 of 43,1.01192491560204e-05,0.00013608124611305049,0,0,8.986782106782107,103.35761988876814,GAD1;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
67,BioPlanet_2019,Interleukin-22 soluble receptor signaling pathway,5 of 13,1.0741736358914124e-05,0.0001405161485800158,0,0,24.459086345381525,279.8455499236589,SOCS3;STAT1;STAT3;JAK2;JAK1
68,BioPlanet_2019,Viral myocarditis,10 of 71,1.0809420351404234e-05,0.0001405161485800158,0,0,6.462940178898015,73.90431908607867,CD40;SGCB;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ACTG1;ICAM1;HLA-E
69,BioPlanet_2019,BDNF signaling pathway,20 of 261,1.0916903885239853e-05,0.0001405161485800158,0,0,3.308505794524196,37.80033429888052,TMOD1;DUSP5;HSPA8;CDKN1A;BTG1;GCH1;HSPA5;INPP1;FNDC3A;SLC39A14;DNAJA1;ZFP36;TXNIP;CALR;TIMP1;JUNB;CLIC1;IER2;ATF3;S100A11
70,BioPlanet_2019,Interleukin-7 interactions in immune response,7 of 34,1.8216859860258245e-05,0.000231174517381587,0,0,10.176971326164876,111.0629472009506,CXCL10;CXCL11;CXCL8;UBC;CXCL3;CXCL2;LITAF
71,BioPlanet_2019,Cellular response to hypoxia,6 of 25,2.8954675037328024e-05,0.0003623355862310077,0,0,12.37615164672244,129.328048098225,UBB;EPAS1;UBE2D3;UBC;HIF1A;RBX1
72,BioPlanet_2019,Apoptosis modulation and signaling,10 of 80,3.1500682132619216e-05,0.0003887960904313687,0,0,5.629382787597797,58.35137492596296,NFKBIA;CASP7;TNFSF10;PMAIP1;FAS;CFLAR;NFKB1;TNFRSF1A;BIRC3;MCL1
73,BioPlanet_2019,p75 neurotrophin receptor signaling via NF-kB,5 of 16,3.424523123816065e-05,0.00041695882899436137,0,0,17.785688207374953,182.87179229070244,NFKBIA;UBB;RIPK2;UBC;NFKB1
74,BioPlanet_2019,Phagosome,14 of 154,3.57455216373462e-05,0.000429422866603319,0,0,3.958486707566462,40.53128410889096,ATP6V1G1;C1R;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;CTSS;ACTG1;HLA-E;CTSL;HLA-DRA;CALR
75,BioPlanet_2019,Interleukin-27-mediated signaling events,6 of 26,3.684568406580794e-05,0.000436815280832802,0,0,11.756740442655936,120.02188344025308,STAT1;STAT2;STAT3;JAK2;IL6ST;JAK1
76,BioPlanet_2019,Autoimmune thyroid disease,8 of 52,4.3071387649482414e-05,0.0005039911723660215,0,0,7.1452708907254365,71.82891914466714,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
77,BioPlanet_2019,Lysosome,12 of 121,5.488271666697113e-05,0.0006339657399607819,0,0,4.347166426876436,42.64705928450234,SCARB2;LAPTM4A;CTSO;CTSL;LAMP3;CTSZ;ACP2;AP3B1;CD68;GNS;CTSS;LGMN
78,BioPlanet_2019,Binding of chemokines to chemokine receptors,8 of 54,5.698837284023058e-05,0.0006499559991018704,0,0,6.8339042599912165,66.78544533133815,CXCL10;CXCL9;CXCL11;CXCL8;CXCL3;CXCL2;CX3CL1;CXCL16
79,BioPlanet_2019,Graft-versus-host disease,7 of 41,6.53895817573414e-05,0.0007364501645420575,0,0,8.078806925996204,77.84049726516157,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
80,BioPlanet_2019,Interferon-alpha signaling pathway,4 of 10,7.359522847835279e-05,0.0008100240971391435,0,0,26.04008016032064,247.8216295792741,STAT1;STAT2;IRF9;JAK1
81,BioPlanet_2019,DNA replication,16 of 207,7.37202840903549e-05,0.0008100240971391435,0,0,3.320855327520776,31.598710777764232,CDKN1A;PPP2R5B;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
82,BioPlanet_2019,Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),7 of 42,7.678351364800606e-05,0.0008335174192391984,0,0,7.84758064516129,74.3520645368611,PTPN1;CSF1;STAT1;STAT3;EIF2AK2;PTPN2;JAK1
83,BioPlanet_2019,TRAF6-mediated IRF7 activation,6 of 30,8.725429920092894e-05,0.0009248955715298468,0,0,9.795271629778671,91.55330591016065,IFIH1;DDX58;IRF1;IRF2;IRF7;TANK
84,BioPlanet_2019,Tumor necrosis factor (TNF) pathway,6 of 30,8.725429920092894e-05,0.0009248955715298468,0,0,9.795271629778671,91.55330591016065,NFKBIA;CFLAR;NFKB1;NFKB2;TNFRSF1A;BIRC3
85,BioPlanet_2019,Growth hormone receptor signaling,7 of 43,8.974609231876593e-05,0.0009402468509210244,0,0,7.629200268817204,71.09290160713154,LYN;SOCS3;PTPN1;SOCS1;STAT1;STAT3;JAK2
86,BioPlanet_2019,HIV-1 Nef as negative effector of Fas and TNF,8 of 58,9.615339744807304e-05,0.000995795529893262,0,0,6.28589898989899,58.14183601549208,NFKBIA;CASP7;FAS;CFLAR;NFKB1;ACTG1;TNFRSF1A;BIRC3
87,BioPlanet_2019,EGFR1 pathway,13 of 152,0.00012586504433653573,0.0012886864198547,0,0,3.694817207458523,33.18056808293821,CDKN1A;BTG1;CSF1;ITGA3;PDCD5;ARID5B;MT1X;EHD1;BCL6;MT1F;LCN2;TXNIP;IER3
88,BioPlanet_2019,Toll-like receptor endosomal trafficking and processing,4 of 12,0.000166654364536479,0.0016871413758131,0,0,19.528056112224448,169.88605362550462,CTSL;CTSS;HSP90B1;LGMN
89,BioPlanet_2019,Induction of apoptosis through DR3 and DR4/5 death receptors,6 of 34,0.00018149500308151976,0.0018042815851615,0,0,8.394222477723483,72.31020325263566,NFKBIA;CASP7;TNFSF10;CFLAR;NFKB1;BIRC3
90,BioPlanet_2019,TRAF6 mediated NF-kB activation,5 of 22,0.00018223043756903143,0.0018042815851615,0,0,11.504842901015827,99.05944164262915,IFIH1;NFKBIA;DDX58;NFKB1;NFKB2
91,BioPlanet_2019,p53 signaling pathway,12 of 139,0.00020801046706126416,0.0020371459871978,0,0,3.7275686771332808,31.6020370800516,DUSP5;CDKN1A;CD82;BCL6;TAP1;PMAIP1;RPS27L;FAS;ATF3;CX3CL1;PML;MCL1
92,BioPlanet_2019,CTL mediated immune response against target cells,4 of 13,0.00023594938492472531,0.0022615999555018,0,0,17.357381429525716,144.966996739894,FAS;HLA-A;B2M;ICAM1
93,BioPlanet_2019,Death receptor signaling,4 of 13,0.00023594938492472531,0.0022615999555018,0,0,17.357381429525716,144.966996739894,TNFSF10;FAS;CFLAR;TNFRSF1A
94,BioPlanet_2019,Notch signaling pathway,11 of 121,0.0002417452201894772,0.0022927625620075,0,0,3.9404471544715447,32.81457094569781,PSENEN;CDKN1A;DTX3L;STAT3;RBBP8;CIR1;CFLAR;JAK2;HIF1A;NFKB1;BIRC3
95,BioPlanet_2019,Proteasome complex,5 of 24,0.0002821672035463337,0.0026482567749504,0,0,10.292749947157048,84.12275588650826,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3
96,BioPlanet_2019,Alternative NF-kappaB pathway,3 of 6,0.00029885918891945143,0.0027760013321281,0,0,38.988,316.40859693078033,NFKB1;NFKB2;RELB
97,BioPlanet_2019,Interleukin-2 receptor beta chain in T cell activation,7 of 52,0.00030664260072168527,0.002790757406568,0,0,6.100537634408602,49.35229806872238,SOCS3;SOCS1;FAS;CFLAR;NMI;PPIA;JAK1
98,BioPlanet_2019,Signaling events mediated by PTP1B,7 of 52,0.00030664260072168527,0.002790757406568,0,0,6.100537634408602,49.35229806872238,LYN;SOCS3;PTPN1;CSF1;STAT3;TXN;JAK2
99,BioPlanet_2019,Cytokine-cytokine receptor interaction,17 of 265,0.0004173990195882351,0.0037607651664899,0,0,2.714995685649808,21.12665180958619,CD40;CXCL9;CXCL8;TNFRSF12A;CSF1;CXCL3;CXCL2;CX3CL1;CXCL16;TNFRSF1A;CXCL10;CXCL11;TNFSF10;FAS;TNFRSF14;IL6ST;IL13RA1
100,BioPlanet_2019,Leptin influence on immune response,10 of 110,0.0004591274042929686,0.004095780111564,0,0,3.93448275862069,30.241153773695963,SOCS3;IRF2;TNFSF10;TIMP1;NFKB1;CTSS;CX3CL1;ANGPTL1;CXCL16;IFIT2
101,BioPlanet_2019,Cytosolic DNA-sensing pathway,7 of 56,0.00048758381286495865,0.0043069903469738,0,0,5.601382488479263,42.71641373147482,NFKBIA;CXCL10;DDX58;IRF7;ADAR;TMEM173;NFKB1
102,BioPlanet_2019,Oxidative stress,5 of 27,0.000503631205422561,0.004405550641609,0,0,8.887824023366193,67.49116970448063,MT1X;SOD2;JUNB;NFKB1;NFE2L2
103,BioPlanet_2019,TWEAK signaling pathway,6 of 42,0.0005973261671969927,0.0051749122754277,0,0,6.5261569416499,48.44397133910578,NFKBIA;CASP7;TNFRSF12A;NFKB1;RELB;NFKB2
104,BioPlanet_2019,Pathways in cancer,19 of 325,0.000619276634200628,0.005313983308712,0,0,2.4619794198671205,18.186539753426214,CDKN1A;HSP90AA1;CXCL8;EPAS1;STAT1;MAX;ITGA3;STAT3;HIF1A;NFKB1;PML;RBX1;HSP90B1;NFKB2;NFKBIA;CTNNA1;FAS;JAK1;BIRC3
105,BioPlanet_2019,Fas signaling pathway,10 of 115,0.0006529281992424316,0.0055498896935606,0,0,3.746160533178789,27.474503896057797,CASP7;CXCL8;RIPK2;FAS;CD47;CFLAR;NFKB1;ACTG1;NFKB2;BIRC3
106,BioPlanet_2019,Caspase cascade in apoptosis,7 of 59,0.0006723048316929723,0.0056611836762183,0,0,5.277411600496278,38.55042940766391,CASP7;CASP4;TNFSF10;FAS;TOP1;TNFRSF1A;BIRC3
107,BioPlanet_2019,Gastrin pathway,6 of 44,0.0007704583671966052,0.0064276202670753,0,0,6.182039606057397,44.31610508467274,CHGA;CXCL8;S100A6;NFKB1;IER3;BIRC3
108,BioPlanet_2019,Bystander B cell activation,3 of 8,0.0008058544900832821,0.0066612375739911,0,0,23.3904,166.62402571383245,CD40;FAS;HLA-DRA
109,BioPlanet_2019,Leptin signaling pathway,7 of 61,0.000823505877497808,0.0067452617784138,0,0,5.081429211469534,36.088004719389865,SOCS3;PTPN1;STAT1;STAT3;JAK2;NFKB1;JAK1
110,BioPlanet_2019,Senescence and autophagy,9 of 99,0.0008747904280617237,0.00710077635751,0,0,3.928542510121457,27.66293505636442,ATG3;GABARAPL1;CDKN1A;CEBPB;CXCL8;IRF1;CREG1;IRF7;IL6ST
111,BioPlanet_2019,Shigellosis,7 of 62,0.0009085437461386584,0.0071594213438333,0,0,4.9887829912023465,34.93977739600071,NFKBIA;CXCL8;RIPK2;ARPC5;PFN1;NFKB1;ACTG1
112,BioPlanet_2019,Bone remodeling,4 of 18,0.0009137996165825072,0.0071594213438333,0,0,11.1554537646722,78.06474151559458,NFKBIA;EIF2AK2;NFKB1;IRF9
113,BioPlanet_2019,Corticosteroids and cardioprotection,4 of 18,0.0009137996165825072,0.0071594213438333,0,0,11.1554537646722,78.06474151559458,HSP90AA1;CALM3;CALM2;NFKB1
114,BioPlanet_2019,Transcriptional activity regulation by PML,4 of 18,0.0009137996165825072,0.0071594213438333,0,0,11.1554537646722,78.06474151559458,SP100;FAS;PML;TNFRSF1A
115,BioPlanet_2019,Regular glucocorticoid receptor pathway,8 of 82,0.0010575848118598,0.0082145165128077,0,0,4.241987441987442,29.065111477976654,CDKN1A;HSP90AA1;CXCL8;STAT1;IRF1;NFKB1;ICAM1;FKBP5
116,BioPlanet_2019,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",6 of 47,0.0010998819396652,0.0083982510816812,0,0,5.728811895764833,39.0278314159129,CYLD;RIPK2;CASP4;TXNIP;TXN;BIRC3
117,BioPlanet_2019,Regulation of NFAT transcription factors,6 of 47,0.0010998819396652,0.0083982510816812,0,0,5.728811895764833,39.0278314159129,PTPN1;BATF3;CXCL8;CALM3;JUNB;GBP3
118,BioPlanet_2019,Apoptosis modulation by HSP70,4 of 19,0.0011346425319512,0.008590864884774,0,0,10.41122244488978,70.60305563582463,CASP7;FAS;NFKB1;TNFRSF1A
119,BioPlanet_2019,Response to elevated platelet cytosolic calcium,8 of 83,0.0011451684255169,0.00859830626159,0,0,4.185212121212121,28.343108411026183,HSPA5;TMSB4X;CFL1;SERPING1;SCG3;TIMP1;PFN1;PPIA
120,BioPlanet_2019,"cAMP receptor, G-protein-independent pathways inferred from amoeba model",3 of 9,0.0011862577484359,0.0088332085234777,0,0,19.491,131.30992512056272,STAT1;STAT2;STAT3
121,BioPlanet_2019,Cell cycle,23 of 453,0.0012153231753956,0.0089425786711228,0,0,2.124714147286822,14.262664798911208,CDKN1A;HSP90AA1;GADD45B;MAX;YWHAB;PPP2R5B;RANGAP1;PSMB8;REC8;PSMB10;PSMB9;RBX1;GADD45G;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
122,BioPlanet_2019,ATM pathway,6 of 48,0.0012307211489669,0.0089425786711228,0,0,5.592124173613107,37.4680986386165,NFKBIA;CDKN1A;YWHAB;RBBP8;NBN;NFKB1
123,BioPlanet_2019,Diurnally regulated genes with circadian orthologs,6 of 48,0.0012307211489669,0.0089425786711228,0,0,5.592124173613107,37.4680986386165,DNAJA1;HSPA8;CEBPB;BTG1;PSMA4;ETV6
124,BioPlanet_2019,Interleukin-1 signaling pathway,10 of 125,0.0012442324032087,0.0089684271623289,0,0,3.418643619366787,22.868115620407732,NFKBIA;ZFP36;CXCL8;RIPK2;UBE2D3;UBE2L6;MAP3K8;UBE2Z;NFKB1;RBX1
125,BioPlanet_2019,Amino acid metabolism,13 of 195,0.001366103180642,0.0097416982315431,0,0,2.815597667638484,18.571099347070287,MAT2B;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;GLUL;IDO1
126,BioPlanet_2019,Interleukin-5 signaling pathway,6 of 49,0.0013731361547236,0.0097416982315431,0,0,5.461794019933555,35.99681640406105,LYN;STAT1;STAT3;HLA-DRA;JAK2;JAK1
127,BioPlanet_2019,Telomerase regulation,7 of 67,0.0014428196319408,0.0101560975654585,0,0,4.571875,29.90534759752588,HSP90AA1;ZNFX1;MAX;IRF1;NCL;NBN;NFKB1
128,BioPlanet_2019,PDGFB signaling pathway,10 of 129,0.0015786665696818,0.0110261905370798,0,0,3.303049414491963,21.30854891967703,LYN;SLC9A3R1;PTPN1;YWHAB;STAT1;STAT3;EIF2AK2;ARPC5;JAK2;PTPN2
129,BioPlanet_2019,Jak-STAT signaling pathway,13 of 199,0.0016391011392194,0.0113602317418208,0,0,2.754476629361422,17.666131344046935,PTPN1;CXCL8;STAT1;STAT2;STAT3;SOCS3;SOCS1;JAK2;IL6ST;IRF9;PTPN2;JAK1;IL13RA1
130,BioPlanet_2019,Type I interferon (interferon-alpha/beta) pathway,6 of 51,0.0016953341621847,0.0116602754208276,0,0,5.21851106639839,33.2934504384537,PTPN1;STAT1;STAT2;IRF9;PTPN2;JAK1
131,BioPlanet_2019,Hemostasis pathway,23 of 468,0.0018521994520596,0.0125388260763489,0,0,2.051479400749064,12.906639453207957,LYN;PTPN1;HSPA5;ITGA3;H3F3A;PPP2R5B;ATP1B1;EHD1;GNG10;GNG5;PPP2R5E;TMSB4X;IRF1;CFL1;IRF2;IRF7;SERPING1;SCG3;TIMP1;CD47;JAK2;PFN1;PPIA
132,BioPlanet_2019,AP-1 transcription factor network,7 of 70,0.0018648198604114,0.0125388260763489,0,0,4.353494623655914,27.3599323473704,MT2A;CXCL8;TIMP1;HLA-A;JUNB;HIF1A;ATF3
133,BioPlanet_2019,MicroRNA regulation of DNA damage response,7 of 70,0.0018648198604114,0.0125388260763489,0,0,4.353494623655914,27.3599323473704,CDKN1A;GADD45B;PMAIP1;FAS;NBN;PML;GADD45G
134,BioPlanet_2019,Membrane trafficking,10 of 133,0.0019825560671796,0.013231726048362,0,0,3.19497353188542,19.883497073734823,GJD2;VAMP8;HSPA8;UBB;FTH1;UBC;CTSZ;AP3B1;GNS;CHMP5
135,BioPlanet_2019,Epstein-Barr virus LMP1 signaling,4 of 22,0.0020173091677359,0.0133646732362504,0,0,8.674682698730795,53.83500059424647,HSP90AA1;CXCL8;NFKB1;NFKB2
136,BioPlanet_2019,Costimulation by the CD28 family,7 of 72,0.0021953707580331,0.0144381682699843,0,0,4.219106699751861,25.826858047819243,LYN;CD274;PPP2R5E;PPP2R5B;HLA-DRA;MAP3K8;TNFRSF14
137,BioPlanet_2019,B lymphocyte cell surface molecules,3 of 11,0.0022442799782903,0.0146528714524612,0,0,14.61675,89.15297421769729,CD40;HLA-DRA;ICAM1
138,BioPlanet_2019,Kit receptor signaling pathway,6 of 54,0.0022822698984374,0.0146880369892294,0,0,4.891599597585513,29.75356917298481,LYN;SOCS1;STAT1;STAT3;JAK2;JUNB
139,BioPlanet_2019,RANKL signaling pathway,6 of 54,0.0022822698984374,0.0146880369892294,0,0,4.891599597585513,29.75356917298481,LYN;NFKBIA;NFKB1;ICAM1;RELB;NFKB2
140,BioPlanet_2019,Signaling by ERBB4,8 of 93,0.0023788843639248,0.0150838337238739,0,0,3.690932857991682,22.29738180057488,PSENEN;BTC;CDKN1A;UBB;YWHAB;UBC;JAK2;RBX1
141,BioPlanet_2019,Downregulation of SMAD2/3-SMAD4 transcriptional activity,4 of 23,0.0023939935876958,0.0150838337238739,0,0,8.217698555004747,49.59210437713905,UBB;UBE2D3;UBC;SKIL
142,BioPlanet_2019,Modulation of interferon signaling by chaperones,4 of 23,0.0023939935876958,0.0150838337238739,0,0,8.217698555004747,49.59210437713905,NFKBIA;JAK2;NFKB1;TNFRSF1A
143,BioPlanet_2019,CXCR4 signaling pathway,9 of 116,0.0026515527990504,0.0165906185551695,0,0,3.301487002913466,19.58643430879601,LYN;ITGA3;STAT1;STAT2;CFL1;STAT3;HLA-DRA;JAK2;NFKB1
144,BioPlanet_2019,G13 signaling pathway,5 of 39,0.0028043993923999,0.0172621826071339,0,0,5.747401370186629,33.77498280961888,CFL1;CALM3;PAK3;PFN1;CALM2
145,BioPlanet_2019,Lysosome vesicle biogenesis,4 of 24,0.002816360536347,0.0172621826071339,0,0,7.806412825651303,45.84167467559578,VAMP8;HSPA8;CTSZ;GNS
146,BioPlanet_2019,TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex,4 of 24,0.002816360536347,0.0172621826071339,0,0,7.806412825651303,45.84167467559578,NFKBIA;RIPK2;NFKB1;NFKB2
147,BioPlanet_2019,Activation of chaperones by ATF6 alpha,3 of 12,0.0029368250987252,0.0177589222412851,0,0,12.992,75.7488969245148,HSPA5;CALR;HSP90B1
148,BioPlanet_2019,Assembly of HIV virion,3 of 12,0.0029368250987252,0.0177589222412851,0,0,12.992,75.7488969245148,UBB;UBC;NMT1
149,BioPlanet_2019,Keratinocyte differentiation,6 of 57,0.0030104759322766,0.0180829254332084,0,0,4.603148301574151,26.72430059952477,NFKBIA;FAS;ETS2;NFKB1;TNFRSF1A;BIRC3
150,BioPlanet_2019,Signaling by SCF-KIT,7 of 78,0.003462624328716,0.0206308322667747,0,0,3.8613698318945935,21.877473109091923,LYN;CDKN1A;SOCS1;YWHAB;STAT1;STAT3;JAK2
151,BioPlanet_2019,Bioactive peptide-induced signaling pathway,5 of 41,0.00350334887549,0.0206308322667747,0,0,5.427543507362785,30.687526091171424,STAT1;STAT3;CALM3;JAK2;CALM2
152,BioPlanet_2019,Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer,5 of 41,0.00350334887549,0.0206308322667747,0,0,5.427543507362785,30.687526091171424,UBB;UBE2D3;UBC;JUNB;SKIL
153,BioPlanet_2019,Unfolded protein response,7 of 79,0.0037189190227218,0.0215813547474152,0,0,3.807543682795699,21.300626297638985,CXCL8;HSPA5;PPP2R5B;CALR;PDIA6;ATF3;HSP90B1
154,BioPlanet_2019,Alzheimer's disease,11 of 169,0.0037399131295513,0.0215813547474152,0,0,2.736557064937738,15.29377702617652,PSENEN;NDUFA9;COX7B;CASP7;NDUFB4;NDUFB1;FAS;CALM3;NDUFV2;CALM2;TNFRSF1A
155,BioPlanet_2019,Double stranded RNA-induced gene expression,3 of 13,0.0037470913195406,0.0215813547474152,0,0,11.6922,65.3216951926604,NFKBIA;EIF2AK2;NFKB1
156,BioPlanet_2019,Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP,4 of 26,0.0038084743671909,0.0215813547474152,0,0,7.096010202222627,39.52851357538448,NFKBIA;CALM3;CALM2;NFKB1
157,BioPlanet_2019,Interleukin-9 regulation of target genes,4 of 26,0.0038084743671909,0.0215813547474152,0,0,7.096010202222627,39.52851357538448,SOCS3;BCL3;LCN2;JUNB
158,BioPlanet_2019,Physiological and pathological hypertrophy  of the heart,4 of 26,0.0038084743671909,0.0215813547474152,0,0,7.096010202222627,39.52851357538448,STAT3;CALM3;IL6ST;CALM2
159,BioPlanet_2019,Clathrin derived vesicle budding,6 of 61,0.0042351352808204,0.0238491055501202,0,0,4.2674958843972925,23.31904849451209,VAMP8;HSPA8;FTH1;CTSZ;AP3B1;GNS
160,BioPlanet_2019,TNF/stress-related signaling,4 of 27,0.004383231678782,0.0242287836968257,0,0,6.787139496384072,36.853957067080295,NFKBIA;TANK;NFKB1;TNFRSF1A
161,BioPlanet_2019,TWEAK regulation of gene expression,4 of 27,0.004383231678782,0.0242287836968257,0,0,6.787139496384072,36.853957067080295,CXCL10;CXCL8;TNFRSF12A;ICAM1
162,BioPlanet_2019,VEGFR1 pathway,4 of 27,0.004383231678782,0.0242287836968257,0,0,6.787139496384072,36.853957067080295,HSP90AA1;CALM3;HIF1A;CD2AP
163,BioPlanet_2019,SMAD2/3 nuclear pathway,7 of 82,0.0045747201572782,0.025072682769436,0,0,3.654677419354839,19.68851382641021,HSPA8;CDKN1A;CEBPB;MAX;IRF7;SKIL;ATF3
164,BioPlanet_2019,Circadian rhythm,6 of 62,0.0045915567779766,0.025072682769436,0,0,4.191075021557919,22.56280386537756,HELZ2;UBB;NAMPT;UBC;HIF1A;RBX1
165,BioPlanet_2019,TRAF3-dependent IRF activation pathway,3 of 14,0.0046807243157534,0.0254056181234569,0,0,10.628727272727271,57.01570735306985,IFIH1;DDX58;IRF7
166,BioPlanet_2019,Interleukin-3 signaling pathway,5 of 45,0.005262233299125,0.0283908515120461,0,0,4.883785140562249,25.626196221156864,LYN;CXCL8;STAT3;JAK2;JAK1
167,BioPlanet_2019,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,3 of 15,0.0057427136653465,0.0307987203123646,0,0,9.7425,50.26957963399144,UBB;UBC;IRF7
168,BioPlanet_2019,"Platelet activation, signaling and aggregation",12 of 205,0.0058797387424334,0.0313470095084765,0,0,2.4444983801694757,12.555537570497236,LYN;PTPN1;GNG10;HSPA5;GNG5;TMSB4X;CFL1;SERPING1;SCG3;TIMP1;PFN1;PPIA
169,BioPlanet_2019,Myometrial relaxation and contraction pathways,10 of 155,0.0059288319704191,0.0314228094432213,0,0,2.707141358326922,13.88202612007668,GNG5;CALD1;YWHAB;GSTO1;CALM3;CALM2;ETS2;ATF3;NFKB1;ACTG1
170,BioPlanet_2019,APOBEC3G-mediated resistance to HIV-1 infection,2 of 5,0.0060024672366929,0.0316270349722827,0,0,25.940119760479043,132.69887945576022,APOBEC3G;PPIA
171,BioPlanet_2019,MAPK signaling pathway,16 of 314,0.0062016575382062,0.0324865897786271,0,0,2.1166710306905725,10.758909050053424,DUSP5;HSPA8;GADD45B;H3F3B;HSPA5;STAT1;MAX;H3F3A;NFKB1;GADD45G;RELB;NFKB2;TNFRSF1A;CASP7;FAS;MAP3K8
172,BioPlanet_2019,Signaling by TGF-beta receptor complex,6 of 66,0.0062407633024571,0.032502472459618,0,0,3.910865191146881,19.85410464472394,USP15;UBB;UBE2D3;UBC;JUNB;SKIL
173,BioPlanet_2019,Apoptosis intrinsic pathway,4 of 30,0.0064508506030574,0.0332126651048841,0,0,6.003083089255434,30.27680937665548,CASP7;YWHAB;NMT1;PMAIP1
174,BioPlanet_2019,Interferon-beta enhancer pathway,4 of 30,0.0064508506030574,0.0332126651048841,0,0,6.003083089255434,30.27680937665548,IRF1;IRF2;IRF7;NFKB1
175,BioPlanet_2019,Cell adhesion molecules (CAMs),9 of 133,0.0065264704932558,0.0334110790592245,0,0,2.846366070262505,14.322598085376178,CD274;CD40;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
176,BioPlanet_2019,Adipocytokine signaling pathway,6 of 67,0.0067126933246528,0.033970782852439,0,0,3.84655473826566,19.24721757695009,NFKBIA;SOCS3;STAT3;JAK2;NFKB1;TNFRSF1A
177,BioPlanet_2019,HES/HEY pathway,5 of 48,0.0069365047280782,0.033970782852439,0,0,4.542355468385169,22.57985495130606,STAT3;ID1;RBBP8;JAK2;HIF1A
178,BioPlanet_2019,Acetylation and deacetylation of RelA in the nucleus,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,NFKBIA;NFKB1;TNFRSF1A
179,BioPlanet_2019,CD40L signaling pathway,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,NFKBIA;CD40;NFKB1
180,BioPlanet_2019,Cell death signaling by NRIF in the nucleus,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,PSENEN;UBB;UBC
181,BioPlanet_2019,Hypoxia-inducible factor in the cardivascular system,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,HSP90AA1;P4HB;HIF1A
182,BioPlanet_2019,Interleukin-10 anti-inflammatory signaling pathway,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,STAT1;STAT3;JAK1
183,BioPlanet_2019,Interleukin-9 signaling pathway,3 of 16,0.0069374295725291,0.033970782852439,0,0,8.992615384615384,44.70070794198986,STAT1;STAT3;JAK1
184,BioPlanet_2019,CD40/CD40L signaling,4 of 31,0.0072619651368549,0.035367732909764,0,0,5.780449788465821,28.46932103843721,NFKBIA;CD40;NFKB1;BIRC3
185,BioPlanet_2019,Antigen-activated B-cell receptor generation of second messengers,12 of 211,0.0073413525719292,0.0355621433726248,0,0,2.370058029454809,11.647015434982876,LYN;NFKBIA;CD40;CD72;BCL6;MAX;FAS;HLA-DRA;CALM3;CALM2;NFKB1;NFKB2
186,BioPlanet_2019,Ubiquitin-mediated proteolysis,9 of 136,0.0075192859852136,0.0362292870196657,0,0,2.778698715292168,13.58862613025372,SOCS3;SOCS1;UBA6;UBE2D3;UBE2L6;UBE2Z;PML;RBX1;BIRC3
187,BioPlanet_2019,Ceramide signaling pathway,5 of 49,0.0075687073013844,0.036273432332699,0,0,4.438891931361811,21.67836297362191,NFKBIA;EIF2AK2;NFKB1;TNFRSF1A;BIRC3
188,BioPlanet_2019,Diabetes pathways,9 of 137,0.007874599742599,0.0375397585612789,0,0,2.756847798582996,13.354482044824076,CXCL8;SPCS1;HSPA5;PPP2R5B;RAB27A;CALR;PDIA6;ATF3;HSP90B1
189,BioPlanet_2019,Atypical NF-kappaB pathway,3 of 17,0.0082686579796667,0.039075548705737,0,0,8.349857142857143,40.03992850096259,NFKBIA;BCL3;NFKB1
190,BioPlanet_2019,Signaling events mediated by HDAC class I,6 of 70,0.0082834958965546,0.039075548705737,0,0,3.6656815895372232,17.571408738969488,NFKBIA;MAX;STAT3;RANGAP1;NFKB1;TNFRSF1A
191,BioPlanet_2019,NF-kappaB activation,2 of 6,0.0088542834833845,0.0415505698881744,0,0,19.454091816367267,91.9566503107693,NFKBIA;NFKB1
192,BioPlanet_2019,Leishmaniasis,6 of 72,0.0094672023705767,0.0441966286833662,0,0,3.55423449789647,16.562454945743188,NFKBIA;STAT1;HLA-DRA;JAK2;NFKB1;JAK1
193,BioPlanet_2019,Signaling events mediated by stem cell factor receptor (c-Kit),5 of 52,0.0097039352640447,0.0450021044072757,0,0,4.154917542510467,19.25897259042515,LYN;SOCS1;STAT1;STAT3;JAK2
194,BioPlanet_2019,TNFR2 signaling pathway,3 of 18,0.0097396341391995,0.0450021044072757,0,0,7.7928,36.09275628058279,NFKBIA;TANK;NFKB1
195,BioPlanet_2019,EPO receptor signaling,4 of 34,0.0100898761902971,0.0463825430992742,0,0,5.201603206412826,23.90772681291413,SOCS1;STAT1;STAT3;JAK2
196,BioPlanet_2019,Immunoregulatory interactions between a lymphoid and a non-lymphoid cell,8 of 119,0.0104457451088753,0.0477747022492216,0,0,2.8226044226044227,12.875480982692812,CD40;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
197,BioPlanet_2019,RANKL regulation of apoptosis and immune response,6 of 74,0.0107668285331296,0.0487100966282713,0,0,3.4493431175287017,15.62995777517923,ITGA3;HLA-C;TXNIP;TXN;ICAM1;RELB
198,BioPlanet_2019,Cytokines and inflammatory response,4 of 35,0.0111702737589904,0.0487100966282713,0,0,5.033550972913569,22.62329060843702,CXCL8;CSF1;HLA-DRA;CXCL2
199,BioPlanet_2019,Interleukin-2/PI3K pathway,4 of 35,0.0111702737589904,0.0487100966282713,0,0,5.033550972913569,22.62329060843702,HSP90AA1;CALM3;NFKB1;JAK1
200,BioPlanet_2019,Interleukin-7 signaling pathway,4 of 35,0.0111702737589904,0.0487100966282713,0,0,5.033550972913569,22.62329060843702,STAT1;STAT3;NMI;JAK1
201,BioPlanet_2019,fMLP induced chemokine gene expression in HMC-1 cells,4 of 35,0.0111702737589904,0.0487100966282713,0,0,5.033550972913569,22.62329060843702,NFKBIA;CALM3;CALM2;NFKB1
202,BioPlanet_2019,TSH regulation of gene expression,7 of 97,0.0112356486376237,0.0487100966282713,0,0,3.0432123655913976,13.659956698353556,VMP1;CXCL8;CSF1;GADD45B;ID1;CALM2;ICAM1
203,BioPlanet_2019,Calcineurin in effects in keratinocyte differentiation,3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,CDKN1A;CALM3;CALM2
204,BioPlanet_2019,Destabilization of mRNA by butyrate response factor 1 (BRF1),3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,ZFP36;XRN1;YWHAB
205,BioPlanet_2019,"GABA biosynthesis, release, reuptake and degradation",3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,HSPA8;GAD1;STXBP1
206,BioPlanet_2019,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,HSP90AA1;HIF1A;RBX1
207,BioPlanet_2019,STAT3 pathway,3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,STAT3;JAK2;JAK1
208,BioPlanet_2019,Signaling by constitutively active EGFR,3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,HSP90AA1;UBB;UBC
209,BioPlanet_2019,TP53 network,3 of 19,0.0113530746858345,0.0487100966282713,0,0,7.305375,32.71541740584069,CDKN1A;TNFSF10;PMAIP1
901,Panther_2016,Apoptosis signaling pathway Homo sapiens P00006,15 of 102,3.8755772423761484e-08,2.325346345425689e-06,0,0,6.857687959299039,117.03320757303624,HSPA8;HSPA5;EIF2AK2;CFLAR;NFKB1;NFKB2;TNFRSF1A;RELB;NFKBIA;CASP7;TNFSF10;FAS;ATF3;MCL1;BIRC3
902,Panther_2016,Parkinson disease Homo sapiens P00049,11 of 81,5.652493767181765e-06,0.00016957481301545295,0,0,6.204907084785134,74.97645949554985,LYN;HSPA8;PSMA3;PSMA4;HSPA5;YWHAB;PSMA2;PSMB3;UBE2L6;NDUFV2;PSMB10
903,Panther_2016,JAK/STAT signaling pathway Homo sapiens P00038,5 of 14,1.636422157467663e-05,0.0003272844314935326,0,0,21.74029451137885,239.58702898804245,SOCS1;STAT1;STAT3;JAK2;JAK1
904,Panther_2016,Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,13 of 188,0.0009793145969459035,0.0117705528833389,0,0,2.9292827988338197,20.29599759072062,CXCL8;STAT3;ARPC5;CX3CL1;ACTG1;NFKB2;RELB;CXCL10;GNG10;GNG5;JAK2;PAK3;JUNB
905,Panther_2016,CCKR signaling map ST Homo sapiens P06959,12 of 165,0.000980879406944912,0.0117705528833389,0,0,3.0899724451898885,21.40442772323454,LYN;NFKBIA;CHGA;CXCL8;YWHAB;STAT3;CREM;JAK2;CXCL2;IER3;MCL1;BIRC3
906,Panther_2016,p53 pathway Homo sapiens P00059,7 of 71,0.0020248834477523,0.0202488344775236,0,0,4.285250756048387,26.57816709093493,CDKN1A;CD82;GADD45B;PMAIP1;FAS;PML;GADD45G
907,Panther_2016,Interferon-gamma signaling pathway Homo sapiens P00035,4 of 28,0.0050136794814551,0.0429743955553296,0,0,6.504008016032064,34.44252862946379,SOCS3;STAT1;JAK2;JAK1
908,Panther_2016,Interleukin signaling pathway Homo sapiens P00036,7 of 86,0.0059370533389412,0.044527900042059,0,0,3.4689158840342995,17.78354415193222,CDKN1A;CXCL8;STAT1;STAT2;STAT3;IL6ST;IL13RA1
909,Panther_2016,FAS signaling pathway Homo sapiens P00020,4 of 31,0.0072619651368549,0.0484131009123666,0,0,5.780449788465821,28.46932103843721,CASP7;PARP3;FAS;CFLAR
961,KEGG_2019_Human,Epstein-Barr virus infection,36 of 201,1.3081872437680916e-20,3.2181406196695053e-18,0,0,9.031886314969826,413.50738823363343,CD40;CDKN1A;ICAM1;RELB;CIR1;B2M;JAK1;LYN;PDIA3;GADD45B;STAT1;DDX58;STAT2;STAT3;HLA-B;TAP2;HLA-C;EIF2AK2;TAP1;ISG15;HLA-A;HLA-F;NFKB1;HLA-E;GADD45G;NFKB2;TAPBP;NFKBIA;CXCL10;OAS1;OAS3;IRF7;FAS;HLA-DRA;CALR;IRF9
962,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,33 of 186,7.371246214352929e-19,9.066632843654104e-17,0,0,8.877096370463079,370.63235526559015,CDKN1A;CXCL8;CXCL3;HIF1A;CXCL2;ICAM1;ZFP36;GNG10;UBB;GNG5;JAK2;JAK1;LYN;ATG3;GABARAPL1;STAT1;STAT2;STAT3;HLA-B;HLA-C;EIF2AK2;HLA-A;HLA-F;NFKB1;HLA-E;TNFRSF1A;NFKBIA;IRF7;FAS;CALM3;IL6ST;CALM2;IRF9
963,KEGG_2019_Human,Antigen processing and presentation,22 of 77,1.1617223057713413e-17,9.526122907324998e-16,0,0,16.167983367983368,630.4550375519167,PDIA3;CD74;HSPA8;HSP90AA1;HSPA5;TAP2;HLA-B;TAP1;HLA-C;HLA-A;IFI30;HLA-F;CTSS;TAPBP;HLA-E;CTSL;PSME1;PSME2;HLA-DRA;CALR;B2M;LGMN
964,KEGG_2019_Human,NOD-like receptor signaling pathway,29 of 178,1.0717557942128794e-15,6.591298134409208e-14,0,0,7.944552997479682,273.8445960544247,CXCL8;TXN;CXCL3;CXCL2;TANK;NAMPT;CASP4;GBP2;GBP1;GBP4;JAK1;GBP3;GSDMD;GBP5;GABARAPL1;HSP90AA1;RIPK2;STAT1;STAT2;TMEM173;NFKB1;NFKBIA;OAS1;OAS3;IRF7;TXNIP;RBCK1;IRF9;BIRC3
965,KEGG_2019_Human,Influenza A,27 of 171,2.345722468977461e-14,1.1540954547369109e-12,0,0,7.623293067226891,239.2463639782109,CXCL8;ADAR;ACTG1;ICAM1;IFIH1;SOCS3;TNFSF10;JAK2;JAK1;HSPA8;RSAD2;DDX58;STAT1;STAT2;MX1;EIF2AK2;NFKB1;PML;TNFRSF1A;NFKBIA;CXCL10;OAS1;OAS3;IRF7;HLA-DRA;FAS;IRF9
966,KEGG_2019_Human,TNF signaling pathway,20 of 110,3.813844231054062e-12,1.5636761347321652e-10,0,0,8.928916494133885,234.76249626522724,CEBPB;CSF1;MLKL;CFLAR;CXCL3;CXCL2;NFKB1;CX3CL1;ICAM1;TNFRSF1A;NFKBIA;SOCS3;CXCL10;CASP7;IRF1;BCL3;FAS;MAP3K8;JUNB;BIRC3
967,KEGG_2019_Human,Human immunodeficiency virus 1 infection,26 of 212,2.747250021058793e-11,9.654621502578044e-10,0,0,5.659092446067492,137.61687977087854,SAMHD1;GNG10;GNG5;CFL1;PAK3;B2M;PDIA3;APOBEC3G;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;RBX1;TNFRSF1A;TAPBP;BST2;NFKBIA;FAS;CALM3;CALR;CALM2
968,KEGG_2019_Human,Hepatitis C,22 of 155,5.3185157739189445e-11,1.6354436004800754e-09,0,0,6.65918434339487,157.5379338586578,CDKN1A;RSAD2;YWHAB;DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;CFLAR;IFIT1;NFKB1;TNFRSF1A;NFKBIA;SOCS3;CXCL10;OAS1;OAS3;IRF7;FAS;IRF9;JAK1
969,KEGG_2019_Human,Human cytomegalovirus infection,25 of 225,5.564907986269981e-10,1.5210748495804617e-08,0,0,5.046286610878661,107.53319093802683,CDKN1A;CXCL8;CX3CL1;GNG10;GNG5;B2M;JAK1;PDIA3;STAT3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;TNFRSF1A;TAPBP;NFKBIA;FAS;CALM3;CALR;CALM2
970,KEGG_2019_Human,Necroptosis,21 of 162,8.109778927798858e-10,1.995005616238519e-08,0,0,5.980930519996469,125.19750469261682,HSP90AA1;PARP3;MLKL;STAT1;STAT2;STAT3;EIF2AK2;CFLAR;TNFRSF1A;CYLD;FTH1;TNFSF10;FAS;RBCK1;JAK2;GLUL;PPIA;IRF9;JAK1;CHMP5;BIRC3
971,KEGG_2019_Human,Proteasome,11 of 45,1.0700859806644288e-08,2.3399737162061146e-07,0,0,12.798481587757054,234.8897869782691,PSMA3;PSMA4;PSMB2;PSMB3;PSMA2;POMP;PSME1;PSME2;PSMB10;PSMB8;PSMB9
972,KEGG_2019_Human,Herpes simplex virus 1 infection,36 of 492,1.1414505932712756e-08,2.3399737162061146e-07,0,0,3.2189225741012057,58.86888193023696,SP100;IFIH1;SOCS3;TNFRSF14;JAK2;B2M;ZNF267;JAK1;PDIA3;CD74;STAT1;DDX58;STAT2;TAP2;HLA-B;EIF2AK2;TAP1;HLA-C;HLA-A;TMEM173;HLA-F;NFKB1;PML;TNFRSF1A;HLA-E;TAPBP;BST2;NFKBIA;OAS1;OAS3;IRF7;HLA-DRA;FAS;CALR;IRF9;BIRC3
973,KEGG_2019_Human,Apoptosis,18 of 143,2.1047848068077542e-08,3.982900480574673e-07,0,0,5.751686597938145,101.66950128529449,PARP3;GADD45B;CTSZ;CFLAR;NFKB1;CTSS;ACTG1;GADD45G;TNFRSF1A;NFKBIA;CTSO;CASP7;CTSL;TNFSF10;PMAIP1;FAS;MCL1;BIRC3
974,KEGG_2019_Human,Measles,17 of 138,7.167514819751702e-08,1.2594347468992278e-06,0,0,5.601333197292793,92.14821443325492,HSPA8;DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;ADAR;NFKB1;NFKBIA;IFIH1;OAS1;OAS3;IRF7;FAS;IRF9;JAK1
975,KEGG_2019_Human,NF-kappa B signaling pathway,14 of 95,1.0719428611470985e-07,1.7579862922812412e-06,0,0,6.862682723623419,110.13660705132004,LYN;CD40;CXCL8;GADD45B;DDX58;CFLAR;CXCL2;NFKB1;ICAM1;TNFRSF1A;RELB;NFKB2;NFKBIA;BIRC3
976,KEGG_2019_Human,RIG-I-like receptor signaling pathway,12 of 70,1.5894001368035228e-07,2.443702710335416e-06,0,0,8.191165109909404,128.2305517242972,IFIH1;NFKBIA;CXCL10;CYLD;CXCL8;DDX58;DHX58;IRF7;ISG15;TMEM173;TANK;NFKB1
977,KEGG_2019_Human,Pathways in cancer,34 of 530,6.576672104611107e-07,9.51683139843725e-06,0,0,2.777159708370589,39.53166536290208,CDKN1A;CXCL8;MAX;EPAS1;HIF1A;HSP90B1;GNG10;CASP7;GNG5;CTNNA1;PMAIP1;JAK2;JAK1;IL13RA1;HSP90AA1;GADD45B;STAT1;GSTO1;ITGA3;STAT2;STAT3;NFKB1;PML;RBX1;NFKB2;GADD45G;NFKBIA;LPAR6;FAS;CALM3;IL6ST;CALM2;BIRC3;NFE2L2
978,KEGG_2019_Human,Viral carcinogenesis,19 of 201,8.355630213585904e-07,1.1419361291900736e-05,0,0,4.166117972936155,58.30548786942489,LYN;CDKN1A;SP100;YWHAB;STAT3;HLA-B;HLA-C;EIF2AK2;HLA-A;HLA-F;NFKB1;HLA-E;NFKB2;NFKBIA;IRF7;PMAIP1;IL6ST;IRF9;JAK1
979,KEGG_2019_Human,Protein processing in endoplasmic reticulum,17 of 165,9.533575807424274e-07,1.234347183487564e-05,0,0,4.573086975864753,63.39796594791271,PDIA3;HSPA8;HSP90AA1;HSPA5;UBE2D3;DERL1;EIF2AK2;PDIA6;RBX1;HSP90B1;DNAJA1;LMAN2;FBXO6;CALR;P4HB;SIL1;NFE2L2
980,KEGG_2019_Human,Viral myocarditis,10 of 59,1.926010324752665e-06,2.368992699445778e-05,0,0,8.05066854327938,105.94728013482258,CD40;SGCB;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ACTG1;ICAM1;HLA-E
981,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,19 of 219,3.026381529151064e-06,3.545189791291246e-05,0,0,3.787634297520661,48.13379778041503,CD40;CDKN1A;HLA-B;HLA-C;HLA-A;HLA-F;ETS2;NFKB1;ICAM1;HLA-E;RELB;NFKB2;TNFRSF1A;NFKBIA;ZFP36;HLA-DRA;CALR;B2M;JAK1
982,KEGG_2019_Human,Allograft rejection,8 of 38,3.810819863556809e-06,4.170406209707539e-05,0,0,10.487272727272726,130.8566884884567,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
983,KEGG_2019_Human,Osteoclast differentiation,14 of 127,3.899160277368838e-06,4.170406209707539e-05,0,0,4.911160576940478,61.167273961685154,CSF1;STAT1;STAT2;NFKB1;NFKB2;TNFRSF1A;RELB;NFKBIA;SOCS3;CYLD;SOCS1;JUNB;IRF9;JAK1
984,KEGG_2019_Human,Transcriptional misregulation in cancer,17 of 186,4.970516032415695e-06,5.094778933226088e-05,0,0,4.000487009034018,48.85389492308355,CD40;CDKN1A;CEBPB;CXCL8;GADD45B;H3F3B;MAX;H3F3A;NFKB1;PML;GADD45G;ETV6;ETV7;SPINT1;BCL6;NFKBIZ;BIRC3
985,KEGG_2019_Human,Chemokine signaling pathway,17 of 190,6.6150556318157225e-06,6.50921474170667e-05,0,0,3.90718142677038,46.59768002845634,LYN;CXCL9;CXCL8;STAT1;STAT2;STAT3;CXCL3;CXCL2;NFKB1;CX3CL1;CXCL16;NFKBIA;CXCL10;GNG10;CXCL11;GNG5;JAK2
986,KEGG_2019_Human,Type I diabetes mellitus,8 of 43,1.01192491560204e-05,9.574366509157765e-05,0,0,8.986782106782107,103.35761988876814,GAD1;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
987,KEGG_2019_Human,C-type lectin receptor signaling pathway,12 of 104,1.191692211942156e-05,0.00010857640153250752,0,0,5.15496325157177,58.44465949532688,NFKBIA;CYLD;STAT1;IRF1;STAT2;BCL3;CALM3;CALM2;NFKB1;IRF9;NFKB2;RELB
988,KEGG_2019_Human,Lysosome,13 of 123,1.3650648311412868e-05,0.00011993069587884162,0,0,4.675899814471243,52.378137032355056,SCARB2;CTSZ;AP3B1;GNS;LITAF;CTSS;LAPTM4A;CTSO;CTSL;LAMP3;ACP2;CD68;LGMN
989,KEGG_2019_Human,Toxoplasmosis,12 of 113,2.777766897835327e-05,0.00023563126098878975,0,0,4.693432276017826,49.24010341185263,NFKBIA;HSPA8;CD40;SOCS1;STAT1;STAT3;HLA-DRA;JAK2;NFKB1;JAK1;TNFRSF1A;BIRC3
990,KEGG_2019_Human,Phagosome,14 of 152,3.0902172208573664e-05,0.000253397812110304,0,0,4.016271005601494,41.70770556688842,ATP6V1G1;C1R;TAP2;HLA-B;TAP1;HLA-C;HLA-A;HLA-F;CTSS;ACTG1;HLA-E;CTSL;HLA-DRA;CALR
991,KEGG_2019_Human,Human papillomavirus infection,22 of 330,3.528113677675133e-05,0.000279972891841317,0,0,2.8495693495693497,29.21424690345144,ATP6V1G1;CDKN1A;STAT1;ITGA3;STAT2;MX1;HLA-B;PPP2R5B;HLA-C;EIF2AK2;ISG15;HLA-A;HLA-F;NFKB1;HLA-E;TNFRSF1A;SLC9A3R1;PPP2R5E;IRF1;FAS;IRF9;JAK1
992,KEGG_2019_Human,Autoimmune thyroid disease,8 of 53,4.96249267036536e-05,0.000381491624034337,0,0,6.986127946127946,69.23963490588085,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
993,KEGG_2019_Human,Legionellosis,8 of 55,6.523855669972145e-05,0.0004690783168043289,0,0,6.688158177519879,64.45685626338556,NFKBIA;HSPA8;CASP7;CXCL8;CXCL3;CXCL2;NFKB1;NFKB2
994,KEGG_2019_Human,Graft-versus-host disease,7 of 41,6.53895817573414e-05,0.0004690783168043289,0,0,8.078806925996204,77.84049726516157,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
995,KEGG_2019_Human,Hepatitis B,14 of 163,6.673878491118501e-05,0.0004690783168043289,0,0,3.717654163407036,35.74421979086355,CDKN1A;CXCL8;YWHAB;DDX58;STAT1;STAT2;STAT3;NFKB1;NFKBIA;IFIH1;IRF7;FAS;JAK2;JAK1
996,KEGG_2019_Human,IL-17 signaling pathway,10 of 93,0.0001155634318409038,0.0007896834509128426,0,0,4.744495222268384,43.01212756644174,NFKBIA;CXCL10;HSP90AA1;CEBPB;CXCL8;LCN2;CXCL3;CXCL2;NFKB1;HSP90B1
997,KEGG_2019_Human,Pertussis,9 of 76,0.00011969194694904688,0.0007957897013369063,0,0,5.283400809716599,47.71222242154287,CASP7;CXCL8;C1R;IRF1;CFL1;SERPING1;CALM3;CALM2;NFKB1
998,KEGG_2019_Human,Cytokine-cytokine receptor interaction,19 of 294,0.0001776525985330464,0.0011500668220823,0,0,2.7439368895567244,23.6957625876606,IL32;CD40;CXCL9;CXCL8;TNFRSF12A;CSF1;CXCL3;CXCL2;CX3CL1;CXCL16;BMP5;TNFRSF1A;CXCL10;CXCL11;TNFSF10;FAS;TNFRSF14;IL6ST;IL13RA1
999,KEGG_2019_Human,Fluid shear stress and atherosclerosis,12 of 139,0.00020801046706126416,0.0012921839541859,0,0,3.7275686771332808,31.6020370800516,HSP90AA1;CTSL;GSTO1;CALM3;TXN;CALM2;NFKB1;ACTG1;ICAM1;HSP90B1;NFE2L2;TNFRSF1A
1000,KEGG_2019_Human,Cellular senescence,13 of 160,0.00021011121206274927,0.0012921839541859,0,0,3.4922948771345275,29.572311545219225,CDKN1A;CXCL8;GADD45B;HLA-B;HLA-C;HLA-A;HLA-F;NFKB1;HLA-E;GADD45G;CALM3;NBN;CALM2
1001,KEGG_2019_Human,JAK-STAT signaling pathway,13 of 162,0.0002374923475226139,0.0014249540851356,0,0,3.4450623202301056,28.75033749800325,CDKN1A;STAT1;STAT2;STAT3;SOCS3;SOCS1;IL6ST;JAK2;IRF9;PTPN2;IL13RA1;MCL1;JAK1
1002,KEGG_2019_Human,Mineral absorption,7 of 51,0.0002711617054703664,0.0015882328463264,0,0,6.239506964809384,51.2437929500744,MT2A;FTH1;MT1F;MT1X;ATP1B1;ATOX1;MT1E
1003,KEGG_2019_Human,Toll-like receptor signaling pathway,10 of 104,0.0002920671554090511,0.0016708958193168,0,0,4.186914677830046,34.07531730587634,NFKBIA;CXCL10;CXCL11;CD40;CXCL9;CXCL8;STAT1;IRF7;MAP3K8;NFKB1
1004,KEGG_2019_Human,Th17 cell differentiation,10 of 107,0.0003677591065956512,0.0020561077323302,0,0,4.056795131845842,32.08147032771925,NFKBIA;HSP90AA1;STAT1;STAT3;HLA-DRA;IL6ST;JAK2;HIF1A;NFKB1;JAK1
1005,KEGG_2019_Human,Cytosolic DNA-sensing pathway,7 of 63,0.0010003507084662,0.0054685838729486,0,0,4.899445564516129,33.842452986569384,NFKBIA;CXCL10;DDX58;IRF7;ADAR;TMEM173;NFKB1
1006,KEGG_2019_Human,Shigellosis,7 of 65,0.0012057631464992,0.0064482116095396,0,0,4.730012513904338,31.78872358009936,NFKBIA;CXCL8;RIPK2;ARPC5;PFN1;NFKB1;ACTG1
1007,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),11 of 149,0.0013955167938851,0.0073041942828882,0,0,3.1363997879109227,20.6202305180712,NDUFA9;SOCS3;COX7B;CASP7;CXCL8;NDUFB4;NDUFB1;FAS;NDUFV2;NFKB1;TNFRSF1A
1008,KEGG_2019_Human,Prolactin signaling pathway,7 of 70,0.0018648198604114,0.0095572017846089,0,0,4.353494623655914,27.3599323473704,SOCS3;SOCS1;STAT1;IRF1;STAT3;JAK2;NFKB1
1009,KEGG_2019_Human,Tuberculosis,12 of 179,0.0019670206157832,0.0098752463567896,0,0,2.8288839835603743,17.627441621429785,CD74;CEBPB;RIPK2;STAT1;HLA-DRA;CALM3;JAK2;CALM2;NFKB1;CTSS;JAK1;TNFRSF1A
1010,KEGG_2019_Human,p53 signaling pathway,7 of 72,0.0021953707580331,0.010801224129523,0,0,4.219106699751861,25.826858047819243,CDKN1A;CD82;GADD45B;SHISA5;PMAIP1;FAS;GADD45G
1011,KEGG_2019_Human,Small cell lung cancer,8 of 93,0.0023788843639248,0.0114746186965788,0,0,3.690932857991682,22.29738180057488,NFKBIA;CDKN1A;GADD45B;ITGA3;MAX;NFKB1;BIRC3;GADD45G
1012,KEGG_2019_Human,Pancreatic cancer,7 of 75,0.0027738691613094,0.0131225348785022,0,0,4.032347011385199,23.740491918819767,CDKN1A;GADD45B;STAT1;STAT3;NFKB1;JAK1;GADD45G
1013,KEGG_2019_Human,Alzheimer disease,11 of 171,0.004087850394065,0.0189737961686793,0,0,2.702070630081301,14.86067518125682,PSENEN;NDUFA9;COX7B;CASP7;NDUFB4;NDUFB1;FAS;CALM3;NDUFV2;CALM2;TNFRSF1A
1014,KEGG_2019_Human,Mitophagy,6 of 65,0.0057934327133189,0.0263923045828975,0,0,3.977355659380009,20.48747949053367,GABARAPL1;USP15;UBB;CALCOCO2;HIF1A;OPTN
1015,KEGG_2019_Human,Salmonella infection,7 of 86,0.0059370533389412,0.0265548203887188,0,0,3.4689158840342995,17.78354415193222,CXCL8;ARPC5;CXCL3;PFN1;CXCL2;NFKB1;ACTG1
1016,KEGG_2019_Human,Adipocytokine signaling pathway,6 of 69,0.0077333225425296,0.0339713811689696,0,0,3.724058637539523,18.107180040910738,NFKBIA;SOCS3;STAT3;JAK2;NFKB1;TNFRSF1A
1017,KEGG_2019_Human,Ubiquitin mediated proteolysis,9 of 137,0.007874599742599,0.0339851146785852,0,0,2.756847798582996,13.354482044824076,SOCS3;SOCS1;UBA6;UBE2D3;UBE2L6;UBE2Z;PML;RBX1;BIRC3
1018,KEGG_2019_Human,Endocytosis,13 of 244,0.0091109041762825,0.0386428004718189,0,0,2.212721971905645,10.395994736099858,ARF3;HSPA8;HLA-B;HLA-C;HLA-A;ARPC5;HLA-F;PML;HLA-E;EHD1;UBB;SNX6;CHMP5
1019,KEGG_2019_Human,Leishmaniasis,6 of 74,0.0107668285331296,0.0448922003245742,0,0,3.4493431175287017,15.62995777517923,NFKBIA;STAT1;HLA-DRA;JAK2;NFKB1;JAK1
1020,KEGG_2019_Human,Cell adhesion molecules (CAMs),9 of 145,0.0111959830458468,0.0459035304879721,0,0,2.593608597285068,11.651009115557311,CD274;CD40;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
1207,Reactome_2022,Immune System R-HSA-168256,170 of 1943,4.0580809872393994e-51,4.2366365506779315e-48,0,0,5.103377489164291,592.1506545574855,IFITM3;CSF1;TMEM179B;UBE2D3;IFIT5;RNF19B;UBE2L6;IFI35;IFI30;IFIT1;UBE2Z;IFIT3;IFIT2;ICAM1;ACTG1;HERC5;MT2A;RNF114;FTH1;DHX58;MAP3K8;FBXO6;FBXO7;TRIM21;B2M;TRIM22;IL13RA1;PDIA3;GBP5;ATP6V1G1;RSAD2;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;RBX1;HLA-E;PSME1;PSME2;SERPING1;TXNIP;RBCK1;IL6ST;PPIA;CFB;CD274;UBA6;GNS;HIF1A;HSP90B1;SOCS3;SDCBP;RNF213;SOCS1;UBB;DHX36;UBC;TNFRSF14;S100A11;MCL1;GSDMD;LYN;HSPA8;HSPA5;EIF2AK2;RAB27A;ISG15;ARPC5;NFKB1;NFKB2;BST2;ISG20;NFKBIA;CYLD;CXCL10;BCL6;LCN2;HLA-DRA;CYSTM1;CALR;XAF1;LGMN;CDKN1A;CD40;CXCL8;YWHAB;CTSZ;ADAR;CXCL2;CTSS;IL18BP;IFIH1;HEBP2;CTSO;CTSL;PPP2R5E;CASP4;TRIM69;MUC13;QSOX1;TIMP1;JAK2;JAK1;SERPINB1;HSP90AA1;DTX3L;BTN3A1;TNFRSF12A;DYNLT1;RIPK2;GSTO1;PPP2R5B;BTN3A3;BTN3A2;TNFRSF1A;TAPBP;VAMP8;PSMA3;PSMA4;OAS1;PSMA2;IRF1;OAS3;IRF2;IRF7;CD47;IRF9;BIRC3;TRIM56;CSTB;SP100;CEBPD;C1R;NLRC5;IFI6;SAMHD1;TANK;USP18;PSMB10;RELB;PSMB2;PSMB3;CREG1;STOM;GBP2;GBP1;GBP4;CHGA;IL32;PTPN1;CD74;ERAP2;GCA;STAT1;STAT2;MX1;STAT3;CMTM6;PSMB8;ATOX1;PML;PSMB9;ERP44;KLHL5;HNRNPA2B1;P4HB;TRIM38;CD68;PTPN2
1208,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,104 of 702,1.0482375547323568e-50,5.471800035702903e-48,0,0,8.237550397733465,947.9949644988516,IFITM3;CSF1;UBE2D3;IFIT5;UBE2L6;IFI35;IFI30;IFIT1;IFIT3;IFIT2;ICAM1;HERC5;MT2A;MAP3K8;TRIM21;B2M;TRIM22;IL13RA1;GBP5;RSAD2;HLA-B;HLA-C;HLA-A;HLA-F;RBX1;HLA-E;PSME1;PSME2;IL6ST;PPIA;HIF1A;HSP90B1;SOCS3;SOCS1;UBB;UBC;TNFRSF14;MCL1;GSDMD;LYN;HSPA8;EIF2AK2;ISG15;NFKB1;NFKB2;BST2;ISG20;NFKBIA;CXCL10;BCL6;LCN2;HLA-DRA;XAF1;CDKN1A;CD40;CXCL8;ADAR;CXCL2;IL18BP;TIMP1;JAK2;JAK1;HSP90AA1;TNFRSF12A;RIPK2;GSTO1;TNFRSF1A;PSMA3;PSMA4;OAS1;PSMA2;IRF1;OAS3;IRF2;IRF7;IRF9;BIRC3;SP100;CEBPD;NLRC5;IFI6;SAMHD1;TANK;USP18;PSMB10;RELB;PSMB2;PSMB3;GBP2;GBP1;GBP4;IL32;PTPN1;STAT1;STAT2;MX1;STAT3;PSMB8;PML;PSMB9;HNRNPA2B1;P4HB;TRIM38;PTPN2
1209,Reactome_2022,Interferon Signaling R-HSA-913531,55 of 200,1.6119122475304978e-41,5.6094546214061326e-39,0,0,16.38485221674877,1539.0056991743595,IFITM3;IFIT5;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;JAK2;B2M;TRIM21;TRIM22;JAK1;GBP5;RSAD2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;IRF9;SP100;IFI6;SAMHD1;USP18;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;PTPN1;STAT1;STAT2;MX1;EIF2AK2;ISG15;PSMB8;PML;BST2;ISG20;HLA-DRA;TRIM38;XAF1;PTPN2
1210,Reactome_2022,Interferon Alpha/Beta Signaling R-HSA-909733,35 of 72,5.858599375599064e-37,1.5290944370313555e-34,0,0,39.33356433356433,3281.5102951131003,IFITM3;IFIT5;IFI6;ADAR;IFI35;IFIT1;SAMHD1;USP18;IFIT3;IFIT2;SOCS3;SOCS1;GBP2;JAK1;PTPN1;RSAD2;STAT1;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;BST2;ISG20;OAS1;IRF1;OAS3;IRF2;IRF7;XAF1;IRF9
1211,Reactome_2022,Interferon Gamma Signaling R-HSA-877300,32 of 89,1.0143833811473758e-28,2.1180324998357208e-26,0,0,23.17130405631914,1493.5782729715077,SP100;IFI30;ICAM1;SOCS3;MT2A;SOCS1;JAK2;GBP2;B2M;TRIM21;GBP1;TRIM22;GBP4;JAK1;GBP5;PTPN1;STAT1;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;HLA-DRA;TRIM38;IRF9;PTPN2
1212,Reactome_2022,Signaling By Interleukins R-HSA-449147,55 of 453,2.18480417928771e-22,3.801559271960616e-20,0,0,5.891314833094041,293.8313647634968,CDKN1A;CXCL8;CSF1;CXCL2;IL18BP;ICAM1;MAP3K8;TIMP1;JAK2;JAK1;IL13RA1;HSP90AA1;GSTO1;RIPK2;RBX1;TNFRSF1A;PSMA3;PSMA4;PSMA2;PSME1;PSME2;IL6ST;PPIA;CEBPD;NLRC5;HIF1A;TANK;USP18;PSMB10;HSP90B1;SOCS3;SOCS1;PSMB2;UBB;PSMB3;UBC;MCL1;GSDMD;LYN;IL32;HSPA8;STAT1;STAT2;STAT3;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;CXCL10;BCL6;HNRNPA2B1;LCN2;P4HB;PTPN2
1213,Reactome_2022,Innate Immune System R-HSA-168249,82 of 1035,1.15863161325804e-20,1.7280162917734197e-18,0,0,3.790026743899126,173.97913938272367,TMEM179B;UBE2D3;CTSZ;UBE2L6;CTSS;ACTG1;IFIH1;HERC5;HEBP2;CTSL;FTH1;DHX58;CASP4;MUC13;MAP3K8;QSOX1;TRIM21;B2M;SERPINB1;HSP90AA1;ATP6V1G1;DYNLT1;RIPK2;HLA-B;HLA-C;HLA-A;HLA-E;VAMP8;PSMA3;PSMA4;PSMA2;PSME1;IRF7;PSME2;SERPING1;TXNIP;CD47;PPIA;CFB;BIRC3;TRIM56;CSTB;C1R;NLRC5;GNS;TANK;USP18;PSMB10;HSP90B1;RELB;SDCBP;SOCS1;PSMB2;UBB;PSMB3;CREG1;DHX36;UBC;STOM;S100A11;CHGA;GSDMD;LYN;HSPA8;GCA;CMTM6;RAB27A;ISG15;ARPC5;PSMB8;NFKB1;ATOX1;PSMB9;NFKB2;BST2;NFKBIA;CYLD;ERP44;LCN2;CYSTM1;CD68;LGMN
1214,Reactome_2022,Adaptive Immune System R-HSA-1280218,66 of 733,1.498082074704948e-19,1.9549971074899568e-17,0,0,4.26370338858031,184.80992958228748,CD40;YWHAB;UBE2D3;RNF19B;UBE2L6;IFI30;UBE2Z;CTSS;ICAM1;HERC5;CTSO;RNF114;CTSL;PPP2R5E;TRIM69;MAP3K8;FBXO6;FBXO7;TRIM21;B2M;PDIA3;DTX3L;BTN3A1;RIPK2;HLA-B;PPP2R5B;HLA-C;BTN3A3;LMO7;HLA-A;BTN3A2;HLA-F;RBX1;HLA-E;TAPBP;VAMP8;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1;PPIA;CD274;UBA6;PSMB10;SOCS3;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;LYN;CD74;ERAP2;HSPA5;PSMB8;NFKB1;PSMB9;NFKBIA;KLHL5;HLA-DRA;CALR;LGMN
1215,Reactome_2022,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,45 of 378,3.838024741463988e-18,4.452108700098226e-16,0,0,5.65443172430072,226.7516112580666,UBA6;UBE2D3;RNF19B;UBE2L6;UBE2Z;CTSS;PSMB10;HERC5;SOCS3;RNF114;RNF213;SOCS1;PSMB2;UBB;CTSL;PSMB3;UBC;TRIM69;FBXO6;B2M;FBXO7;TRIM21;PDIA3;HSPA5;DTX3L;ERAP2;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;PSMB8;HLA-E;PSMB9;RBX1;TAPBP;VAMP8;PSMA3;PSMA4;KLHL5;PSMA2;PSME1;PSME2;RBCK1;CALR
1216,Reactome_2022,Antigen processing-Cross Presentation R-HSA-1236975,24 of 104,8.560023677347187e-17,8.936664719150465e-15,0,0,12.160960334029228,449.917147804304,PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;UBB;PSMB2;CTSL;PSMA2;PSMB3;UBC;PSME1;PSME2;CALR;B2M
1217,Reactome_2022,ER-Phagosome Pathway R-HSA-1236974,22 of 89,3.477253006474278e-16,3.3002292170537694e-14,0,0,13.264033264033264,472.1348407526059,PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;CALR;B2M
1218,Reactome_2022,Programmed Cell Death R-HSA-5357801,29 of 208,7.035414474327259e-14,6.120810592664716e-12,0,0,6.602809796572614,199.96764434916795,YWHAB;TANK;PSMB10;SDCBP;CASP7;PSMB2;UBB;PSMB3;UBC;CASP4;TNFSF10;FLOT1;PMAIP1;GSDMD;HSP90AA1;MLKL;STAT3;CFLAR;PSMB8;PSMB9;PSMA3;PSMA4;PSMA2;IRF1;IRF2;PSME1;NMT1;PSME2;BIRC3
1219,Reactome_2022,Interleukin-1 Family Signaling R-HSA-446652,25 of 152,8.313258710265438e-14,6.6761862257823984e-12,0,0,7.976970974862452,240.2531210131114,NLRC5;TANK;USP18;PSMB10;IL18BP;UBB;PSMB2;PSMB3;UBC;MAP3K8;GSDMD;RIPK2;STAT3;NFKB1;PSMB8;RBX1;NFKB2;PSMB9;NFKBIA;PSMA3;PSMA4;PSMA2;PSME1;PSME2;PTPN2
1220,Reactome_2022,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,20 of 100,5.870800512334131e-13,4.377939810626309e-11,0,0,10.050207039337474,283.050163845774,CD40;TNFRSF12A;TANK;PSMB10;PSMB8;NFKB2;TNFRSF1A;RELB;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TNFRSF14;BIRC3
1221,Reactome_2022,Interleukin-1 Signaling R-HSA-9020702,21 of 114,8.412138238781212e-13,5.854848214191723e-11,0,0,9.090349350823184,252.74744173186951,RIPK2;NLRC5;TANK;USP18;NFKB1;PSMB10;PSMB8;RBX1;NFKB2;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;MAP3K8
1222,Reactome_2022,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,16 of 64,3.250886807163954e-12,2.12120364167448e-10,0,0,13.31211498973306,352.1333076364237,EPAS1;UBE2D3;HIF1A;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1223,Reactome_2022,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,14 of 51,1.86554122176886e-11,1.1192585984725852e-09,0,0,15.057757143646716,372.0001557698748,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;NFE2L2
1224,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,52 of 736,1.9297562042630784e-11,1.1192585984725852e-09,0,0,3.1712374061539657,78.2377323397142,CDKN1A;COX7B;CXCL8;UBE2D3;MT1X;ETS2;MT2A;TRIM21;HSP90AA1;ATP6V1G1;HSBP1;PPP2R5B;PDIA6;RBX1;PSMA3;PSMA4;PSMA2;PSME1;MT1F;PSME2;TXNIP;ATF3;FKBP5;MT1E;CEBPB;EPAS1;HM13;RPS27L;HIF1A;PSMB10;HSP90B1;HELZ2;PSMB2;UBB;PSMB3;UBC;STAP2;COX14;FNIP2;HSPA8;HSPA5;STAT3;PSMB8;NFKB1;ATOX1;PSMB9;DNAJA1;MOV10;ID1;P4HB;CALR;NFE2L2
1225,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,19 of 107,2.0438965817313023e-11,1.1230673849092e-09,0,0,8.658222201352366,213.10982704318093,HSPA8;CDKN1A;HSP90AA1;CXCL8;CEBPD;STAT1;STAT3;HIF1A;ICAM1;HSP90B1;SOCS3;SOCS1;BCL6;LCN2;TIMP1;JAK2;IL13RA1;MCL1;JAK1
1226,Reactome_2022,Endosomal/Vacuolar Pathway R-HSA-1236977,8 of 11,2.3387651083012005e-11,1.2208353865332267e-09,0,0,105.01818181818182,2570.72043058436,CTSL;HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
1227,Reactome_2022,Cellular Response To Hypoxia R-HSA-1234174,16 of 73,2.8483212883936916e-11,1.4160225833728634e-09,0,0,11.205014589862747,272.0768725045698,EPAS1;UBE2D3;HIF1A;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1228,Reactome_2022,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,14 of 53,3.313023445926691e-11,1.501086978301092e-09,0,0,14.284096271826334,344.6834538618755,APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1229,Reactome_2022,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",11 of 28,3.3324211537236736e-11,1.501086978301092e-09,0,0,25.619320899091345,618.0593765019452,PDIA3;ERAP2;HSPA5;HLA-B;HLA-C;HLA-A;CALR;HLA-F;B2M;HLA-E;TAPBP
1230,Reactome_2022,Cellular Response To Chemical Stress R-HSA-9711123,24 of 182,3.4507746627611305e-11,1.501086978301092e-09,0,0,6.132713194683015,147.7360629274414,COX7B;HM13;STAT3;PSMB10;ATOX1;PSMB8;RBX1;PSMB9;HELZ2;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TXNIP;COX14;STAP2;P4HB;TRIM21;NFE2L2
1231,Reactome_2022,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,31 of 307,5.4601021110816054e-11,2.280138641587678e-09,0,0,4.5738992262343405,108.08566868226158,UBA6;UBE2D3;RNF19B;UBE2L6;UBE2Z;PSMB10;HERC5;SOCS3;RNF114;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;TRIM69;FBXO6;FBXO7;TRIM21;DTX3L;LMO7;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;KLHL5;PSMA2;PSME1;PSME2;RBCK1
1232,Reactome_2022,Regulated Necrosis R-HSA-5218859,14 of 57,9.670899485624942e-11,3.883238101150938e-09,0,0,12.952679887763352,298.6799217355472,GSDMD;HSP90AA1;MLKL;CFLAR;TANK;SDCBP;UBB;IRF1;CASP4;IRF2;UBC;FLOT1;TNFSF10;BIRC3
1233,Reactome_2022,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,14 of 58,1.2457758682553474e-10,4.817000023920677e-09,0,0,12.657650120840303,288.67153830845626,PSMB10;PSMB8;RELB;NFKB2;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1234,Reactome_2022,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,16 of 81,1.5083363417908068e-10,5.623939788677151e-09,0,0,9.82189227610172,222.1205581407472,HSP90AA1;UBE2D3;NLRC5;UBE2L6;ISG15;TANK;NFKB1;NFKB2;HERC5;IFIH1;NFKBIA;CYLD;UBB;DHX58;UBC;IRF7
1235,Reactome_2022,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,14 of 59,1.5961649975678035e-10,5.7461939912440935e-09,0,0,12.375732788002727,279.17483771003464,CDKN1A;HSP90AA1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1236,Reactome_2022,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,14 of 60,2.0345586936851964e-10,7.080264254024483e-09,0,0,12.106072730505913,270.15393756650303,DERL1;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1237,Reactome_2022,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,10 of 25,2.1576125360692843e-10,7.266282218246236e-09,0,0,26.344827586206897,586.3528396885765,LYN;SOCS3;SOCS1;UBB;STAT1;UBE2D3;UBC;STAT3;JAK2;JAK1
1238,Reactome_2022,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,14 of 61,2.5804882085363485e-10,8.418842780349837e-09,0,0,11.847887569072793,261.576149021105,PSMB10;PSMB8;RELB;NFKB2;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1239,Reactome_2022,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,13 of 53,4.6371674359862494e-10,1.4670311524756498e-08,0,0,12.905153061224487,277.35428738201387,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1240,Reactome_2022,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,16 of 88,5.528388985850433e-10,1.6975406180081923e-08,0,0,8.863791923340179,188.940185153501,HSPA8;YWHAB;PSMB10;PSMB8;PSMB9;ZFP36;PSMA3;PSMA4;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1241,Reactome_2022,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,13 of 54,5.968928160105209e-10,1.7309891664305106e-08,0,0,12.589746142359385,267.39718821972707,HSPA8;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1242,Reactome_2022,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,13 of 54,5.968928160105209e-10,1.7309891664305106e-08,0,0,12.589746142359385,267.39718821972707,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1243,Reactome_2022,Degradation Of DVL R-HSA-4641258,13 of 55,7.639135876700912e-10,2.1554750960204738e-08,0,0,12.28935860058309,257.98517690686793,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1244,Reactome_2022,Activation Of NF-kappaB In B Cells R-HSA-1169091,14 of 66,7.908589220405622e-10,2.1727808279219656e-08,0,0,10.705914739657072,224.37350677382543,PSMB10;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1245,Reactome_2022,FCERI Mediated NF-kB Activation R-HSA-2871837,15 of 78,8.44036190898237e-10,2.2594199571737423e-08,0,0,9.481850117096018,198.10264220863567,LYN;PSMB10;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1246,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,48 of 722,9.305750984809797e-10,2.4288010070353573e-08,0,0,2.946176671992696,61.26638714886613,CDKN1A;CEBPB;COX7B;CXCL8;EPAS1;HM13;UBE2D3;RPS27L;HIF1A;PSMB10;ETS2;HSP90B1;HELZ2;PSMB2;UBB;PSMB3;UBC;STAP2;COX14;FNIP2;TRIM21;HSPA8;HSP90AA1;ATP6V1G1;HSPA5;HSBP1;STAT3;PPP2R5B;PDIA6;PSMB8;NFKB1;ATOX1;PSMB9;RBX1;DNAJA1;MOV10;PSMA3;PSMA4;PSMA2;ID1;PSME1;PSME2;TXNIP;P4HB;CALR;ATF3;FKBP5;NFE2L2
1247,Reactome_2022,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,15 of 79,1.0180901164929511e-09,2.592405077118637e-08,0,0,9.33321593237705,193.24738490373477,PSMB10;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PPIA
1248,Reactome_2022,Regulation Of Necroptotic Cell Death R-HSA-5675482,10 of 29,1.2077980626454406e-09,3.00224089857581e-08,0,0,20.794277783708765,426.9994092351816,SDCBP;HSP90AA1;UBB;MLKL;UBC;FLOT1;TNFSF10;CFLAR;TANK;BIRC3
1249,Reactome_2022,Downstream TCR Signaling R-HSA-202424,16 of 94,1.5254466015147707e-09,3.70364244646842e-08,0,0,8.179434528510503,166.05052545678245,RIPK2;PSMB10;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1250,Reactome_2022,Infectious Disease R-HSA-5663205,57 of 961,1.6409738826871143e-09,3.8935834852848807e-08,0,0,2.628579011071868,53.1708329935371,YWHAB;ACTG1;IFIH1;CTSL;JAK2;B2M;JAK1;HSP90AA1;RIPK2;RHBDF2;HLA-B;HLA-C;HLA-A;RANGAP1;HLA-F;PARP9;ATP1B1;RBX1;HLA-E;PSMA3;PSMA4;PSMA2;PSME1;SNRPG;IRF7;PSME2;TXNIP;PPIA;CHMP5;CEBPD;RPS27L;PSMB10;GNG10;RNF213;GNG5;PSMB2;UBB;PSMB3;UBC;CHGA;GSDMD;LYN;APOBEC3G;STAT1;STAT2;EIF2AK2;ISG15;ARPC5;PARP14;PSMB8;NFKB1;PML;PSMB9;NFKB2;NMT1;CALR;NFE2L2
1251,Reactome_2022,Signaling By CSF3 (G-CSF) R-HSA-9674555,10 of 30,1.7712081116148691e-09,4.1092028189464975e-08,0,0,19.753549695740364,398.0657105543509,LYN;SOCS3;SOCS1;UBB;STAT1;UBE2D3;UBC;STAT3;JAK2;JAK1
1252,Reactome_2022,Degradation Of GLI1 By Proteasome R-HSA-5610780,13 of 59,1.943756504038325e-09,4.141391408604105e-08,0,0,11.218411712511092,225.0261199869593,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1253,Reactome_2022,Degradation Of GLI2 By Proteasome R-HSA-5610783,13 of 59,1.943756504038325e-09,4.141391408604105e-08,0,0,11.218411712511092,225.0261199869593,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1254,Reactome_2022,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,13 of 59,1.943756504038325e-09,4.141391408604105e-08,0,0,11.218411712511092,225.0261199869593,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1255,Reactome_2022,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,13 of 59,1.943756504038325e-09,4.141391408604105e-08,0,0,11.218411712511092,225.0261199869593,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1256,Reactome_2022,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,12 of 49,2.225882314347812e-09,4.647642272358232e-08,0,0,12.854076071998678,256.0932030767236,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1257,Reactome_2022,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,15 of 84,2.491962412826672e-09,5.101193645080481e-08,0,0,8.654668567355666,171.45067474286515,PPP2R5B;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
1258,Reactome_2022,RIPK1-mediated Regulated Necrosis R-HSA-5213460,10 of 31,2.5562150171057718e-09,5.1320932266508195e-08,0,0,18.81193856853086,372.18927926429706,SDCBP;HSP90AA1;UBB;MLKL;UBC;FLOT1;TNFSF10;CFLAR;TANK;BIRC3
1259,Reactome_2022,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,14 of 72,2.659075371104123e-09,5.237876768740951e-08,0,0,9.595444608983852,189.4648113377832,STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1260,Reactome_2022,CLEC7A (Dectin-1) Signaling R-HSA-5607764,16 of 99,3.347561273811231e-09,6.471951796035048e-08,0,0,7.684718339477005,149.9675376325721,NFKB1;PSMB10;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1261,Reactome_2022,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,12 of 51,3.658908058725426e-09,6.586034505705769e-08,0,0,12.193639354535485,236.8748706178997,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1262,Reactome_2022,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,12 of 51,3.658908058725426e-09,6.586034505705769e-08,0,0,12.193639354535485,236.8748706178997,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1263,Reactome_2022,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,12 of 51,3.658908058725426e-09,6.586034505705769e-08,0,0,12.193639354535485,236.8748706178997,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1264,Reactome_2022,Vpu Mediated Degradation Of CD4 R-HSA-180534,12 of 51,3.658908058725426e-09,6.586034505705769e-08,0,0,12.193639354535485,236.8748706178997,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1265,Reactome_2022,Host Interactions Of HIV Factors R-HSA-162909,18 of 130,4.551481769232362e-09,7.956933142026687e-08,0,0,6.42360088365243,123.38332451764602,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M;PPIA
1266,Reactome_2022,Apoptosis R-HSA-109581,21 of 178,4.586272916658255e-09,7.956933142026687e-08,0,0,5.366968840024315,103.04686515820585,GSDMD;YWHAB;STAT3;CFLAR;TANK;PSMB10;PSMB8;PSMB9;CASP7;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;TNFSF10;PSME1;NMT1;PSME2;PMAIP1
1267,Reactome_2022,Regulation Of Apoptosis R-HSA-169911,12 of 52,4.649165916318274e-09,7.956933142026687e-08,0,0,11.888187372708758,228.0936343796444,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1268,Reactome_2022,Hedgehog Ligand Biogenesis R-HSA-5358346,13 of 64,5.625507789598754e-09,9.472629245711452e-08,0,0,10.11596638655462,192.16243840858604,PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;P4HB
1269,Reactome_2022,ABC Transporter Disorders R-HSA-5619084,14 of 77,6.6624355151234865e-09,1.103829235772998e-07,0,0,8.831629175187457,166.27114593708905,DERL1;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1270,Reactome_2022,Regulation Of RAS By GAPs R-HSA-5658442,13 of 65,6.872500031153722e-09,1.103829235772998e-07,0,0,9.92091836734694,186.47098127419304,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1271,Reactome_2022,p53-Dependent G1 DNA Damage Response R-HSA-69563,13 of 65,6.872500031153722e-09,1.103829235772998e-07,0,0,9.92091836734694,186.47098127419304,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1272,Reactome_2022,Degradation Of AXIN R-HSA-4641257,12 of 54,7.382016901776689e-09,1.133356712566892e-07,0,0,11.32091940645912,211.9753735997461,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1273,Reactome_2022,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,12 of 54,7.382016901776689e-09,1.133356712566892e-07,0,0,11.32091940645912,211.9753735997461,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1274,Reactome_2022,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,12 of 54,7.382016901776689e-09,1.133356712566892e-07,0,0,11.32091940645912,211.9753735997461,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1275,Reactome_2022,Neddylation R-HSA-8951664,24 of 237,7.929087634512132e-09,1.1834825298439366e-07,0,0,4.536211002969802,84.61270935535377,EPAS1;UBE2D3;LMO7;HIF1A;PSMB8;PSMB10;PSMB9;RBX1;SOCS3;NUB1;PSMA3;PSMA4;PSMB2;KLHL5;UBB;PSMA2;PSMB3;UBD;UBC;PSME1;PSME2;FBXO6;FBXO7;NFE2L2
1276,Reactome_2022,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,14 of 78,7.935227690524477e-09,1.1834825298439366e-07,0,0,8.693187627811861,162.14493391237255,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;NFE2L2
1277,Reactome_2022,Hh Mutants Are Degraded By ERAD R-HSA-5362768,12 of 55,9.228956458525608e-09,1.357046555309963e-07,0,0,11.057073840761616,204.5660369540089,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1278,Reactome_2022,G1/S DNA Damage Checkpoints R-HSA-69615,13 of 67,1.0142675827145513e-08,1.4706879949360992e-07,0,0,9.55249433106576,175.82812049942433,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1279,Reactome_2022,Neutrophil Degranulation R-HSA-6798695,35 of 468,1.055617452161638e-08,1.5096775617215756e-07,0,0,3.292670890823316,60.47502063623185,CSTB;TMEM179B;CTSZ;GNS;CTSS;SDCBP;HEBP2;FTH1;CREG1;STOM;QSOX1;B2M;S100A11;GSDMD;HSPA8;SERPINB1;HSP90AA1;GCA;DYNLT1;CMTM6;HLA-B;HLA-C;RAB27A;ARPC5;HLA-A;NFKB1;VAMP8;BST2;ERP44;PSMA2;LCN2;CYSTM1;CD47;CD68;PPIA
1280,Reactome_2022,Stabilization Of P53 R-HSA-69541,12 of 56,1.1480804863550873e-08,1.6197243618306905e-07,0,0,10.805221255323088,197.5474229221328,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1281,Reactome_2022,Signaling By NOTCH4 R-HSA-9013694,14 of 81,1.3190740966687884e-08,1.8361511425629535e-07,0,0,8.302658486707566,150.6413656918455,PSENEN;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1282,Reactome_2022,Signaling By B Cell Receptor (BCR) R-HSA-983705,16 of 109,1.4019794219640666e-08,1.925876995434849e-07,0,0,6.854871828840167,123.95524637185171,LYN;NFKB1;PSMB10;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PPIA
1283,Reactome_2022,Orc1 Removal From Chromatin R-HSA-68949,13 of 69,1.4758836459045058e-08,2.0010682160055893e-07,0,0,9.210386297376091,166.07637916467516,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1284,Reactome_2022,Cyclin E Associated Events During G1/S Transition R-HSA-69202,14 of 82,1.554493582402605e-08,2.0730916227779562e-07,0,0,8.180139540478768,147.07507181303643,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1285,Reactome_2022,Post-translational Protein Modification R-HSA-597592,70 of 1383,1.5687187566997942e-08,2.0730916227779562e-07,0,0,2.238900742090553,40.23399011330364,ARF3;RAB3B;CSF1;UBE2D3;CTSZ;UBE2Z;IFIH1;NUB1;MUC13;FBXO6;QSOX1;TIMP1;FBXO7;PDIA3;RAB2B;RIPK2;HLA-B;SHISA5;LMO7;HLA-A;RANGAP1;PDIA6;RBX1;PSMA3;RCN1;PSMA4;VGF;PSMA2;PSME1;PSME2;SCG3;TOP1;LY6E;BIRC3;SP100;USP15;EPAS1;UBA6;DERL1;MAT2B;HIF1A;TANK;USP18;PSMB10;HSP90B1;SOCS3;PSMB2;UBB;PSMB3;LMAN2;UBD;UBC;APOL1;CHGA;HSPA8;TRAPPC4;RAB27A;CP;PSMB8;PML;PSMB9;NFKB2;NFKBIA;CYLD;KLHL5;TNIP1;NUCB1;P4HB;CALR;NFE2L2
1286,Reactome_2022,C-type Lectin Receptors (CLRs) R-HSA-5621481,18 of 141,1.682857526162013e-08,2.196129071641427e-07,0,0,5.845813427206437,104.64115636109892,LYN;NFKB1;PSMB10;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;MUC13
1287,Reactome_2022,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,12 of 58,1.7517689576453105e-08,2.257835545409512e-07,0,0,10.334366421677146,184.57234889504687,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1288,Reactome_2022,Regulation Of IFNG Signaling R-HSA-877312,7 of 14,1.7981913127174047e-08,2.2894045493621595e-07,0,0,39.29435483870968,700.7715715938344,PTPN1;SOCS3;SOCS1;STAT1;JAK2;PTPN2;JAK1
1289,Reactome_2022,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,14 of 84,2.143044145219504e-08,2.695588057360436e-07,0,0,7.94560327198364,140.3070653352424,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1290,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,19 of 162,2.749171652241429e-08,3.4168276249286337e-07,0,0,5.313038201467953,92.4967068217324,GSDMD;RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;CTSS;HSP90B1;NFKB2;NFKBIA;SOCS1;UBB;CTSL;UBC;IRF7;MAP3K8;LGMN;BIRC3
1291,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,15 of 100,2.9474597404163844e-08,3.620174081170242e-07,0,0,7.0197685631629705,121.720941033649,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TRIM21;NFE2L2
1292,Reactome_2022,TCR Signaling R-HSA-202403,16 of 116,3.4740512029750494e-08,4.2173365766348274e-07,0,0,6.372731006160164,109.45394499095543,RIPK2;NFKB1;PSMB10;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1293,Reactome_2022,Asymmetric Localization Of PCP Proteins R-HSA-4608870,12 of 62,3.87305317681547e-08,4.647663812178565e-07,0,0,9.505661914460283,162.2296871693858,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1294,Reactome_2022,Ub-specific Processing Proteases R-HSA-5689880,21 of 201,3.987834362548305e-08,4.731021675568671e-07,0,0,4.675622406639004,79.66060080578366,USP15;MAT2B;HIF1A;TANK;USP18;PSMB8;PSMB10;PSMB9;IFIH1;NFKBIA;CYLD;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;BIRC3
1295,Reactome_2022,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,12 of 63,4.6764452190567345e-08,5.485627874938461e-07,0,0,9.318797172636875,157.2839865265321,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1296,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,12 of 67,9.593378565355403e-08,1.1006029914539604e-06,0,0,8.63928902055175,139.60752065531284,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1297,Reactome_2022,Regulation Of PTEN Stability And Activity R-HSA-8948751,12 of 67,9.593378565355403e-08,1.1006029914539604e-06,0,0,8.63928902055175,139.60752065531284,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1298,Reactome_2022,Interleukin-6 Signaling R-HSA-1059683,6 of 11,1.0195661933707103e-07,1.1569859846511105e-06,0,0,47.06317907444668,757.6568676222387,SOCS3;STAT1;STAT3;IL6ST;JAK2;JAK1
1299,Reactome_2022,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,13 of 83,1.4657646715806024e-07,1.6247683659233248e-06,0,0,7.363002915451895,115.86214181469722,STAT1;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;HERC5;OAS1;UBB;OAS3;UBC;JAK1
1300,Reactome_2022,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,9 of 35,1.4784769613286958e-07,1.6247683659233248e-06,0,0,13.643646838990968,214.57476862301715,HERC5;IFIH1;CYLD;UBB;UBE2D3;UBC;NLRC5;UBE2L6;ISG15
1301,Reactome_2022,Regulation Of TNFR1 Signaling R-HSA-5357905,9 of 35,1.4784769613286958e-07,1.6247683659233248e-06,0,0,13.643646838990968,214.57476862301715,CYLD;UBB;SPPL2A;UBC;CFLAR;RBCK1;TANK;TNFRSF1A;BIRC3
1302,Reactome_2022,Hedgehog Off State R-HSA-5610787,14 of 98,1.5971666038591616e-07,1.7369186816968385e-06,0,0,6.616564417177914,103.54833634714588,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;IFT57
1303,Reactome_2022,Hedgehog On State R-HSA-5632684,13 of 85,1.9556644968970106e-07,2.104859520371628e-06,0,0,7.157738095238095,110.56819736334408,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1304,Reactome_2022,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,12 of 72,2.1929276668356454e-07,2.312541903208499e-06,0,0,7.917311608961303,121.39501595405656,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1305,Reactome_2022,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,12 of 72,2.1929276668356454e-07,2.312541903208499e-06,0,0,7.917311608961303,121.39501595405656,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1306,Reactome_2022,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,12 of 73,2.5651976539111695e-07,2.6289947075415748e-06,0,0,7.787118960969583,118.17778549184683,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1307,Reactome_2022,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,12 of 73,2.5651976539111695e-07,2.6289947075415748e-06,0,0,7.787118960969583,118.17778549184683,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1308,Reactome_2022,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,10 of 48,2.5685580475980905e-07,2.6289947075415748e-06,0,0,10.386996904024768,157.62009145363325,PSMA3;PSMA4;PSMB2;PSMB3;PSMA2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1309,Reactome_2022,ABC-family Proteins Mediated Transport R-HSA-382556,14 of 102,2.655261233958397e-07,2.6913521633520065e-06,0,0,6.314510131994795,95.61148735671702,ERLIN1;DERL1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1310,Reactome_2022,PCP/CE Pathway R-HSA-4086400,13 of 88,2.967361788372434e-07,2.9787747183277125e-06,0,0,6.870367346938775,103.26452312782772,PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1311,Reactome_2022,Transcriptional Regulation By RUNX2 R-HSA-8878166,15 of 119,3.109080275579536e-07,3.091314102576224e-06,0,0,5.731695302648172,85.88239667277782,CDKN1A;STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1312,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,12 of 75,3.482508143864449e-07,3.429941983202344e-06,0,0,7.539132964794879,112.1094922479739,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1313,Reactome_2022,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,10 of 50,3.856195231176869e-07,3.7162550498366096e-06,0,0,9.866632860040568,145.71452522705914,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1314,Reactome_2022,MAPK6/MAPK4 Signaling R-HSA-5687128,13 of 90,3.879998088430944e-07,3.7162550498366096e-06,0,0,6.691227140206732,98.77764138707433,PSMB10;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1315,Reactome_2022,Switching Of Origins To A Post-Replicative State R-HSA-69052,13 of 90,3.879998088430944e-07,3.7162550498366096e-06,0,0,6.691227140206732,98.77764138707433,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1316,Reactome_2022,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,12 of 76,4.0423399334878497e-07,3.836548082328468e-06,0,0,7.420952138492872,109.24585444881676,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1317,Reactome_2022,Beta-catenin Independent WNT Signaling R-HSA-3858494,16 of 142,5.958600435010672e-07,5.6043052740100375e-06,0,0,5.050943580717708,72.3964877079581,PSMB10;PSMB8;PSMB9;MOV10;GNG10;PSMA3;PSMA4;UBB;GNG5;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1318,Reactome_2022,Disease R-HSA-1643685,77 of 1736,6.522246399122235e-07,6.034099236689012e-06,0,0,1.943483686931717,27.68079870531697,CDKN1A;YWHAB;ACTG1;IFIH1;CTSL;PPP2R5E;MUC13;JAK2;B2M;JAK1;PSENEN;HSP90AA1;RIPK2;RHBDF2;HLA-B;PPP2R5B;HLA-C;AP3B1;LMO7;HLA-A;RANGAP1;HLA-F;PARP9;ATP1B1;RBX1;HLA-E;ETV6;BTC;PSMA3;PSMA4;PSMA2;RBP1;PSME1;SNRPG;IRF7;PSME2;SERPING1;TXNIP;PPIA;CHMP5;CEBPB;CEBPD;DERL1;RPS27L;GNS;TANK;PSMB10;GNG10;RNF213;GNG5;PSMB2;UBB;PSMB3;UBC;RBBP8;CHGA;GSDMD;LYN;APOBEC3G;STAT1;STAT2;STAT3;ERLIN1;EIF2AK2;ISG15;ARPC5;PARP14;CP;PSMB8;NFKB1;PML;PSMB9;NFKB2;NFKBIA;NMT1;CALR;NFE2L2
1319,Reactome_2022,Metabolism Of Proteins R-HSA-392499,82 of 1890,6.53116105120554e-07,6.034099236689012e-06,0,0,1.905621360855948,27.13892742161625,ARF3;RAB3B;CSF1;UBE2D3;CTSZ;UBE2L6;UBE2Z;IFIH1;NUB1;MUC13;FBXO6;QSOX1;TIMP1;FBXO7;B2M;PSENEN;PDIA3;RAB2B;RIPK2;HLA-B;SHISA5;LMO7;HLA-A;RANGAP1;PDIA6;RBX1;PSMA3;RCN1;PSMA4;VGF;PSMA2;PPA1;PSME1;PSME2;SCG3;TOP1;LY6E;BIRC3;SP100;USP15;EPAS1;UBA6;DERL1;RPS27L;MRPL14;MAT2B;HIF1A;TANK;USP18;PSMB10;HSP90B1;SOCS3;GNG10;GNG5;PSMB2;UBB;PSMB3;LMAN2;UBD;UBC;APOL1;CHGA;HSPA8;TRAPPC4;STAT3;RAB27A;CP;PSMB8;PML;PSMB9;NFKB2;NFKBIA;CYLD;SPCS1;KLHL5;TNIP1;NUCB1;P4HB;CALR;ITM2B;MSRB1;NFE2L2
1320,Reactome_2022,Deubiquitination R-HSA-5688426,23 of 279,6.884792364277274e-07,6.305020375706556e-06,0,0,3.601424153645833,51.099817440665966,USP15;RIPK2;MAT2B;HIF1A;TANK;USP18;PSMB8;PSMB10;PSMB9;IFIH1;NFKBIA;CYLD;PSMA3;PSMA4;PSMB2;UBB;TNIP1;PSMA2;PSMB3;UBC;PSME1;PSME2;BIRC3
1321,Reactome_2022,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,12 of 80,7.16695393319558e-07,6.506347744570596e-06,0,0,6.982987899844256,98.7996067970498,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1322,Reactome_2022,Transcriptional Regulation By RUNX3 R-HSA-8878159,13 of 95,7.349108625936332e-07,6.557666158527803e-06,0,0,6.281607765057243,88.71839167306464,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1323,Reactome_2022,UCH Proteinases R-HSA-5689603,13 of 95,7.349108625936332e-07,6.557666158527803e-06,0,0,6.281607765057243,88.71839167306464,USP15;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1324,Reactome_2022,Interleukin-12 Family Signaling R-HSA-447115,10 of 54,8.209644379733447e-07,7.263448078340439e-06,0,0,8.967822238613314,125.66417430971744,GSTO1;STAT1;STAT3;HNRNPA2B1;PSME2;P4HB;JAK2;IL6ST;PPIA;JAK1
1325,Reactome_2022,Mitotic G1 Phase And G1/S Transition R-HSA-453279,16 of 147,9.528035074634768e-07,8.35904925875521e-06,0,0,4.856905497123689,67.33544394340922,LYN;CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1326,Reactome_2022,Signaling By NOTCH R-HSA-157118,19 of 203,9.714797493945647e-07,8.451873819732712e-06,0,0,4.120407384117859,57.04475510884462,PSENEN;STAT1;WWC1;HIF1A;PSMB8;PSMB10;PSMB9;RBX1;MOV10;PSMA3;PSMA4;PSMB2;UBB;ELF3;PSMA2;PSMB3;UBC;PSME1;PSME2
1327,Reactome_2022,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,15 of 130,9.859884755845283e-07,8.50720635132436e-06,0,0,5.180506058446187,71.64443625958485,LYN;NFKB1;PSMB10;PSMB8;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1328,Reactome_2022,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,13 of 98,1.0566959339423692e-06,9.042545533080602e-06,0,0,6.058967587034814,83.37359680427399,LMO1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1329,Reactome_2022,TNF Signaling R-HSA-75893,9 of 44,1.2139362358398215e-06,1.0303653904201412e-05,0,0,10.130595720069405,137.99535210380802,CYLD;UBB;SPPL2A;UBC;CFLAR;RBCK1;TANK;TNFRSF1A;BIRC3
1330,Reactome_2022,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,29 of 424,1.2432539855313631e-06,1.0467396458828576e-05,0,0,2.958703199273621,40.23179055456722,CDKN1A;CEBPB;YWHAB;PSMB10;RNF213;PSMB2;UBB;PSMB3;PPP2R5E;UBC;JAK2;LYN;PSENEN;HSP90AA1;STAT1;STAT3;PPP2R5B;AP3B1;LMO7;PSMB8;PSMB9;RBX1;ETV6;BTC;PSMA3;PSMA4;PSMA2;PSME1;PSME2
1331,Reactome_2022,Growth Hormone Receptor Signaling R-HSA-982772,7 of 24,1.4573376031873422e-06,1.2171683661820683e-05,0,0,16.171726755218216,217.3302081210784,LYN;PTPN1;SOCS3;SOCS1;STAT1;STAT3;JAK2
1332,Reactome_2022,Interleukin-10 Signaling R-HSA-6783783,9 of 45,1.4839118022694782e-06,1.2198456075349096e-05,0,0,9.848684210526317,132.177505161744,CXCL10;CXCL8;CSF1;STAT3;TIMP1;CXCL2;ICAM1;JAK1;TNFRSF1A
1333,Reactome_2022,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,9 of 45,1.4839118022694782e-06,1.2198456075349096e-05,0,0,9.848684210526317,132.177505161744,NFKBIA;UBB;RIPK2;UBC;NLRC5;TANK;USP18;NFKB1;NFKB2
1334,Reactome_2022,HIV Infection R-HSA-162906,20 of 229,1.5044812633206376e-06,1.227092530395895e-05,0,0,3.8214112355988794,51.233898871528254,APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;NMT1;PSME2;B2M;PPIA;CHMP5
1335,Reactome_2022,Signaling By Hedgehog R-HSA-5358351,15 of 135,1.598937660684227e-06,1.294023967251421e-05,0,0,4.963370901639344,66.24199734218227,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;P4HB;IFT57
1336,Reactome_2022,Metabolism Of Polyamines R-HSA-351202,10 of 58,1.6359587659524391e-06,1.3138007320418049e-05,0,0,8.218813387423936,109.50156455622717,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1337,Reactome_2022,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,12 of 87,1.799251376942628e-06,1.4339072042199266e-05,0,0,6.3289613034623216,83.72038542535586,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1338,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,13 of 103,1.877602180251804e-06,1.4850126334718816e-05,0,0,5.720884353741496,75.43280663812692,RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;NFKB2;NFKBIA;UBB;UBC;IRF7;MAP3K8;BIRC3
1339,Reactome_2022,Regulation Of IFNA/IFNB Signaling R-HSA-912694,7 of 25,1.980388264755593e-06,1.554530337146496e-05,0,0,15.272513440860216,200.5619704025362,SOCS3;PTPN1;SOCS1;STAT1;STAT2;USP18;JAK1
1340,Reactome_2022,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,14 of 121,2.18651280301406e-06,1.7035219151840886e-05,0,0,5.188158171358676,67.61831662329956,HSP90AA1;RIPK2;STAT1;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;HLA-E;IFIH1;IRF7;B2M;JAK1
1341,Reactome_2022,SARS-CoV Infections R-HSA-9679506,26 of 369,2.573505434773959e-06,1.990177536225195e-05,0,0,3.043829571361339,39.17482199101077,YWHAB;RPS27L;IFIH1;UBB;CTSL;UBC;JAK2;B2M;JAK1;HSP90AA1;RIPK2;STAT1;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PARP14;PARP9;ATP1B1;HLA-E;RBX1;SNRPG;IRF7;NFE2L2
1342,Reactome_2022,Post-translational Protein Phosphorylation R-HSA-8957275,13 of 106,2.606564524033391e-06,1.993119702702874e-05,0,0,5.535483870967742,71.17235920077981,CSF1;SHISA5;PDIA6;CP;HSP90B1;RCN1;VGF;NUCB1;SCG3;QSOX1;TIMP1;P4HB;APOL1
1343,Reactome_2022,ISG15 Antiviral Mechanism R-HSA-1169408,11 of 75,2.615492330175227e-06,1.993119702702874e-05,0,0,6.788713160569106,87.26251411380383,HERC5;UBB;STAT1;UBC;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;JAK1
1344,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,13 of 107,2.9000766069086114e-06,2.1939709982699928e-05,0,0,5.476313504125054,69.82723258663614,RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;NFKB2;NFKBIA;UBB;UBC;IRF7;MAP3K8;BIRC3
1345,Reactome_2022,SARS-CoV-2 Infection R-HSA-9694516,22 of 283,3.164279690777967e-06,2.3766244583972645e-05,0,0,3.3709465433603363,42.68826846699852,HSP90AA1;RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;RPS27L;ISG15;HLA-A;HLA-F;PARP14;PARP9;HLA-E;IFIH1;UBB;CTSL;UBC;SNRPG;IRF7;B2M;JAK1
1346,Reactome_2022,Interleukin-27 Signaling R-HSA-9020956,5 of 11,4.020521274428068e-06,2.9981601503592167e-05,0,0,32.61546184738956,405.21772671017067,STAT1;STAT3;IL6ST;JAK2;JAK1
1347,Reactome_2022,Transcriptional Regulation By RUNX1 R-HSA-8878171,18 of 204,4.332684458345526e-06,3.208030194689879e-05,0,0,3.8532091785833056,47.58452566060728,LMO1;PCGF5;PSMB8;PSMB10;PML;PSMB9;MOV10;SOCS3;PSMA3;PSMA4;PSMB2;UBB;CTSL;PSMA2;PSMB3;UBC;PSME1;PSME2
1348,Reactome_2022,G1/S Transition R-HSA-69206,14 of 129,4.691150467909278e-06,3.448986682040343e-05,0,0,4.825251178091936,59.20502470640453,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1349,Reactome_2022,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9 of 52,5.269961721074541e-06,3.847440585176099e-05,0,0,8.242444214292439,100.1744423898328,BTC;SOCS3;PTPN1;UBB;EPAS1;UBC;STAT3;STAP2;HIF1A
1350,Reactome_2022,Interleukin-35 Signaling R-HSA-8984722,5 of 12,6.749799314881756e-06,4.893604503289273e-05,0,0,27.95467584624211,332.82830869597984,STAT1;STAT3;IL6ST;JAK2;JAK1
1351,Reactome_2022,MAPK1/MAPK3 Signaling R-HSA-5684996,21 of 277,7.79019316897655e-06,5.608939081663117e-05,0,0,3.2746126167012446,38.5181053997195,DUSP5;YWHAB;PPP2R5B;PSMB8;PSMB10;PSMB9;RBX1;BTC;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;JAK2;IL6ST;JAK1
1352,Reactome_2022,Synthesis Of DNA R-HSA-69239,13 of 119,9.50914483596392e-06,6.799689869004337e-05,0,0,4.853350019252984,56.120531681364085,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1353,Reactome_2022,SARS-CoV-2-host Interactions R-HSA-9705683,17 of 196,1.0002229010091012e-05,7.103623868391168e-05,0,0,3.775041956916569,43.4609353102215,HSP90AA1;RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;RPS27L;ISG15;HLA-A;HLA-F;HLA-E;IFIH1;SNRPG;IRF7;B2M;JAK1
1354,Reactome_2022,Death Receptor Signaling R-HSA-73887,14 of 139,1.1207063267105604e-05,7.852465805945135e-05,0,0,4.436940695296523,50.5765375920724,PSENEN;RIPK2;SPPL2A;CFLAR;TANK;NFKB1;TNFRSF1A;NFKBIA;CYLD;UBB;UBC;TNFSF10;RBCK1;BIRC3
1355,Reactome_2022,PTEN Regulation R-HSA-6807070,14 of 139,1.1207063267105604e-05,7.852465805945135e-05,0,0,4.436940695296523,50.5765375920724,PSMB10;PML;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1356,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,14 of 140,1.2170728056898554e-05,8.470826727601393e-05,0,0,4.401499659168371,49.80946890517574,RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;NFKB2;NFKBIA;SOCS1;UBB;UBC;IRF7;MAP3K8;BIRC3
1357,Reactome_2022,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,4 of 7,1.3028029003799824e-05,9.007458463554316e-05,0,0,52.08817635270541,585.9090306450679,DHX36;IRF7;NFKB1;NFKB2
1358,Reactome_2022,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,13 of 123,1.3650648311412868e-05,9.375840024417784e-05,0,0,4.675899814471243,52.378137032355056,CSF1;SHISA5;PDIA6;CP;HSP90B1;RCN1;VGF;NUCB1;SCG3;QSOX1;TIMP1;P4HB;APOL1
1359,Reactome_2022,S Phase R-HSA-69242,15 of 161,1.4137975046596676e-05,9.647088855324792e-05,0,0,4.07400909499214,45.49301783390496,CDKN1A;MAX;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1360,Reactome_2022,G2/M Transition R-HSA-69275,16 of 182,1.5346157439485475e-05,0.00010403498939495348,0,0,3.8259320650157096,42.40910043714152,CDKN1A;HSP90AA1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1361,Reactome_2022,Mitotic G2-G2/M Phases R-HSA-453274,16 of 184,1.7590414324355795e-05,0.0001184799519653384,0,0,3.779994133176885,41.383967131022665,CDKN1A;HSP90AA1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1362,Reactome_2022,RAF/MAP Kinase Cascade R-HSA-5673001,20 of 271,1.8896971534422265e-05,0.0001264643479611336,0,0,3.1750430988262277,34.533384474678975,DUSP5;YWHAB;PPP2R5B;PSMB8;PSMB10;PSMB9;RBX1;BTC;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;JAK2;JAK1
1363,Reactome_2022,MAPK Family Signaling Cascades R-HSA-5683057,22 of 318,2.006793871206363e-05,0.00013344540137193904,0,0,2.966946676406136,32.09164377297035,DUSP5;YWHAB;PPP2R5B;PSMB8;PSMB10;PSMB9;RBX1;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;JAK2;IL6ST;JAK1
1364,Reactome_2022,Assembly Of Pre-Replicative Complex R-HSA-68867,12 of 110,2.116265387593821e-05,0.00013983424459797144,0,0,4.837856935034706,52.071172698263446,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1365,Reactome_2022,Interleukin-6 Family Signaling R-HSA-6783589,6 of 24,2.2480804502317315e-05,0.00014760981069446088,0,0,13.064386317907443,139.8261507213059,SOCS3;STAT1;STAT3;IL6ST;JAK2;JAK1
1366,Reactome_2022,G2/M Checkpoints R-HSA-69481,14 of 148,2.291130093639283e-05,0.00014949623860996324,0,0,4.137014314928425,44.19936565096381,YWHAB;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;RBBP8;PSME2
1367,Reactome_2022,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,9 of 63,2.653732283778147e-05,0.00017208052821517924,0,0,6.559716599190283,69.11946096656777,NFKBIA;UBB;DHX36;UBC;IRF7;TRIM21;NFKB1;TRIM56;NFKB2
1368,Reactome_2022,Separation Of Sister Chromatids R-HSA-2467813,15 of 170,2.6981405871290283e-05,0.0001738801711705374,0,0,3.835668958223162,40.35262825651423,PPP2R5B;RANGAP1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
1369,Reactome_2022,p75NTR Signals Via NF-kB R-HSA-193639,5 of 16,3.424523123816065e-05,0.0002193375546787713,0,0,17.785688207374953,182.87179229070244,NFKBIA;UBB;RIPK2;UBC;NFKB1
1370,Reactome_2022,Interleukin-20 Family Signaling R-HSA-8854691,6 of 26,3.684568406580794e-05,0.00023455423271160668,0,0,11.756740442655936,120.02188344025308,SOCS3;STAT1;STAT2;STAT3;JAK2;JAK1
1371,Reactome_2022,Disorders Of Transmembrane Transporters R-HSA-5619115,15 of 176,4.045937962812273e-05,0.0002559975292833947,0,0,3.6915792689135527,37.341107138813264,ERLIN1;DERL1;CP;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1372,Reactome_2022,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,11 of 102,5.171173102623988e-05,0.0003252231758517737,0,0,4.767845975163048,47.057809675992665,NFKBIA;UBB;RIPK2;UBC;IRF7;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1373,Reactome_2022,PIP3 Activates AKT Signaling R-HSA-1257604,19 of 268,5.252784371952023e-05,0.00032837765774358755,0,0,3.03455142885592,29.90297707317253,CDKN1A;PPP2R5B;PSMB8;PSMB10;PML;PSMB9;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;IER3
1374,Reactome_2022,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,11 of 103,5.660530390770393e-05,0.0003517615314264459,0,0,4.715778543655002,46.11752179605919,NFKBIA;UBB;RIPK2;UBC;IRF7;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1375,Reactome_2022,Signal Transduction R-HSA-162582,92 of 2465,6.047202657093292e-05,0.0003735668386985442,0,0,1.615301091045552,15.689952014576503,CDKN1A;CXCL9;CXCL8;YWHAB;WWC1;UBE2D3;SPPL2A;CXCL3;CXCL2;CX3CL1;CXCL16;ACTG1;RND1;GRM4;PPP2R5E;EPSTI1;TNFSF10;FLOT1;MUC13;JAK2;IFT57;IER3;JAK1;PSENEN;DUSP5;HSP90AA1;ATP6V1G1;RIPK2;ITGA3;PPP2R5B;RANGAP1;SSTR2;RBX1;TNFRSF1A;UHMK1;BTC;PSMA3;PSMA4;SPINT1;ELF3;VGF;PSMA2;ALDH1A1;PSME1;PSME2;RBCK1;IL6ST;PFN1;FKBP5;BIRC3;CD274;USP15;EPAS1;HIF1A;TANK;PSMB10;MYL12B;SOCS3;GNG10;SOCS1;GNG5;PSMB2;UBB;PSMB3;UBD;UBC;CTNNA1;STOM;STAP2;SKIL;CHGA;LYN;IL32;PTPN1;STAT1;STAT3;ARPC5;CFLAR;PSMB8;NFKB1;PML;PSMB9;NFKBIA;MOV10;CYLD;CXCL10;CXCL11;LPAR6;ID1;P4HB;PTPN2;CDC42SE2
1376,Reactome_2022,Regulation Of NF-kappa B Signaling R-HSA-9758274,5 of 18,6.44323868113166e-05,0.0003956906578294973,0,0,15.047883843064566,145.210486274131,UBB;UBC;NLRC5;TANK;USP18
1377,Reactome_2022,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,11 of 106,7.374244064747772e-05,0.00045021700605828505,0,0,4.566153187847668,43.44663739305047,NFKBIA;UBB;RIPK2;UBC;IRF7;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1378,Reactome_2022,Chemokine Receptors Bind Chemokines R-HSA-380108,8 of 56,7.445728717289984e-05,0.0004519384174913223,0,0,6.548484848484849,62.245214302277645,CXCL10;CXCL9;CXCL11;CXCL8;CXCL3;CXCL2;CX3CL1;CXCL16
1379,Reactome_2022,Cytoprotection By HMOX1 R-HSA-9707564,8 of 57,8.473149939125847e-05,0.0005113276610663228,0,0,6.414512471655329,60.14261731347375,HELZ2;COX7B;HM13;STAT3;TXNIP;COX14;STAP2;NFE2L2
1380,Reactome_2022,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,14 of 167,8.67577512445179e-05,0.0005205465074671074,0,0,3.619712097517944,33.85296208909562,RPS27L;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1381,Reactome_2022,DNA Replication Pre-Initiation R-HSA-69002,12 of 127,8.80292563615799e-05,0.0005251573922370823,0,0,4.119082617550695,38.46333994938581,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1382,Reactome_2022,Interleukin-12 Signaling R-HSA-9020591,7 of 44,0.00010443632093316556,0.0006194972673535503,0,0,7.422624237140366,68.04269937304761,GSTO1;HNRNPA2B1;PSME2;P4HB;JAK2;PPIA;JAK1
1383,Reactome_2022,Metallothioneins Bind Metals R-HSA-5661231,4 of 11,0.00011335255492232898,0.0006685879510672963,0,0,22.31892356140853,202.7675910975761,MT2A;MT1F;MT1X;MT1E
1384,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,11 of 112,0.00012162961580376572,0.000713378196062536,0,0,4.293568381228367,38.70450126759616,NFKBIA;SOCS1;UBB;RIPK2;UBC;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1385,Reactome_2022,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,10 of 96,0.00015088445761624316,0.0008800188477729489,0,0,4.578281994433699,40.28428585048773,NFKBIA;UBB;RIPK2;UBC;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1386,Reactome_2022,DNA Replication R-HSA-69306,13 of 155,0.0001531945673718163,0.0008854074783151991,0,0,3.616197183098592,31.76395918974746,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1387,Reactome_2022,TCF Dependent Signaling In Response To WNT R-HSA-201681,15 of 198,0.00015350455323280752,0.0008854074783151991,0,0,3.244087610857296,28.488864765354588,PPP2R5B;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
1388,Reactome_2022,TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,4 of 12,0.000166654364536479,0.0009559733877806818,0,0,19.528056112224448,169.88605362550462,UBB;UBC;IRF7;TANK
1389,Reactome_2022,Signaling By WNT R-HSA-195721,19 of 294,0.0001776525985330464,0.0010134935129426,0,0,2.7439368895567244,23.6957625876606,PPP2R5B;PSMB8;PSMB10;PSMB9;RBX1;MOV10;GNG10;PSMA3;PSMA4;PSMB2;UBB;GNG5;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;PFN1
1390,Reactome_2022,Cell Cycle Checkpoints R-HSA-69620,18 of 271,0.0001864949438082908,0.0010581560942166,0,0,2.822965649321544,24.2411064795098,CDKN1A;YWHAB;PPP2R5B;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;RBBP8;PSME2
1391,Reactome_2022,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,10 of 101,0.0002298591407128082,0.0012971510427252,0,0,4.325613534538483,36.24017994983745,NFKBIA;UBB;RIPK2;UBC;NLRC5;MAP3K8;TANK;USP18;NFKB1;NFKB2
1392,Reactome_2022,NF-kB Is Activated And Signals Survival R-HSA-209560,4 of 13,0.00023594938492472531,0.0013172789190449,0,0,17.357381429525716,144.966996739894,NFKBIA;UBB;UBC;NFKB1
1393,Reactome_2022,Trafficking And Processing Of Endosomal TLR R-HSA-1679131,4 of 13,0.00023594938492472531,0.0013172789190449,0,0,17.357381429525716,144.966996739894,CTSL;CTSS;HSP90B1;LGMN
1394,Reactome_2022,Signaling By ROBO Receptors R-HSA-376176,15 of 209,0.0002766817107894693,0.0015364665216181,0,0,3.0584016393442623,25.056392081304523,RPS27L;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1395,Reactome_2022,Intracellular Signaling By Second Messengers R-HSA-9006925,19 of 306,0.00029507899135995235,0.0016299601427502,0,0,2.6275664468569127,21.357562875633764,CDKN1A;PPP2R5B;PSMB8;PSMB10;PML;PSMB9;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;IER3
1396,Reactome_2022,Response To Metal Ions R-HSA-5660526,4 of 14,0.000323784061865734,0.0017791082136201,0,0,15.620841683366734,125.52023831110846,MT2A;MT1F;MT1X;MT1E
1397,Reactome_2022,TRAF6 Mediated NF-kB Activation R-HSA-933542,5 of 25,0.00034547071097728227,0.0018800383458366,0,0,9.777610441767068,77.93344810073964,IFIH1;NFKBIA;TANK;NFKB1;NFKB2
1398,Reactome_2022,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",7 of 53,0.0003457541785446646,0.0018800383458366,0,0,5.967610448807855,47.5605573339088,CYLD;RIPK2;CASP4;TXNIP;NFKB1;BIRC3;NFKB2
1399,Reactome_2022,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,5 of 26,0.00041895327785028847,0.0022662550366616,0,0,9.311531841652323,72.4227775173303,CYLD;RBCK1;TANK;TNFRSF1A;BIRC3
1400,Reactome_2022,Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,4 of 15,0.000432782759660286,0.0023289958818831,0,0,14.200036436509382,109.98318246302772,UBB;UBC;TRIM21;TRIM56
1401,Reactome_2022,IkBA Variant Leads To EDA-ID R-HSA-5603029,3 of 7,0.0005132342717553011,0.0027337580597578,0,0,29.2395,221.48272562766405,NFKBIA;NFKB1;NFKB2
1402,Reactome_2022,Modulation By Mtb Of Host Immune System R-HSA-9637628,3 of 7,0.0005132342717553011,0.0027337580597578,0,0,29.2395,221.48272562766405,UBB;UBC;B2M
1403,Reactome_2022,Negative Regulation Of MAPK Pathway R-HSA-5675221,6 of 41,0.0005229626287543561,0.0027714364691347,0,0,6.712963495257258,50.723155875646,DUSP5;UBB;YWHAB;PPP2R5E;UBC;PPP2R5B
1404,Reactome_2022,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,4 of 16,0.0005656294126134083,0.0029824096301434,0,0,13.016032064128256,97.32830965394106,UBB;UBC;MAP3K8;NFKB1
1405,Reactome_2022,Protein Ubiquitination R-HSA-8852135,8 of 76,0.0006377478190868717,0.0033457724780235,0,0,4.617706476530006,33.9750876533707,UBB;UBA6;UBE2D3;UBC;HLA-B;DERL1;HLA-A;UBE2Z
1406,Reactome_2022,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,4 of 17,0.0007250505492874883,0.0037659341962991,0,0,12.014182210574996,86.85375720646778,UBB;UBC;IRF7;TANK
1407,Reactome_2022,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,4 of 17,0.0007250505492874883,0.0037659341962991,0,0,12.014182210574996,86.85375720646778,CD40;TNFRSF12A;TANK;BIRC3
1408,Reactome_2022,Mitotic Anaphase R-HSA-68882,15 of 232,0.0008262180213639016,0.004270156506455,0,0,2.730981340182821,19.386285799851983,PPP2R5B;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
1409,Reactome_2022,Mitotic Metaphase And Anaphase R-HSA-2555396,15 of 233,0.0008631993519214073,0.0044393109527386,0,0,2.71831290419612,19.177330280913434,PPP2R5B;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
1410,Reactome_2022,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,5 of 31,0.0009758433356001084,0.0049940217763064,0,0,7.518921841210997,52.12273390779109,UBB;STAT1;UBE2D3;UBC;SKIL
1411,Reactome_2022,Signaling By MET R-HSA-6806834,7 of 63,0.0010003507084662,0.0050944689738474,0,0,4.899445564516129,33.842452986569384,PTPN1;SPINT1;UBB;ITGA3;UBC;STAT3;PTPN2
1412,Reactome_2022,Nicotinamide Salvaging R-HSA-197264,4 of 19,0.0011346425319512,0.0056950327084478,0,0,10.41122244488978,70.60305563582463,NNMT;NAMPT;PARP14;PARP9
1413,Reactome_2022,Signaling By KIT In Disease R-HSA-9669938,4 of 19,0.0011346425319512,0.0056950327084478,0,0,10.41122244488978,70.60305563582463,LYN;STAT1;STAT3;JAK2
1414,Reactome_2022,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",4 of 19,0.0011346425319512,0.0056950327084478,0,0,10.41122244488978,70.60305563582463,UBB;UBE2D3;UBC;BIRC3
1415,Reactome_2022,ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,HSPA5;CALR;HSP90B1
1416,Reactome_2022,Interleukin-1 Processing R-HSA-448706,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,GSDMD;NFKB1;NFKB2
1417,Reactome_2022,Interleukin-23 Signaling R-HSA-9020933,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,STAT3;P4HB;JAK2
1418,Reactome_2022,Interleukin-9 Signaling R-HSA-8985947,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,STAT1;STAT3;JAK1
1419,Reactome_2022,MAPK1 (ERK2) Activation R-HSA-112411,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,IL6ST;JAK2;JAK1
1420,Reactome_2022,Regulation Of PTEN Localization R-HSA-8948747,3 of 9,0.0011862577484359,0.0057871639690053,0,0,19.491,131.30992512056272,UBB;UBC;PML
1421,Reactome_2022,Platelet Degranulation R-HSA-114608,10 of 125,0.0012442324032087,0.0060417610648835,0,0,3.418643619366787,22.868115620407732,LGALS3BP;HSPA5;TMSB4X;ENDOD1;SERPING1;SCG3;QSOX1;TIMP1;PFN1;PPIA
1422,Reactome_2022,Oncogene Induced Senescence R-HSA-2559585,5 of 33,0.001307968730812,0.0063218488655914,0,0,6.9811388410786,46.3497350124518,MOV10;UBB;UBC;ID1;ETS2
1423,Reactome_2022,Chaperone Mediated Autophagy R-HSA-9613829,4 of 20,0.0013903443947925,0.0066890301758681,0,0,9.76002004008016,64.2034008814805,HSPA8;HSP90AA1;UBB;UBC
1424,Reactome_2022,Nervous System Development R-HSA-9675108,26 of 545,0.0014665462713032,0.0070232766387182,0,0,1.9931411398310728,13.00493723539922,RPS27L;PSMB10;MYL12B;ACTG1;RND1;SDCBP;PSMB2;UBB;PSMB3;UBC;LYN;PSENEN;HSPA8;HSP90AA1;CD72;ARPC5;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMA2;PSME1;PSME2;UTRN;PFN1
1425,Reactome_2022,Costimulation By CD28 Family R-HSA-388841,7 of 68,0.0015742155211743,0.007476831557421,0,0,4.496694870438922,29.02166065634204,LYN;CD274;PPP2R5E;PPP2R5B;HLA-DRA;MAP3K8;TNFRSF14
1426,Reactome_2022,Axon Guidance R-HSA-422475,25 of 519,0.0015755775312573,0.007476831557421,0,0,2.0119043585791,12.983087188612492,RPS27L;PSMB10;MYL12B;ACTG1;RND1;SDCBP;PSMB2;UBB;PSMB3;UBC;LYN;PSENEN;HSPA8;HSP90AA1;CD72;ARPC5;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMA2;PSME1;PSME2;PFN1
1427,Reactome_2022,Interleukin-21 Signaling R-HSA-9020958,3 of 10,0.001663115791958,0.0077860667569693,0,0,16.705714285714286,106.90090903355524,STAT1;STAT3;JAK1
1428,Reactome_2022,MAPK3 (ERK1) Activation R-HSA-110056,3 of 10,0.001663115791958,0.0077860667569693,0,0,16.705714285714286,106.90090903355524,IL6ST;JAK2;JAK1
1429,Reactome_2022,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,3 of 10,0.001663115791958,0.0077860667569693,0,0,16.705714285714286,106.90090903355524,CD274;STAT3;HIF1A
1430,Reactome_2022,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,10 of 130,0.0016727478206686,0.0077961996641878,0,0,3.2753549695740367,20.94028632287909,LGALS3BP;HSPA5;TMSB4X;ENDOD1;SERPING1;SCG3;QSOX1;TIMP1;PFN1;PPIA
1431,Reactome_2022,Negative Regulation Of MET Activity R-HSA-6807004,4 of 21,0.0016836572976231,0.0078121698609715,0,0,9.185429682895204,58.66538186713483,PTPN1;UBB;UBC;PTPN2
1432,Reactome_2022,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,5 of 35,0.0017168155397278,0.0079307762100702,0,0,6.515060240963855,41.48323970801261,PDIA3;UBB;UBC;DERL1;CALR
1433,Reactome_2022,Unfolded Protein Response (UPR) R-HSA-381119,8 of 89,0.0017994869558763,0.0082760545459689,0,0,3.873999251777029,24.484658024340632,CEBPB;CXCL8;HSPA5;PPP2R5B;CALR;PDIA6;ATF3;HSP90B1
1434,Reactome_2022,ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,HSPA5;CALR;HSP90B1
1435,Reactome_2022,CASP8 Activity Is Inhibited R-HSA-5218900,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,TNFSF10;CFLAR;TANK
1436,Reactome_2022,Dimerization Of Procaspase-8 R-HSA-69416,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,TNFSF10;CFLAR;TANK
1437,Reactome_2022,Pexophagy R-HSA-9664873,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,UBB;EPAS1;UBC
1438,Reactome_2022,Regulation Of BACH1 Activity R-HSA-9708530,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,UBB;UBC;RBX1
1439,Reactome_2022,Signaling By Leptin R-HSA-2586552,3 of 11,0.0022442799782903,0.0100559154392067,0,0,14.61675,89.15297421769729,SOCS3;STAT3;JAK2
1440,Reactome_2022,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,4 of 23,0.0023939935876958,0.0106354438534233,0,0,8.217698555004747,49.59210437713905,UBB;UBE2D3;UBC;BIRC3
1441,Reactome_2022,RAF-independent MAPK1/3 Activation R-HSA-112409,4 of 23,0.0023939935876958,0.0106354438534233,0,0,8.217698555004747,49.59210437713905,DUSP5;IL6ST;JAK2;JAK1
1442,Reactome_2022,Intrinsic Pathway For Apoptosis R-HSA-109606,6 of 55,0.002508351512635,0.0110962668609787,0,0,4.791524658153,28.692270200884288,GSDMD;CASP7;YWHAB;STAT3;NMT1;PMAIP1
1443,Reactome_2022,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,6 of 56,0.0027508444133176,0.0121176437447408,0,0,4.695452716297787,27.683672478139705,UBB;UBE2D3;UBC;HLA-B;DERL1;HLA-A
1444,Reactome_2022,Ovarian Tumor Domain Proteases R-HSA-5689896,5 of 39,0.0028043993923999,0.0123016511162418,0,0,5.747401370186629,33.77498280961888,IFIH1;UBB;TNIP1;RIPK2;UBC
1445,Reactome_2022,Signaling By EGFR In Cancer R-HSA-1643713,4 of 24,0.002816360536347,0.0123024284516582,0,0,7.806412825651303,45.84167467559578,BTC;HSP90AA1;UBB;UBC
1446,Reactome_2022,Butyrophilin (BTN) Family Interactions R-HSA-8851680,3 of 12,0.0029368250987252,0.012775189179455,0,0,12.992,75.7488969245148,BTN3A1;BTN3A3;BTN3A2
1447,Reactome_2022,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,4 of 25,0.0032870079937342,0.014239154960409,0,0,7.434297165760092,42.50765745209775,GSDMD;TXNIP;NFKB1;NFKB2
1448,Reactome_2022,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,5 of 41,0.00350334887549,0.015113620768643,0,0,5.427543507362785,30.687526091171424,HSP90AA1;FTH1;CALR;APOL1;HSP90B1
1449,Reactome_2022,Iron Uptake And Transport R-HSA-917937,6 of 59,0.0035840947205555,0.015398332873498,0,0,4.428989028510687,24.940741612283,ATP6V1G1;UBB;FTH1;UBC;LCN2;CP
1450,Reactome_2022,TNFR1-induced Proapoptotic Signaling R-HSA-5357786,3 of 13,0.0037470913195406,0.0159041889573893,0,0,11.6922,65.3216951926604,CYLD;TANK;TNFRSF1A
1451,Reactome_2022,p75NTR Recruits Signaling Complexes R-HSA-209543,3 of 13,0.0037470913195406,0.0159041889573893,0,0,11.6922,65.3216951926604,UBB;RIPK2;UBC
1452,Reactome_2022,Transport Of Small Molecules R-HSA-382551,30 of 706,0.0037840867286296,0.0159041889573893,0,0,1.7658593642493463,9.8481106320797,SLC43A2;DERL1;SLC5A4;PSMB10;GNG10;GNG5;PSMB2;UBB;PSMB3;FTH1;UBC;STOM;SLC12A7;SLC38A4;ATP6V1G1;ERLIN1;LSR;SLC50A1;ATP1B1;CP;SLC39A14;PSMB8;PSMB9;PSMA3;PSMA4;PSMA2;PSME1;LCN2;PSME2;P4HB
1453,Reactome_2022,Attenuation Phase R-HSA-3371568,4 of 26,0.0038084743671909,0.0159041889573893,0,0,7.096010202222627,39.52851357538448,HSPA8;HSP90AA1;UBB;HSBP1
1454,Reactome_2022,Calnexin/calreticulin Cycle R-HSA-901042,4 of 26,0.0038084743671909,0.0159041889573893,0,0,7.096010202222627,39.52851357538448,PDIA3;UBB;UBC;CALR
1455,Reactome_2022,Infection With Mycobacterium Tuberculosis R-HSA-9635486,4 of 26,0.0038084743671909,0.0159041889573893,0,0,7.096010202222627,39.52851357538448,RNF213;UBB;UBC;B2M
1456,Reactome_2022,Pyroptosis R-HSA-5620971,4 of 26,0.0038084743671909,0.0159041889573893,0,0,7.096010202222627,39.52851357538448,GSDMD;IRF1;CASP4;IRF2
1457,Reactome_2022,Signaling By SCF-KIT R-HSA-1433557,5 of 42,0.0038960558906386,0.016205108963453,0,0,5.280581786605883,29.2955617218686,LYN;SOCS1;STAT1;STAT3;JAK2
1458,Reactome_2022,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,7 of 81,0.004274476199745,0.0177085442560865,0,0,3.70425566695728,20.207061790813057,CDKN1A;CEBPB;CXCL8;UBB;UBC;STAT3;NFKB1
1459,Reactome_2022,FLT3 Signaling In Disease R-HSA-9682385,4 of 27,0.004383231678782,0.0180873275598752,0,0,6.787139496384072,36.853957067080295,CDKN1A;UBB;UBC;ETV6
1460,Reactome_2022,Methylation R-HSA-156581,3 of 14,0.0046807243157534,0.0192388826206559,0,0,10.628727272727271,57.01570735306985,NNMT;GSTO1;MAT2B
1461,Reactome_2022,"Platelet Activation, Signaling And Aggregation R-HSA-76002",14 of 254,0.0052039999086526,0.0213057878613074,0,0,2.2971881390593047,12.079368106161972,LYN;LGALS3BP;PTPN1;HSPA5;ENDOD1;GNG10;GNG5;TMSB4X;SERPING1;QSOX1;SCG3;TIMP1;PFN1;PPIA
1462,Reactome_2022,Budding And Maturation Of HIV Virion R-HSA-162588,4 of 29,0.0057021394494384,0.0231635548062793,0,0,6.243527054108217,32.25976629982229,UBB;UBC;PPIA;CHMP5
1463,Reactome_2022,Downregulation Of ERBB2 Signaling R-HSA-8863795,4 of 29,0.0057021394494384,0.0231635548062793,0,0,6.243527054108217,32.25976629982229,BTC;HSP90AA1;UBB;UBC
1464,Reactome_2022,PTK6 Expression R-HSA-8849473,2 of 5,0.0060024672366929,0.0241952733401831,0,0,25.940119760479043,132.69887945576022,EPAS1;HIF1A
1465,Reactome_2022,Regulation Of HMOX1 Expression And Activity R-HSA-9707587,2 of 5,0.0060024672366929,0.0241952733401831,0,0,25.940119760479043,132.69887945576022,HM13;NFE2L2
1466,Reactome_2022,Cyclin D Associated Events In G1 R-HSA-69231,5 of 47,0.0063421508818601,0.0254661750794691,0,0,4.650745840504877,23.535272855681967,LYN;CDKN1A;UBB;UBC;JAK2
1467,Reactome_2022,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,4 of 30,0.0064508506030574,0.0257049161434806,0,0,6.003083089255434,30.27680937665548,UBB;UBA6;UBC;UBE2Z
1468,Reactome_2022,Translation Of Structural Proteins R-HSA-9683701,4 of 30,0.0064508506030574,0.0257049161434806,0,0,6.003083089255434,30.27680937665548,UBB;UBC;PARP14;PARP9
1469,Reactome_2022,DNA Damage Bypass R-HSA-73893,5 of 48,0.0069365047280782,0.0272281070440618,0,0,4.542355468385169,22.57985495130606,UBB;UBC;UBE2L6;ISG15;RBX1
1470,Reactome_2022,Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,3 of 16,0.0069374295725291,0.0272281070440618,0,0,8.992615384615384,44.70070794198986,TNFSF10;CFLAR;TANK
1471,Reactome_2022,NRIF Signals Cell Death From Nucleus R-HSA-205043,3 of 16,0.0069374295725291,0.0272281070440618,0,0,8.992615384615384,44.70070794198986,PSENEN;UBB;UBC
1472,Reactome_2022,NLRP3 Inflammasome R-HSA-844456,3 of 16,0.0069374295725291,0.0272281070440618,0,0,8.992615384615384,44.70070794198986,TXNIP;NFKB1;NFKB2
1473,Reactome_2022,Nicotinate Metabolism R-HSA-196807,4 of 31,0.0072619651368549,0.028395099636242,0,0,5.780449788465821,28.46932103843721,NNMT;NAMPT;PARP14;PARP9
1474,Reactome_2022,Signaling By NOTCH3 R-HSA-9012852,5 of 49,0.0075687073013844,0.0294840687412141,0,0,4.438891931361811,21.67836297362191,PSENEN;UBB;STAT1;WWC1;UBC
1475,Reactome_2022,Circadian Clock R-HSA-400253,6 of 69,0.0077333225425296,0.0300133410200779,0,0,3.724058637539523,18.107180040910738,HELZ2;UBB;NAMPT;UBC;CREM;HIF1A
1476,Reactome_2022,PERK Regulates Gene Expression R-HSA-381042,4 of 32,0.0081375447965831,0.0312338116457087,0,0,5.573718866304037,26.816648347296947,CEBPB;CXCL8;HSPA5;ATF3
1477,Reactome_2022,RAF Activation R-HSA-5673000,4 of 32,0.0081375447965831,0.0312338116457087,0,0,5.573718866304037,26.816648347296947,YWHAB;PPP2R5E;PPP2R5B;JAK2
1478,Reactome_2022,Termination Of Translesion DNA Synthesis R-HSA-5656169,4 of 32,0.0081375447965831,0.0312338116457087,0,0,5.573718866304037,26.816648347296947,UBB;UBC;UBE2L6;ISG15
1479,Reactome_2022,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,3 of 17,0.0082686579796667,0.0313908324755349,0,0,8.349857142857143,40.03992850096259,IL6ST;JAK2;JAK1
1480,Reactome_2022,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,3 of 17,0.0082686579796667,0.0313908324755349,0,0,8.349857142857143,40.03992850096259,NFKBIA;NFKB1;NFKB2
1481,Reactome_2022,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",3 of 17,0.0082686579796667,0.0313908324755349,0,0,8.349857142857143,40.03992850096259,ZFP36;XRN1;YWHAB
1482,Reactome_2022,APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,2 of 6,0.0088542834833845,0.0332773694076555,0,0,19.454091816367267,91.9566503107693,APOBEC3G;PPIA
1483,Reactome_2022,Scavenging By Class F Receptors R-HSA-3000484,2 of 6,0.0088542834833845,0.0332773694076555,0,0,19.454091816367267,91.9566503107693,HSP90AA1;CALR
1484,Reactome_2022,trans-Golgi Network Vesicle Budding R-HSA-199992,6 of 71,0.0088612152254101,0.0332773694076555,0,0,3.609100758396533,17.05686774818585,VAMP8;HSPA8;FTH1;CTSZ;AP3B1;GNS
1485,Reactome_2022,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,5 of 51,0.0089512926614922,0.0334951596365517,0,0,4.245460101274664,20.021408665458434,UBB;STAT1;UBE2D3;UBC;SKIL
1486,Reactome_2022,Cellular Senescence R-HSA-2559583,10 of 165,0.0090576912873783,0.0337333036858928,0,0,2.5311784335536216,11.90702028858345,MOV10;CDKN1A;CEBPB;CXCL8;UBB;UBC;ID1;STAT3;ETS2;NFKB1
1487,Reactome_2022,NOD1/2 Signaling Pathway R-HSA-168638,4 of 33,0.0090795577928504,0.0337333036858928,0,0,5.381245249118927,25.30116108852838,CYLD;RIPK2;CASP4;BIRC3
1488,Reactome_2022,SARS-CoV-1 Infection R-HSA-9678108,5 of 52,0.0097039352640447,0.0358034438074799,0,0,4.154917542510467,19.25897259042515,UBB;CTSL;UBC;PARP9;PARP14
1489,Reactome_2022,Assembly Of HIV Virion R-HSA-175474,3 of 18,0.0097396341391995,0.0358034438074799,0,0,7.7928,36.09275628058279,UBB;UBC;PPIA
1490,Reactome_2022,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,3 of 18,0.0097396341391995,0.0358034438074799,0,0,7.7928,36.09275628058279,HSP90AA1;UBB;UBC
1491,Reactome_2022,Lysosome Vesicle Biogenesis R-HSA-432720,4 of 34,0.0100898761902971,0.0369608096234043,0,0,5.201603206412826,23.90772681291413,VAMP8;HSPA8;CTSZ;GNS
1492,Reactome_2022,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,4 of 35,0.0111702737589904,0.0405911300411346,0,0,5.033550972913569,22.62329060843702,GSTO1;HNRNPA2B1;PSME2;PPIA
1493,Reactome_2022,Potential Therapeutics For SARS R-HSA-9679191,7 of 97,0.0112356486376237,0.0405911300411346,0,0,3.0432123655913976,13.659956698353556,HSP90AA1;STAT2;ATP1B1;JAK2;RBX1;NFE2L2;JAK1
1494,Reactome_2022,Hemostasis R-HSA-109582,24 of 576,0.0113315473551606,0.0405911300411346,0,0,1.7196151402378144,7.704158948731146,LYN;LGALS3BP;PTPN1;CD74;HSPA5;ITGA3;ENDOD1;PPP2R5B;ATP1B1;EHD1;GNG10;GNG5;PPP2R5E;TMSB4X;IRF1;IRF2;SERPING1;QSOX1;SCG3;TIMP1;CD47;JAK2;PFN1;PPIA
1495,Reactome_2022,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",3 of 19,0.0113530746858345,0.0405911300411346,0,0,7.305375,32.71541740584069,HSPA8;GAD1;STXBP1
1496,Reactome_2022,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,3 of 19,0.0113530746858345,0.0405911300411346,0,0,7.305375,32.71541740584069,CEBPB;STAT3;RBX1
1497,Reactome_2022,Scavenging By Class A Receptors R-HSA-3000480,3 of 19,0.0113530746858345,0.0405911300411346,0,0,7.305375,32.71541740584069,FTH1;CALR;HSP90B1
1498,Reactome_2022,Signaling By PDGFR In Disease R-HSA-9671555,3 of 19,0.0113530746858345,0.0405911300411346,0,0,7.305375,32.71541740584069,STAT1;STAT3;ETV6
1499,Reactome_2022,Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,2 of 7,0.0121907154713434,0.0431012770607999,0,0,15.5624750499002,68.5850825637473,LYN;JAK2
1500,Reactome_2022,Erythropoietin Activates STAT5 R-HSA-9027283,2 of 7,0.0121907154713434,0.0431012770607999,0,0,15.5624750499002,68.5850825637473,LYN;JAK2
1501,Reactome_2022,FLT3 Signaling By CBL Mutants R-HSA-9706377,2 of 7,0.0121907154713434,0.0431012770607999,0,0,15.5624750499002,68.5850825637473,UBB;UBC
1502,Reactome_2022,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,5 of 55,0.0122202854501884,0.0431012770607999,0,0,3.905020080321285,17.200277805149266,CEBPB;RNF213;STAT3;LMO7;RBX1
1503,Reactome_2022,HSF1-dependent Transactivation R-HSA-3371571,4 of 36,0.0123224242560736,0.0433151882940771,0,0,4.876002004008016,21.436536155092032,HSPA8;HSP90AA1;UBB;HSBP1
1504,Reactome_2022,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,8 of 123,0.0125880148273696,0.0441002935562881,0,0,2.723864734299517,11.916935783201888,CD40;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
1505,Reactome_2022,CD209 (DC-SIGN) Signaling R-HSA-5621575,3 of 20,0.0131112082961751,0.0457796035491867,0,0,6.875294117647059,29.79950354932281,LYN;NFKB1;RELB
1506,Reactome_2022,"Cell Cycle, Mitotic R-HSA-69278",22 of 523,0.0135104547260047,0.0470163824464965,0,0,1.7342114108581177,7.464551381374044,LYN;CDKN1A;HSP90AA1;MAX;PPP2R5B;RANGAP1;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;JAK2;OPTN
2251,GO_Biological_Process_2023,Defense Response To Virus (GO:0051607),44 of 189,5.526670023391338e-30,1.4363815390794084e-26,0,0,12.793749530463526,861.8889002866194,IFITM3;RTP4;CD40;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;TANK;USP18;IFIT3;IFIT2;IFIH1;DHX58;PMAIP1;GBP2;TRIM21;GBP5;RAB2B;RSAD2;APOBEC3G;MLKL;STAT1;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;ISG20;NT5C3A;CXCL10;MOV10;PLSCR1;ZNFX1;OAS1;IRF1;OAS3;IRF2;IRF7;SHFL;TRIM56
2252,GO_Biological_Process_2023,Defense Response To Symbiont (GO:0140546),39 of 148,6.772036251387533e-29,8.800261108678101e-26,0,0,14.95041126225878,969.716055258508,IFITM3;RTP4;CD40;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;TANK;IFIT3;IFIT2;IFIH1;PMAIP1;GBP2;GBP5;RAB2B;RSAD2;APOBEC3G;MLKL;STAT1;STAT2;MX1;EIF2AK2;ISG15;BST2;ISG20;NT5C3A;MOV10;PLSCR1;ZNFX1;OAS1;IRF1;OAS3;IRF2;IRF7;SHFL;TRIM56
2253,GO_Biological_Process_2023,Response To Cytokine (GO:0034097),30 of 125,3.320866606675053e-21,2.8769774369161546e-18,0,0,12.953377100255926,610.8043362458899,IFITM3;CD274;CD40;SP100;CALCOCO2;ADAR;CXCL16;RELB;NUB1;LAMP3;UBD;TIMP1;JAK2;TRIM21;MCL1;CD74;GCH1;STAT1;MX1;EIF2AK2;ISG15;NFKB1;PML;NFKB2;BST2;PLSCR1;IL6ST;XAF1;SHFL;TRIM56
2254,GO_Biological_Process_2023,Negative Regulation Of Viral Process (GO:0048525),21 of 61,8.174705283321265e-19,5.311514757837991e-16,0,0,21.19279045643153,882.6388649661736,IFITM3;RSAD2;APOBEC3G;STAT1;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;ZFP36;PLSCR1;ZNFX1;OAS1;TNIP1;OAS3;TRIM21;PPIA;SHFL
2255,GO_Biological_Process_2023,Regulation Of Viral Genome Replication (GO:0045069),20 of 67,1.3683652322813738e-16,7.112762477398581e-14,0,0,17.13580899519845,625.9324565760096,IFITM3;CXCL8;RSAD2;STAU1;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;PLSCR1;ZNFX1;OAS1;TNIP1;OAS3;PPIA;SHFL
2256,GO_Biological_Process_2023,Negative Regulation Of Viral Genome Replication (GO:0045071),17 of 53,6.907759210824808e-15,2.992211031488946e-12,0,0,18.90929355281207,616.5589044363616,IFITM3;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;PLSCR1;ZNFX1;OAS1;TNIP1;OAS3;SHFL
2257,GO_Biological_Process_2023,Response To Type II Interferon (GO:0034341),19 of 80,8.16388746590449e-14,3.0311347891265376e-11,0,0,12.507925755317707,376.9447398096541,IFITM3;GBP5;CD74;CD40;SP100;GCH1;CALCOCO2;STAT1;CX3CL1;CXCL16;BST2;NUB1;UBD;CD47;GBP2;TRIM21;GBP1;SHFL;GBP4
2258,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),10 of 18,3.383974763545752e-12,1.099368801306926e-09,0,0,49.41430020283976,1305.1290210408772,PDIA3;ERAP2;TAP2;TAP1;HLA-A;TAPBPL;CALR;IFI30;B2M;TAPBP
2259,GO_Biological_Process_2023,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),27 of 232,3.873573829713976e-11,1.1068087504655682e-08,0,0,5.338020086083214,127.97507327151924,CD40;IFIT5;SECTM1;LITAF;TANK;CX3CL1;UBD;ZC3H12A;DHX36;MIER1;TNFSF10;S100A13;TRIM21;TRIM22;APOL2;CD74;RIPK2;STAT1;SHISA5;CFLAR;TNFRSF1A;BST2;TNIP1;RBCK1;TRIM38;OPTN;BIRC3
2260,GO_Biological_Process_2023,Positive Regulation Of Type I Interferon Production (GO:0032481),15 of 64,4.2585946535804856e-11,1.1068087504655682e-08,0,0,12.199732351957175,291.3234697888055,RAB2B;HSP90AA1;RIPK2;STAT1;ISG15;TANK;IFIH1;OAS1;IRF1;OAS3;DHX58;DHX36;FLOT1;IRF7;TRIM56
2261,GO_Biological_Process_2023,Cellular Response To Cytokine Stimulus (GO:0071345),30 of 308,2.7148682196679687e-10,6.414493184470048e-08,0,0,4.38476280286553,96.58364168915804,CD40;CXCL8;MT1X;CIB1;IFIT1;HIF1A;TANK;CX3CL1;MT2A;ZFP36;SOCS1;ZC3H12A;JAK2;GBP2;GBP1;GBP4;JAK1;IL13RA1;GBP3;GBP5;STAT1;STAT3;NFKB1;TNFRSF1A;NFKBIA;OAS1;IRF1;CD47;IL6ST;NFE2L2
2262,GO_Biological_Process_2023,Negative Regulation Of Innate Immune Response (GO:0045824),13 of 52,3.580997618946585e-10,7.755844009701811e-08,0,0,13.236734693877551,287.90175273854936,USP15;STAT2;NLRC5;TRAFD1;ISG15;SAMHD1;USP18;OAS1;OAS3;DHX58;SERPING1;TRIM21;PTPN2
2263,GO_Biological_Process_2023,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),22 of 175,5.81058939012938e-10,1.1616709096112508e-07,0,0,5.782723900370959,122.97638328380523,CD74;CD40;RIPK2;IFIT5;SHISA5;SECTM1;CFLAR;LITAF;CX3CL1;TNFRSF1A;BST2;UBD;DHX36;MIER1;TNFSF10;S100A13;RBCK1;TRIM38;TRIM21;TRIM22;BIRC3;APOL2
2264,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),8 of 15,8.345765071047469e-10,1.3710312875903236e-07,0,0,44.998556998557,940.6541867168028,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18;PTPN2
2265,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),9 of 21,8.422205994286646e-10,1.3710312875903236e-07,0,0,29.58248987854251,618.1255089637083,ERAP2;HLA-B;TAP2;HLA-C;TAP1;HLA-DRA;HLA-A;HLA-F;HLA-E
2266,GO_Biological_Process_2023,Regulation Of Innate Immune Response (GO:0045088),15 of 78,8.44036190898237e-10,1.3710312875903236e-07,0,0,9.481850117096018,198.10264220863567,GBP5;AKIRIN2;PTPN1;TRAFD1;IFI35;PARP9;SAMHD1;HLA-E;PLSCR1;IRF1;DHX58;TRIM21;BIRC3;TRIM56;NFE2L2
2267,GO_Biological_Process_2023,Cellular Response To Tumor Necrosis Factor (GO:0071356),18 of 119,1.060734729178855e-09,1.6216762124328496e-07,0,0,7.127243033581709,147.27951692879404,EIF5A;CD40;CXCL8;STAT1;CIB1;TANK;CX3CL1;TNFRSF1A;NFKBIA;ZFP36;TMSB4X;ZC3H12A;JAK2;GBP2;GBP1;NFE2L2;BIRC3;GBP3
2268,GO_Biological_Process_2023,Response To Tumor Necrosis Factor (GO:0034612),17 of 108,1.645400885224447e-09,2.375776055943521e-07,0,0,7.459458237236015,150.86964479806838,CD40;CXCL8;GCH1;CIB1;TANK;CX3CL1;CXCL16;NFKBIA;NUB1;ZFP36;UBD;ZC3H12A;JAK2;GBP2;GBP1;NFE2L2;GBP3
2269,GO_Biological_Process_2023,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),10 of 33,5.0990094249477925e-09,6.974908155494374e-07,0,0,17.174353999470853,327.9308858349268,PTPN1;OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18;PTPN2;TRIM56
2270,GO_Biological_Process_2023,Regulation Of Protein Deubiquitination (GO:0090085),5 of 5,9.866810605991536e-09,1.2821920382486e-06,0,0,97485.0,1797047.1833170792,OTUD4;TNIP1;ZC3H12A;TANK;TRIM21
2271,GO_Biological_Process_2023,Positive Regulation Of Interferon-Beta Production (GO:0032728),10 of 36,1.3085314283578305e-08,1.61946342014381e-06,0,0,15.190357310032766,275.7319523546871,IFIH1;HSP90AA1;OAS1;RIPK2;IRF1;OAS3;FLOT1;IRF7;ISG15;TRIM56
2272,GO_Biological_Process_2023,Cellular Response To Lipopolysaccharide (GO:0071222),17 of 124,1.4238093577665333e-08,1.6820366003796452e-06,0,0,6.338794661743779,114.52518888357584,LYN;CD274;CXCL9;CXCL8;CXCL3;CXCL2;NFKB1;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;ZC3H12A;GBP2;CD68;CHMP5;GBP3
2273,GO_Biological_Process_2023,Response To Type I Interferon (GO:0034340),6 of 9,1.9351760083371037e-08,2.186748889420927e-06,0,0,78.44668008048289,1393.2508857108494,SP100;MX1;ISG15;IFIT1;SHFL;TRIM56
2274,GO_Biological_Process_2023,Regulation Of Interferon-Beta Production (GO:0032648),11 of 50,3.5151218023519714e-08,3.8065839851303223e-06,0,0,11.154784240150091,191.45632803912923,IFIH1;HSP90AA1;OAS1;RIPK2;IRF1;OAS3;FLOT1;IRF7;ISG15;TRIM56;RELB
2275,GO_Biological_Process_2023,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),16 of 117,3.932522393720455e-08,4.0882502805117845e-06,0,0,6.309309370362088,107.58255586394498,CD274;CXCL9;CXCL8;CXCL3;CXCL2;NFKB1;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;ZC3H12A;GBP2;CD68;CHMP5;GBP3
2276,GO_Biological_Process_2023,Positive Regulation Of Cytokine Production (GO:0001819),27 of 320,4.588491110830247e-08,4.5867263065568505e-06,0,0,3.717756044397281,62.81940536113993,CD274;CD40;CEBPB;HIF1A;TANK;IFIH1;MDK;DHX58;S100A13;FLOT1;TNFRSF14;JAK2;GBP5;CD74;RAB2B;AKIRIN2;BTN3A1;RIPK2;STAT3;EIF2AK2;ISG15;HLA-A;BTN3A2;HLA-E;IRF1;IRF7;IL6ST
2277,GO_Biological_Process_2023,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),36 of 525,5.9603335919042446e-08,5.7373729649478266e-06,0,0,2.9964924265314434,49.84831244906475,CD40;WWC1;IFIT5;SECTM1;IFI35;TXN;LITAF;CX3CL1;SLC9A3R1;GRM4;UBD;DHX36;MIER1;S100A13;TNFSF10;PMAIP1;JAK2;TRIM21;TRIM22;APOL2;TGM2;LYN;CD74;HSP90AA1;RIPK2;ARRDC3;SHISA5;EIF2AK2;CFLAR;TNFRSF1A;BST2;RBCK1;TRIM38;PPIA;BIRC3;TRIM56
2278,GO_Biological_Process_2023,Response To Lipopolysaccharide (GO:0032496),18 of 159,1.1016372368285544e-07,1.022555420899076e-05,0,0,5.094801491555166,81.62533386718239,CD274;CXCL9;CXCL8;GCH1;CXCL3;CXCL2;NFKB1;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;ZC3H12A;JAK2;GBP2;CD68;CHMP5;GBP3
2279,GO_Biological_Process_2023,Cytokine-Mediated Signaling Pathway (GO:0019221),23 of 257,1.5996302754131825e-07,1.433599684758228e-05,0,0,3.944524572649573,61.72519509237973,LYN;EIF5A;CXCL9;CXCL8;STAT1;STAT3;MX1;CXCL3;CXCL2;CX3CL1;TNFRSF1A;NFKBIA;CXCL10;CXCL11;SOCS1;OAS1;TMSB4X;P4HB;JAK2;IL6ST;JAK1;IL13RA1;BIRC3
2280,GO_Biological_Process_2023,Antiviral Innate Immune Response (GO:0140374),10 of 46,1.6746115625920288e-07,1.4507718170588943e-05,0,0,10.965179175118324,171.08436614837956,IFIH1;CXCL10;OAS1;DHX58;MX1;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2
2281,GO_Biological_Process_2023,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),11 of 59,2.1471933593488475e-07,1.800179206757308e-05,0,0,9.05907012195122,139.0923654411275,OTUD4;CYLD;OAS1;OAS3;STAT2;NLRC5;ISG15;SAMHD1;PARP14;USP18;PTPN2
2282,GO_Biological_Process_2023,Defense Response To Bacterium (GO:0042742),20 of 204,2.388743728357217e-07,1.940107796875127e-05,0,0,4.346250787649653,66.26871158981005,GSDMD;CHGA;AKIRIN2;CEBPB;ISG15;HLA-A;HLA-E;RNF213;ZNFX1;OAS1;OAS3;CASP4;LCN2;TNFRSF14;RBCK1;GBP2;GBP1;OPTN;GBP4;GBP3
2283,GO_Biological_Process_2023,Positive Regulation Of Inflammatory Response (GO:0050729),14 of 104,3.39164415313816e-07,2.6711767133351745e-05,0,0,6.173551465576005,91.96604322551632,GSDMD;C2CD4A;C2CD4B;IFI35;CX3CL1;TNFRSF1A;NFKBIA;VAMP8;TNIP1;MDK;CASP4;NFKBIZ;CD47;IL6ST
2284,GO_Biological_Process_2023,Response To Interferon-Beta (GO:0035456),8 of 29,4.081095198050649e-07,3.119637182274599e-05,0,0,14.98874458874459,220.51036744058783,IFITM3;BST2;PLSCR1;OAS1;STAT1;IRF1;XAF1;SHFL
2285,GO_Biological_Process_2023,Regulation Of Immune Response (GO:0050776),12 of 77,4.680782660433713e-07,3.475815466990634e-05,0,0,7.306407645307849,106.4881903966746,LYN;PLSCR1;RSAD2;BCL6;IRF1;SPPL2A;DHX58;IRF7;HLA-DRA;SAMHD1;BIRC3;NFE2L2
2286,GO_Biological_Process_2023,Positive Regulation Of Defense Response (GO:0031349),15 of 124,5.340616921563823e-07,3.8556287164289934e-05,0,0,5.467363513310272,78.96378885529202,GSDMD;GBP5;AKIRIN2;IFI35;CX3CL1;TNFRSF1A;NFKBIA;PLSCR1;TNIP1;MDK;CASP4;NFKBIZ;CD47;OPTN;TRIM56
2287,GO_Biological_Process_2023,Cellular Response To Type II Interferon (GO:0071346),11 of 66,7.031415554293776e-07,4.908051762629459e-05,0,0,7.903252032520325,111.97096393589118,GBP5;SP100;STAT1;IRF1;CD47;JAK2;GBP2;GBP1;CX3CL1;GBP4;JAK1
2288,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),8 of 31,7.176066447861464e-07,4.908051762629459e-05,0,0,13.68397013614405,193.5918364486615,CTSL;HLA-DRA;HLA-A;IFI30;HLA-F;CTSS;HLA-E;LGMN
2289,GO_Biological_Process_2023,Type II Interferon-Mediated Signaling Pathway (GO:0060333),5 of 9,1.1433381481175485e-06,7.619322684506432e-05,0,0,48.928212851405625,669.4142002757947,SP100;STAT1;IRF1;JAK2;JAK1
2290,GO_Biological_Process_2023,Apoptotic Process (GO:0006915),20 of 228,1.4053004830862403e-06,9.130939888852848e-05,0,0,3.839982481286829,51.74476006934094,CSRNP1;RIPK2;MX1;IFI6;CIB1;CFLAR;IFIT2;NFKBIA;PLSCR1;CASP7;PLAGL1;IRF1;CASP4;FAS;PMAIP1;C19ORF12;JAK2;IFT57;PPIA;IER3
2291,GO_Biological_Process_2023,Regulation Of Apoptotic Process (GO:0042981),40 of 705,1.5633562119768897e-06,9.91015315836082e-05,0,0,2.446548336283473,32.70711112028925,TNFAIP8;PDCD5;IFI6;CIB1;UBE2Z;IFIT3;CX3CL1;HSP90B1;IFIT2;SOCS3;GRM4;UBB;UBD;CFL1;TNFSF10;PMAIP1;IFT57;IER3;MCL1;TGM2;CD74;HSP90AA1;GADD45B;TSC22D1;TNFRSF12A;HSPA5;STAT1;CFLAR;NFKB1;GADD45G;DNAJA1;CXCL10;BCL6;BCL3;FAS;CALR;IL6ST;PTMA;PPIA;BIRC3
2292,GO_Biological_Process_2023,Regulation Of Type I Interferon Production (GO:0032479),10 of 59,1.926010324752665e-06,0.0001191833531912423,0,0,8.05066854327938,105.94728013482258,RAB2B;CYLD;IRF1;DHX58;IRF7;XAF1;TRIM21;TANK;RBX1;TRIM56
2293,GO_Biological_Process_2023,Regulation Of Response To External Stimulus (GO:0032101),14 of 127,3.899160277368838e-06,0.00023567250141585136,0,0,4.911160576940478,61.167273961685154,SAMHD1;USP18;CX3CL1;HERC5;CYLD;BCL6;TMSB4X;IRF1;DHX58;CASP4;NMT1;JAK2;NFE2L2;BIRC3
2294,GO_Biological_Process_2023,Cellular Response To Virus (GO:0098586),10 of 64,4.149702643017958e-06,0.0002451153902091744,0,0,7.303358124859139,90.50667478818548,IFIH1;EIF5A;CXCL10;HSP90AA1;OAS1;ZC3H12A;IFI6;JAK2;HIF1A;JAK1
2295,GO_Biological_Process_2023,Positive Regulation Of Programmed Cell Death (GO:0043068),20 of 245,4.244412920779191e-06,0.0002451384262467804,0,0,3.54672187715666,43.87261994112773,GBP5;TNFAIP8;GADD45B;TNFRSF12A;PDCD5;CFLAR;UBE2Z;IFIT2;GADD45G;DNAJA1;BCL6;UBD;TNFSF10;FAS;PMAIP1;GBP2;GBP1;TGM2;MCL1;GBP3
2296,GO_Biological_Process_2023,Positive Regulation Of Defense Response To Virus By Host (GO:0002230),7 of 28,4.569085169261748e-06,0.0002581533120632888,0,0,13.088709677419354,160.94135993199197,HSP90AA1;APOBEC3G;DTX3L;STAT1;ZC3H12A;PARP9;TRIM22
2297,GO_Biological_Process_2023,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),10 of 65,4.795221473641465e-06,0.0002648272855758642,0,0,7.170200995758805,87.81983782234238,LYN;SOCS3;CD40;SOCS1;JAK2;PARP9;IL6ST;PARP14;PTPN2;TNFRSF1A
2298,GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),41 of 766,4.891000272274521e-06,0.0002648272855758642,0,0,2.297811613673683,28.097901720835612,CDKN1A;CXCL9;BTG1;CXCL8;CSF1;PDCD5;COX17;CIB1;IFI35;IFIT3;CX3CL1;SLC9A3R1;SDCBP;SERTAD1;FTH1;NAMPT;S100A13;TIMP1;JAK2;JUNB;S100A11;LYN;TSC22D1;STAT1;STAT2;STAT3;EIF2AK2;SOD2;PLAAT4;PML;BMP5;BTC;CXCL10;CXCL11;BCL6;IRF1;CALR;CD47;IL6ST;PTPN2;LGMN
2299,GO_Biological_Process_2023,Regulation Of Cytokine Production (GO:0001817),16 of 167,5.13827143556538e-06,0.0002725381114496821,0,0,4.209255204862858,51.26365132478313,LYN;BTN3A1;HLA-B;EIF2AK2;ISG15;BTN3A3;BTN3A2;LITAF;IFIH1;BCL6;S100A13;FLOT1;IRF7;CD47;TRIM21;TRIM56
2300,GO_Biological_Process_2023,Cellular Response To Lipid (GO:0071396),19 of 228,5.456997331599914e-06,0.0002794460888980773,0,0,3.622839969947408,43.90379142214706,LYN;CD274;HSPA8;CXCL9;CXCL8;CXCL3;SSTR2;CXCL2;NFKB1;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;ZC3H12A;CD68;GBP2;CHMP5;GBP3
2301,GO_Biological_Process_2023,Cellular Response To Interleukin-1 (GO:0071347),11 of 81,5.652493767181765e-06,0.0002794460888980773,0,0,6.204907084785134,74.97645949554985,CD40;CXCL8;ZC3H12A;CD47;GBP2;HIF1A;TANK;GBP1;CX3CL1;NFKB1;GBP3
2302,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I (GO:0019885),4 of 6,5.6969404966108615e-06,0.0002794460888980773,0,0,78.13627254509018,943.5409102070596,ERAP2;TAP2;TAP1;HLA-A
2303,GO_Biological_Process_2023,Regulation Of Defense Response (GO:0031347),12 of 97,5.761025486734488e-06,0.0002794460888980773,0,0,5.581502336168684,67.33744922977736,HERC5;CYLD;BCL6;TMSB4X;IRF1;DHX58;CASP4;JAK2;SAMHD1;USP18;NFE2L2;BIRC3
2304,GO_Biological_Process_2023,Integrated Stress Response Signaling (GO:0140467),7 of 29,5.89304498000656e-06,0.0002794460888980773,0,0,12.493126832844574,150.43895661571128,BATF2;CEBPB;BATF3;CEBPD;EIF2AK2;JUNB;NFE2L2
2305,GO_Biological_Process_2023,Response To Endoplasmic Reticulum Stress (GO:0034976),13 of 114,5.913634047477588e-06,0.0002794460888980773,0,0,5.094928268337037,61.33402031530786,PDIA3;CEBPB;CXCL8;HSPA5;DERL1;PDIA6;HSP90B1;ERP44;TMX1;CASP4;FLOT1;P4HB;ATF3
2306,GO_Biological_Process_2023,Regulation Of Endopeptidase Activity (GO:0052548),10 of 69,8.325778737620879e-06,0.0003864053381977976,0,0,6.682710489221989,78.16201091521229,PSENEN;SERPINB1;PSMA3;PSME1;PSME2;SERPING1;TIMP1;PSMB8;BIRC3;PSMB9
2307,GO_Biological_Process_2023,Positive Regulation Of Response To External Stimulus (GO:0032103),15 of 155,8.934401807122547e-06,0.0004072019964086035,0,0,4.2499268149882905,49.40795496444768,GSDMD;GBP5;AKIRIN2;IFI35;CX3CL1;TNFRSF1A;NFKBIA;PLSCR1;TNIP1;MDK;CASP4;NFKBIZ;CD47;OPTN;TRIM56
2308,GO_Biological_Process_2023,Response To Interleukin-1 (GO:0070555),11 of 85,9.087231932165837e-06,0.0004072019964086035,0,0,5.8682981762250055,68.12296219664069,CD40;CXCL8;ZC3H12A;CD47;GBP2;HIF1A;TANK;GBP1;CX3CL1;NFKB1;GBP3
2309,GO_Biological_Process_2023,Regulation Of Response To Biotic Stimulus (GO:0002831),7 of 31,9.505250887291151e-06,0.00041871435688253735,0,0,11.45085685483871,132.4138862253453,HERC5;IRF1;DHX58;SAMHD1;CX3CL1;BIRC3;NFE2L2
2310,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),5 of 13,1.0741736358914124e-05,0.0004431392507431398,0,0,24.459086345381525,279.8455499236589,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2311,GO_Biological_Process_2023,"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",5 of 13,1.0741736358914124e-05,0.0004431392507431398,0,0,24.459086345381525,279.8455499236589,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2312,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),5 of 13,1.0741736358914124e-05,0.0004431392507431398,0,0,24.459086345381525,279.8455499236589,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2313,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),5 of 13,1.0741736358914124e-05,0.0004431392507431398,0,0,24.459086345381525,279.8455499236589,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2314,GO_Biological_Process_2023,Regulation Of Inflammatory Response (GO:0050727),19 of 240,1.1398423923132654e-05,0.0004609472747301656,0,0,3.423993119180285,38.97201111263984,GSDMD;STAT3;IFI35;USP18;CX3CL1;TNFRSF1A;NFKBIA;CYLD;BCL6;TNIP1;MDK;TMSB4X;CASP4;NFKBIZ;CD47;JAK2;PTPN2;SNX6;BIRC3
2315,GO_Biological_Process_2023,Chemokine-Mediated Signaling Pathway (GO:0070098),9 of 57,1.1528115758930652e-05,0.0004609472747301656,0,0,7.3819585020242915,83.93819541574528,LYN;CXCL10;CXCL9;CXCL11;CXCL8;CIB1;CXCL3;CXCL2;CX3CL1
2316,GO_Biological_Process_2023,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),8 of 44,1.2098223809960902e-05,0.00047641338912255126,0,0,8.736700336700336,98.92086940302906,CD74;CSF1;CASP4;NLRC5;PARP14;PARP9;HIF1A;TRIM56
2317,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),46 of 938,1.2585000664545556e-05,0.0004881853242858792,0,0,2.099454425920656,23.68815452580432,CSRNP1;CEBPB;CD40;MAX;EPAS1;NLRC5;HIF1A;LITAF;CX3CL1;ETS2;RELB;HELZ2;CHCHD2;PLAGL1;ZC3H12A;NAMPT;DHX36;JUNB;IER2;EIF5A;LMO1;AKIRIN2;PCGF5;RIPK2;STAT1;STAT2;STAT3;LMO7;NFKB1;NFKB2;TNFRSF1A;BMP5;NFKBIA;CXCL10;PLSCR1;TNIP1;ELF3;IRF1;BCL3;IRF2;IRF7;NCOA7;PTMA;ATF3;IRF9;NFE2L2
2318,GO_Biological_Process_2023,I-kappaB kinase/NF-kappaB Signaling (GO:0007249),8 of 45,1.439322853601756e-05,0.0005501176612516123,0,0,8.5001365001365,94.76591977780826,NFKBIA;RIPK2;BCL3;TANK;NFKB1;RELB;NFKB2;BIRC3
2319,GO_Biological_Process_2023,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),7 of 33,1.4784513124909427e-05,0.0005568833277049218,0,0,10.568936104218364,117.5469710719216,CXCL10;CXCL9;CXCL11;GSTO1;CALM3;CALM2;CX3CL1
2320,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Process (GO:0043065),20 of 270,1.7912233450231088e-05,0.0006650556391021513,0,0,3.1879089026915115,34.843929250092664,TNFAIP8;BTG1;GADD45B;TNFRSF12A;PDCD5;CFLAR;UBE2Z;CTSS;IFIT2;GADD45G;DNAJA1;BCL6;CTSL;UBD;ZC3H12A;TNFSF10;FAS;PMAIP1;TGM2;MCL1
2321,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),9 of 62,2.325781385066176e-05,0.0008513670168714072,0,0,6.683828584523718,71.30889427894938,SLC9A3R1;CYLD;TNFRSF12A;CTSL;TNFSF10;PMAIP1;FAS;CTSS;PML
2322,GO_Biological_Process_2023,Defense Response To Protozoan (GO:0042832),5 of 15,2.403959234402169e-05,0.0008677625069737829,0,0,19.565261044176708,208.092367876196,BATF2;CD40;GBP2;GBP1;GBP4
2323,GO_Biological_Process_2023,Interferon-Mediated Signaling Pathway (GO:0140888),8 of 49,2.757334160014864e-05,0.000981686504366936,0,0,7.669278147326928,80.51715242697807,IFITM3;SP100;STAT1;IRF1;STAT2;JAK2;TANK;JAK1
2324,GO_Biological_Process_2023,Positive Regulation Of Peptidase Activity (GO:0010952),6 of 25,2.8954675037328024e-05,0.001016935140838,0,0,12.37615164672244,129.328048098225,PSENEN;CTSL;PSME1;PSME2;TANK;CTSS
2325,GO_Biological_Process_2023,Regulation Of Defense Response To Virus By Host (GO:0050691),7 of 37,3.266196678217197e-05,0.0011318460222248,0,0,9.157862903225809,94.59430643921095,HSP90AA1;APOBEC3G;DTX3L;STAT1;ZC3H12A;PARP9;TRIM22
2326,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),5 of 16,3.424523123816065e-05,0.0011710967893155,0,0,17.785688207374953,182.87179229070244,SOCS3;SOCS1;BCL3;PARP14;PTPN2
2327,GO_Biological_Process_2023,Negative Regulation Of Apoptotic Process (GO:0043066),28 of 482,3.9116820929908026e-05,0.0012888667954544,0,0,2.472543473220496,25.09373981510136,TNFAIP8;IFI6;CIB1;UBE2Z;IFIT3;CX3CL1;HSP90B1;SOCS3;MDK;LAMP3;ZC3H12A;CFL1;IER3;MCL1;SNX6;CD74;TSC22D1;HSPA5;CFLAR;SOD2;NFKB1;DNAJA1;BCL3;FAS;IL6ST;PTMA;LGMN;BIRC3
2328,GO_Biological_Process_2023,Cellular Response To Type I Interferon (GO:0071357),7 of 38,3.917678985798403e-05,0.0012888667954544,0,0,8.861992715920916,89.92641602389865,IFITM3;SP100;STAT1;STAT2;IFIT1;TANK;JAK1
2329,GO_Biological_Process_2023,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),7 of 38,3.917678985798403e-05,0.0012888667954544,0,0,8.861992715920916,89.92641602389865,EIF5A;NFKBIA;STAT1;TMSB4X;JAK2;TNFRSF1A;BIRC3
2330,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),30 of 537,4.299601876572762e-05,0.0013968331596515,0,0,2.375620801381088,23.885448991615768,CDKN1A;BTG1;CXCL8;CCDC125;PDCD5;CIB1;IFI35;IFIT3;RND1;SLC9A3R1;MDK;FTH1;JAK2;S100A11;LYN;APOBEC3G;VPS13C;EIF2AK2;SOD2;PLAAT4;HOPX;PML;BMP5;VAMP8;BST2;BCL6;IRF1;TXNIP;PTPN2;CHMP5
2331,GO_Biological_Process_2023,Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),4 of 9,4.5052707750663606e-05,0.0014455800919009,0,0,31.2496993987976,312.7369126258397,SOCS3;SOCS1;PARP14;PTPN2
2332,GO_Biological_Process_2023,Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),5 of 18,6.44323868113166e-05,0.0020421923575928,0,0,15.047883843064566,145.210486274131,PDIA3;HLA-DRA;TAPBPL;CALR;TAPBP
2333,GO_Biological_Process_2023,Regulation Of Viral Entry Into Host Cell (GO:0046596),7 of 44,0.00010443632093316556,0.0032313095012535,0,0,7.422624237140366,68.04269937304761,IFITM3;CD74;P4HB;TRIM38;TRIM21;TRIM22;LY6E
2334,GO_Biological_Process_2023,Response To Unfolded Protein (GO:0006986),7 of 44,0.00010443632093316556,0.0032313095012535,0,0,7.422624237140366,68.04269937304761,DNAJA1;HSPA8;PTPN1;ERP44;HSP90AA1;DERL1;OPTN
2335,GO_Biological_Process_2023,Inflammatory Response (GO:0006954),17 of 236,0.00010599341620313076,0.0032409045730816,0,0,3.0791476407914766,28.180770512050977,CD40;CXCL9;CEBPB;CXCL8;RIPK2;STAT3;CXCL3;CXCL2;CX3CL1;NFKB1;RELB;NFKB2;TNFRSF1A;CXCL10;CXCL11;ELF3;APOL2
2336,GO_Biological_Process_2023,Cellular Response To Chemokine (GO:1990869),8 of 59,0.00010882059148327492,0.0032886595030817,0,0,6.16232917409388,56.23624508619309,CXCL10;CXCL9;CXCL11;CXCL8;ZC3H12A;CXCL3;CXCL2;CX3CL1
2337,GO_Biological_Process_2023,Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),4 of 11,0.00011335255492232898,0.0033862447154383,0,0,22.31892356140853,202.7675910975761,NLRC5;PARP14;PARP9;PTPN2
2338,GO_Biological_Process_2023,Positive Regulation Of Innate Immune Response (GO:0045089),7 of 45,0.00012102330674441896,0.0035743133435084,0,0,7.226920628183362,65.18340871887324,AKIRIN2;GBP5;PLSCR1;NLRC5;IFI35;HLA-E;TRIM56
2339,GO_Biological_Process_2023,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),13 of 152,0.00012586504433653573,0.0036755421374231,0,0,3.694817207458523,33.18056808293821,CD40;RIPK2;STAT3;EIF2AK2;CIB1;CFLAR;CX3CL1;FLOT1;RBCK1;TRIM38;TRIM21;PPIA;TRIM22
2340,GO_Biological_Process_2023,Positive Regulation Of Interferon-Alpha Production (GO:0032727),5 of 21,0.00014377028539178547,0.0041517663525916,0,0,12.22452309236948,108.15394702658224,IFIH1;RIPK2;STAT1;DHX36;IRF7
2341,GO_Biological_Process_2023,Proteolysis Involved In Protein Catabolic Process (GO:0051603),9 of 78,0.00014656946146501064,0.0041860882455776,0,0,5.129730681218096,45.28531940500187,UBB;CTSL;HM13;CTSZ;PMAIP1;ISG15;TRIM21;CTSS;LGMN
2342,GO_Biological_Process_2023,Interleukin-27-Mediated Signaling Pathway (GO:0070106),3 of 5,0.00015227737490337026,0.0042668612578385,0,0,58.485,514.0718545121449,OAS1;STAT1;MX1
2343,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),6 of 33,0.00015268106847979242,0.0042668612578385,0,0,8.705566733735747,76.49720196423337,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
2344,GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),77 of 2028,0.00015667878625148644,0.0043320017602937,0,0,1.6255561731915498,14.242006100585824,CSRNP1;CD40;WWC1;UBE2D3;BACH1;LITAF;CX3CL1;ETS2;ZFP36;CHCHD2;ZC3H12A;NAMPT;BBX;JUNB;IER2;EIF5A;LMO1;BATF2;BATF3;RIPK2;HSBP1;SP110;ARID5B;LMO7;BAZ1A;PARP9;TNFRSF1A;ETV6;ETV7;PLSCR1;ELF3;SUB1;IRF1;IRF2;IRF7;NCOA7;PTMA;ATF3;IRF9;CEBPB;SP100;CEBPD;MAX;EPAS1;CREM;NLRC5;HIF1A;RELB;HELZ2;SDCBP;PLAGL1;CREG1;DHX36;MIER1;RBBP8;CAMTA1;FNIP2;AKIRIN2;PCGF5;STAT1;STAT2;STAT3;SOD2;NFKB1;HOPX;NFKB2;BMP5;NFKBIA;CXCL10;BCL6;TNIP1;BCL3;ID1;CALR;SP140L;SIM1;NFE2L2
2345,GO_Biological_Process_2023,Positive Regulation Of Immune Response (GO:0050778),9 of 80,0.0001783056933389092,0.0048780683893455,0,0,4.984718024747677,43.0281413318138,GBP5;AKIRIN2;CD74;PLSCR1;RSAD2;HLA-DRA;IFI35;IL6ST;TRIM56
2346,GO_Biological_Process_2023,Cellular Response To Interleukin-6 (GO:0071354),5 of 23,0.0002280656051551098,0.0060483929367156,0,0,10.86512717536814,91.1136225645808,STAT3;IL6ST;JAK2;NFKB1;JAK1
2347,GO_Biological_Process_2023,Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),5 of 23,0.0002280656051551098,0.0060483929367156,0,0,10.86512717536814,91.1136225645808,IFIH1;CYLD;OAS3;DHX58;IRF7
2348,GO_Biological_Process_2023,Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),5 of 23,0.0002280656051551098,0.0060483929367156,0,0,10.86512717536814,91.1136225645808,TXN;SOD2;FBXO7;PPIA;NFE2L2
2349,GO_Biological_Process_2023,Interleukin-6-Mediated Signaling Pathway (GO:0070102),4 of 13,0.00023594938492472531,0.0061942671860541,0,0,17.357381429525716,144.966996739894,STAT3;IL6ST;JAK2;JAK1
2350,GO_Biological_Process_2023,Protein Catabolic Process (GO:0030163),10 of 102,0.00024922307480062194,0.0064187781487448,0,0,4.278375518123291,35.49837554008128,HSPA8;CASP7;HSP90AA1;CTSL;CTSZ;PMAIP1;FBXO6;TRIM21;CTSS;LGMN
2351,GO_Biological_Process_2023,"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",6 of 36,0.0002519104929480459,0.0064187781487448,0,0,7.833802816901408,64.9143113212535,CDKN1A;SP100;BCL3;RPS27L;NBN;PML
2352,GO_Biological_Process_2023,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),6 of 36,0.0002519104929480459,0.0064187781487448,0,0,7.833802816901408,64.9143113212535,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
2353,GO_Biological_Process_2023,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),7 of 51,0.0002711617054703664,0.0068422259467716,0,0,6.239506964809384,51.2437929500744,CXCL10;CXCL9;CXCL11;GSTO1;CALM3;CALM2;CX3CL1
2354,GO_Biological_Process_2023,Negative Regulation Of Programmed Cell Death (GO:0043069),22 of 381,0.00028182991919484897,0.0069843101144468,0,0,2.438258271127352,19.93082732147657,CD74;TNFAIP8;TSC22D1;HSPA5;IFI6;CIB1;CFLAR;UBE2Z;IFIT3;CX3CL1;NFKB1;HSP90B1;DNAJA1;SOCS3;CFL1;BCL3;FAS;IL6ST;PTMA;IER3;MCL1;BIRC3
2355,GO_Biological_Process_2023,Regulation Of Viral Life Cycle (GO:1903900),5 of 24,0.0002821672035463337,0.0069843101144468,0,0,10.292749947157048,84.12275588650826,LAMP3;TRIM38;PPIA;TRIM21;TRIM22
2356,GO_Biological_Process_2023,Protein Ubiquitination (GO:0016567),24 of 434,0.0002869158820354325,0.0070348526170763,0,0,2.332542390142064,19.024965597669603,ATG3;DTX3L;UBA6;UBE2D3;MYCBP2;RNF19B;UBE2L6;LMO7;ISG15;RBX1;HERC5;NUB1;RNF114;RNF213;UBB;UBD;TRIM69;RBCK1;TRIM38;FBXO7;TRIM21;TRIM22;NFE2L2;TRIM56
2357,GO_Biological_Process_2023,Type I Interferon-Mediated Signaling Pathway (GO:0060337),6 of 37,0.00029434592619343407,0.0070612275636514,0,0,7.580710066852729,61.63689523798187,IFITM3;SP100;STAT1;STAT2;TANK;JAK1
2358,GO_Biological_Process_2023,DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),3 of 6,0.00029885918891945143,0.0070612275636514,0,0,38.988,316.40859693078033,RBBP8;NBN;SAMHD1
2359,GO_Biological_Process_2023,Cellular Response To Interleukin-9 (GO:0071355),3 of 6,0.00029885918891945143,0.0070612275636514,0,0,38.988,316.40859693078033,STAT1;STAT3;JAK1
2360,GO_Biological_Process_2023,Interleukin-9-Mediated Signaling Pathway (GO:0038113),3 of 6,0.00029885918891945143,0.0070612275636514,0,0,38.988,316.40859693078033,STAT1;STAT3;JAK1
2361,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via STAT (GO:1904893),4 of 14,0.000323784061865734,0.0075812142053066,0,0,15.620841683366734,125.52023831110846,SOCS3;SOCS1;BCL3;PTPN2
2362,GO_Biological_Process_2023,Neutrophil Chemotaxis (GO:0030593),8 of 70,0.0003640361583893535,0.0084475890683386,0,0,5.06614532420984,40.11504249532258,CXCL10;CXCL9;CXCL11;CXCL8;CXCL3;CXCL2;PPIA;CX3CL1
2363,GO_Biological_Process_2023,Modification-Dependent Protein Catabolic Process (GO:0019941),14 of 192,0.0003730549197663312,0.0085802631546256,0,0,3.107304519657177,24.52839353170958,DTX3L;UBA6;UBE2D3;RNF19B;UBE2L6;ISG15;RBX1;HERC5;NUB1;RNF114;RNF213;UBB;UBD;FBXO7
2364,GO_Biological_Process_2023,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),6 of 39,0.00039591239612984486,0.0090261080486093,0,0,7.120541430400586,55.78458300042309,USP15;RSAD2;DHX58;FLOT1;IFI35;DDX60
2365,GO_Biological_Process_2023,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),8 of 71,0.0004013860771703857,0.0090713253440507,0,0,4.985473785473785,38.98933051769676,CSF1;MDK;CIB1;CALR;P4HB;JAK2;UTRN;CX3CL1
2366,GO_Biological_Process_2023,Regulation Of Interferon-Alpha Production (GO:0032647),5 of 26,0.00041895327785028847,0.0092276234672279,0,0,9.311531841652323,72.4227775173303,IFIH1;RIPK2;STAT1;DHX36;IRF7
2367,GO_Biological_Process_2023,Acute Inflammatory Response (GO:0002526),5 of 26,0.00041895327785028847,0.0092276234672279,0,0,9.311531841652323,72.4227775173303,CEBPB;PLSCR1;C2CD4A;C2CD4B;APOL2
2368,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),5 of 26,0.00041895327785028847,0.0092276234672279,0,0,9.311531841652323,72.4227775173303,CTSL;HLA-DRA;IFI30;CTSS;LGMN
2369,GO_Biological_Process_2023,3'-UTR-mediated mRNA Destabilization (GO:0061158),4 of 15,0.000432782759660286,0.009287010755112,0,0,14.200036436509382,109.98318246302772,MOV10;ZFP36;DHX36;ZC3H12A
2370,GO_Biological_Process_2023,Cellular Response To Zinc Ion (GO:0071294),4 of 15,0.000432782759660286,0.009287010755112,0,0,14.200036436509382,109.98318246302772,MT2A;MT1F;MT1X;MT1E
2371,GO_Biological_Process_2023,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),21 of 367,0.0004337920491248879,0.009287010755112,0,0,2.4115019307797474,18.672127512354727,DTX3L;UBA6;UBE2D3;RNF19B;UBE2L6;PML;RBX1;HERC5;NUB1;PSMA3;RNF114;RNF213;PSMA4;PSMB2;PSMA2;PSMB3;UBD;RBCK1;FBXO7;NFE2L2;CHMP5
2372,GO_Biological_Process_2023,Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),7 of 55,0.0004359427903515467,0.009287010755112,0,0,5.718371975806452,44.24875970698644,LYN;CD40;JAK2;PARP9;IL6ST;PARP14;TNFRSF1A
2373,GO_Biological_Process_2023,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),11 of 130,0.0004496947837511732,0.0095020873412138,0,0,3.640739222518276,28.058964072369797,LYN;CD74;PTPN1;CD40;RIPK2;TNFRSF14;IL6ST;PARP14;JAK2;PARP9;TNFRSF1A
2374,GO_Biological_Process_2023,Regulation Of Protein Dephosphorylation (GO:0035304),6 of 40,0.0004560004401666831,0.0095576221289774,0,0,6.910758669665049,53.16458243018836,YWHAB;CAMTA1;CALM3;CALM2;PPIA;HSP90B1
2375,GO_Biological_Process_2023,Positive Regulation Of Binding (GO:0051099),9 of 91,0.0004725155859429269,0.0098245440629253,0,0,4.313592376814457,33.031074056984785,DTX3L;RIPK2;SUB1;FLOT1;DERL1;TXN;PARP9;B2M;TRIM21
2376,GO_Biological_Process_2023,Granulocyte Chemotaxis (GO:0071621),8 of 73,0.0004854376049108888,0.010013113771138,0,0,4.831577311577312,36.86715642565367,CXCL10;CXCL9;CXCL11;CXCL8;CXCL3;CXCL2;PPIA;CX3CL1
2377,GO_Biological_Process_2023,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),19 of 319,0.000493846627102255,0.0100292922728723,0,0,2.512004132231405,19.124604787671704,AKIRIN2;HSPA5;UBE2D3;ERLIN1;DERL1;PML;RBX1;HSP90B1;PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;FBXO6;RBCK1;CALR;UBXN4;FBXO7;NFE2L2
2378,GO_Biological_Process_2023,Regulation Of Peptidase Activity (GO:0052547),5 of 27,0.000503631205422561,0.0100292922728723,0,0,8.887824023366193,67.49116970448063,CSTB;PSMA3;CTSL;CTSS;PSMB8
2379,GO_Biological_Process_2023,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),5 of 27,0.000503631205422561,0.0100292922728723,0,0,8.887824023366193,67.49116970448063,VMP1;GSTO1;CALM3;ATP1B1;CALM2
2380,GO_Biological_Process_2023,Regulation Of Cyclic-Nucleotide Phosphodiesterase Activity (GO:0051342),3 of 7,0.0005132342717553011,0.0100292922728723,0,0,29.2395,221.48272562766405,CALM3;CALM2;SLC39A14
2381,GO_Biological_Process_2023,T-helper 17 Cell Lineage Commitment (GO:0072540),3 of 7,0.0005132342717553011,0.0100292922728723,0,0,29.2395,221.48272562766405,SOCS3;STAT3;JAK1
2382,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway Via JAK-STAT (GO:0060397),3 of 7,0.0005132342717553011,0.0100292922728723,0,0,29.2395,221.48272562766405,LYN;PTPN1;STAT3
2383,GO_Biological_Process_2023,Positive Regulation Of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060316),3 of 7,0.0005132342717553011,0.0100292922728723,0,0,29.2395,221.48272562766405,GSTO1;CALM3;CALM2
2384,GO_Biological_Process_2023,Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),4 of 16,0.0005656294126134083,0.0109706779356884,0,0,13.016032064128256,97.32830965394106,HLA-B;HLA-A;HLA-F;HLA-E
2385,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),5 of 28,0.0006005573173020556,0.0115618405012447,0,0,8.500960363191899,63.0571696498843,CTSL;HLA-DRA;IFI30;CTSS;LGMN
2386,GO_Biological_Process_2023,Positive Regulation Of Protein Phosphorylation (GO:0001934),21 of 377,0.0006152786610983868,0.0117581561779022,0,0,2.3425392792204764,17.319412564196693,LYN;CD74;CD40;CDKN1A;HSP90AA1;CSF1;RIPK2;CIB1;TXN;CX3CL1;BMP5;SDCBP;FLOT1;FAS;CALM3;TNFRSF14;NBN;JAK2;CALM2;PPIA;FNIP2
2387,GO_Biological_Process_2023,Cellular Response To Oxygen-Containing Compound (GO:1901701),22 of 406,0.0006653412547031322,0.0126220578173243,0,0,2.276539760914761,16.653367526207784,LYN;CD274;CXCL9;CXCL8;CXCL3;SSTR2;CXCL2;NFKB1;HSP90B1;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;ZC3H12A;DHX36;CD68;GBP2;LGMN;TGM2;CHMP5;GBP3
2388,GO_Biological_Process_2023,Positive Regulation Of Protein Binding (GO:0032092),7 of 59,0.0006723048316929723,0.0126617409968843,0,0,5.277411600496278,38.55042940766391,DTX3L;RIPK2;SUB1;FLOT1;DERL1;B2M;TRIM21
2389,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),6 of 43,0.0006796368284450992,0.0127077418498475,0,0,6.349448039588885,46.31256908934186,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
2390,GO_Biological_Process_2023,Neutrophil Migration (GO:1990266),8 of 77,0.0006963202451941956,0.0129068929972478,0,0,4.550548967940272,33.081129841488625,CXCL10;CXCL9;CXCL11;CXCL8;CXCL3;CXCL2;PPIA;CX3CL1
2391,GO_Biological_Process_2023,Positive Regulation Of DNA-templated Transcription (GO:0045893),50 of 1243,0.0007097886691454036,0.0129068929972478,0,0,1.6934694474204752,12.27857352412568,CSRNP1;CD40;LITAF;CX3CL1;ETS2;CHCHD2;ZC3H12A;NAMPT;JUNB;IER2;EIF5A;LMO1;DTX3L;RIPK2;LMO7;PARP9;TNFRSF1A;PLSCR1;ELF3;IRF1;IRF2;IRF7;NCOA7;PTMA;ATF3;IRF9;CEBPB;SP100;MAX;EPAS1;NLRC5;HIF1A;RELB;HELZ2;PLAGL1;DHX36;AKIRIN2;CD74;PCGF5;STAT1;STAT2;STAT3;NFKB1;NFKB2;BMP5;NFKBIA;CXCL10;TNIP1;BCL3;NFE2L2
2392,GO_Biological_Process_2023,Positive Regulation Of Endopeptidase Activity (GO:0010950),5 of 29,0.0007108182432654132,0.0129068929972478,0,0,8.146335341365463,59.05354898479492,LYN;PSENEN;STAT3;PSME1;PSME2
2393,GO_Biological_Process_2023,Response To Interferon-Alpha (GO:0035455),4 of 17,0.0007250505492874883,0.0129068929972478,0,0,12.014182210574996,86.85375720646778,IFITM3;BST2;LAMP3;EIF2AK2
2394,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway (GO:0060396),4 of 17,0.0007250505492874883,0.0129068929972478,0,0,12.014182210574996,86.85375720646778,LYN;PTPN1;STAT3;JAK2
2395,GO_Biological_Process_2023,Negative Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902176),4 of 17,0.0007250505492874883,0.0129068929972478,0,0,12.014182210574996,86.85375720646778,SOD2;HIF1A;PPIA;NFE2L2
2396,GO_Biological_Process_2023,Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),4 of 17,0.0007250505492874883,0.0129068929972478,0,0,12.014182210574996,86.85375720646778,CEBPB;HSPA5;HIF1A;NFE2L2
2397,GO_Biological_Process_2023,Regulation Of Protein Binding (GO:0043393),10 of 118,0.0007985828515396419,0.014119162116677,0,0,3.641537074599955,25.973888934367817,CDKN1A;DTX3L;RIPK2;SUB1;FLOT1;DERL1;IFIT1;B2M;TRIM21;IFIT2
2398,GO_Biological_Process_2023,T-helper 17 Cell Differentiation (GO:0072539),3 of 8,0.0008058544900832821,0.0141514582413949,0,0,23.3904,166.62402571383245,SOCS3;STAT3;JAK1
2399,GO_Biological_Process_2023,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),8 of 79,0.0008264574716197447,0.0144158588506021,0,0,4.421909233176839,31.38831290167852,UBB;TNIP1;RIPK2;ZC3H12A;MYCBP2;DERL1;TANK;BIRC3
2400,GO_Biological_Process_2023,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),5 of 30,0.0008355316358203037,0.0144769781433131,0,0,7.820080321285141,55.42436841905076,SOCS3;SOCS1;MVP;PARP14;PTPN2
2401,GO_Biological_Process_2023,Regulation Of Apoptotic Signaling Pathway (GO:2001233),6 of 45,0.0008703718871693673,0.0149807717533323,0,0,6.023216220399319,42.44313507286145,CYLD;CTSL;FAS;PPIA;CTSS;CX3CL1
2402,GO_Biological_Process_2023,Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),4 of 18,0.0009137996165825072,0.0154218519707658,0,0,11.1554537646722,78.06474151559458,P4HB;SOD2;PPIA;NFE2L2
2403,GO_Biological_Process_2023,Regulation Of RIG-I Signaling Pathway (GO:0039535),4 of 18,0.0009137996165825072,0.0154218519707658,0,0,11.1554537646722,78.06474151559458,USP15;DHX58;DDX60;BIRC3
2404,GO_Biological_Process_2023,Regulation Of Adaptive Immune Response (GO:0002819),4 of 18,0.0009137996165825072,0.0154218519707658,0,0,11.1554537646722,78.06474151559458,AKIRIN2;IRF1;IRF7;IL6ST
2405,GO_Biological_Process_2023,Protein Modification By Small Protein Conjugation (GO:0032446),20 of 364,0.0009723577363371024,0.0159510492404068,0,0,2.305479320140594,15.990312989538422,ATG3;UBA6;MYCBP2;UBE2D3;UBE2L6;LMO7;ISG15;RANGAP1;PML;RBX1;HERC5;IFIH1;NUB1;RNF213;UBB;UBD;TRIM69;FBXO7;TRIM21;NFE2L2
2406,GO_Biological_Process_2023,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),8 of 81,0.000975436339467897,0.0159510492404068,0,0,4.300318251003183,29.81249665056683,NFKBIA;CYLD;TMSB4X;ZC3H12A;BCL3;NLRC5;RBCK1;TRIM21
2407,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),5 of 31,0.0009758433356001084,0.0159510492404068,0,0,7.518921841210997,52.12273390779109,SP100;PMAIP1;CFLAR;ICAM1;BMP5
2408,GO_Biological_Process_2023,Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),5 of 31,0.0009758433356001084,0.0159510492404068,0,0,7.518921841210997,52.12273390779109,CYLD;TNFRSF12A;TNFSF10;PMAIP1;PML
2409,GO_Biological_Process_2023,Receptor Signaling Pathway Via STAT (GO:0097696),5 of 31,0.0009758433356001084,0.0159510492404068,0,0,7.518921841210997,52.12273390779109,STAT1;STAT2;STAT3;JAK2;JAK1
2410,GO_Biological_Process_2023,Protein Transport (GO:0015031),18 of 313,0.0010289557515135,0.016714099988648,0,0,2.415767953870348,16.61857705774362,GSDMD;ARF3;RAB3B;CD74;STXBP1;ARRDC3;CMTM6;AP3B1;DNAJC15;HSP90B1;EHD1;VMP1;ARL5B;TXNIP;SIL1;VAMP5;OPTN;SNX6
2411,GO_Biological_Process_2023,NIK/NF-kappaB Signaling (GO:0038061),5 of 32,0.0011329245030683,0.0182886384066752,0,0,7.2400713966979025,49.10906352038971,NFKBIA;NFKB1;RELB;NFKB2;BIRC3
2412,GO_Biological_Process_2023,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),8 of 83,0.0011451684255169,0.0183721773945594,0,0,4.185212121212121,28.343108411026183,NFKBIA;CYLD;TMSB4X;ZC3H12A;BCL3;EIF2AK2;IFI35;TRIM56
2413,GO_Biological_Process_2023,Myeloid Dendritic Cell Differentiation (GO:0043011),3 of 9,0.0011862577484359,0.0186853568980914,0,0,19.491,131.30992512056272,BATF2;BATF3;UBD
2414,GO_Biological_Process_2023,Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),3 of 9,0.0011862577484359,0.0186853568980914,0,0,19.491,131.30992512056272,USP15;DHX58;DDX60
2415,GO_Biological_Process_2023,"Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001185)",3 of 9,0.0011862577484359,0.0186853568980914,0,0,19.491,131.30992512056272,IRF1;HLA-A;HLA-E
2416,GO_Biological_Process_2023,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),6 of 48,0.0012307211489669,0.0192689413624406,0,0,5.592124173613107,37.4680986386165,LYN;SLC9A3R1;PTPN1;TNIP1;GBP1;PTPN2
2417,GO_Biological_Process_2023,Regulation Of Interleukin-1 Beta Production (GO:0032651),8 of 84,0.0012384417760531,0.0192737136285156,0,0,4.1299308878256245,27.645349828978205,GSDMD;GBP5;SERPINB1;RIPK2;ZC3H12A;STAT3;JAK2;CX3CL1
2418,GO_Biological_Process_2023,Positive Regulation Of Cell Population Proliferation (GO:0008284),24 of 483,0.0012851797027669,0.0198820359969721,0,0,2.0781857628228746,13.834184868763437,LYN;CD74;CDKN1A;CSF1;TSC22D1;STAT1;COX17;CIB1;CX3CL1;BMP5;BTC;BST2;SDCBP;SERTAD1;MDK;NAMPT;S100A13;S100A6;TIMP1;CALR;CD47;JAK2;IL6ST;LGMN
2419,GO_Biological_Process_2023,Defense Response To Gram-positive Bacterium (GO:0050830),8 of 85,0.0013376655624126,0.0205715550101214,0,0,4.076085530630985,26.970762176021317,CHGA;GSDMD;CASP4;TNFRSF14;HLA-A;GBP2;GBP4;HLA-E
2420,GO_Biological_Process_2023,Cellular Response To Copper Ion (GO:0071280),4 of 20,0.0013903443947925,0.0208873126130968,0,0,9.76002004008016,64.2034008814805,MT2A;MT1F;MT1X;MT1E
2421,GO_Biological_Process_2023,Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),4 of 20,0.0013903443947925,0.0208873126130968,0,0,9.76002004008016,64.2034008814805,OTUD4;IRF1;IRF7;BIRC3
2422,GO_Biological_Process_2023,Negative Regulation Of Viral Life Cycle (GO:1903901),4 of 20,0.0013903443947925,0.0208873126130968,0,0,9.76002004008016,64.2034008814805,IFITM3;BST2;PPIA;LY6E
2423,GO_Biological_Process_2023,Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),4 of 20,0.0013903443947925,0.0208873126130968,0,0,9.76002004008016,64.2034008814805,GSTO1;CALM3;ATP1B1;CALM2
2424,GO_Biological_Process_2023,Regulation Of Tumor Necrosis Factor Production (GO:0032680),10 of 127,0.001403366239496,0.0209617750370704,0,0,3.3598585322723253,22.070512460038604,IFIH1;ZFP36;OAS1;OAS3;ZC3H12A;STAT3;CD47;JAK2;CX3CL1;HLA-E
2425,GO_Biological_Process_2023,Proteasomal Protein Catabolic Process (GO:0010498),14 of 220,0.0014158182108263,0.0210269230282156,0,0,2.6810610121706677,17.58788805710978,UBE2D3;DERL1;PML;RBX1;PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PMAIP1;RBCK1;FBXO7;TRIM21;NFE2L2
2426,GO_Biological_Process_2023,Apoptotic Mitochondrial Changes (GO:0008637),5 of 34,0.0015021891490514,0.022182895445368,0,0,6.740063703088215,43.8160204692822,ATG3;IFI6;SOD2;IFIT2;MCL1
2427,GO_Biological_Process_2023,Regulation Of Type II Interferon Production (GO:0032649),8 of 87,0.0015550371601011,0.0228335682435194,0,0,3.972484337041299,25.6871000296603,CD274;BTN3A1;ZC3H12A;ISG15;BTN3A2;HLA-A;CD47;JAK2
2428,GO_Biological_Process_2023,Negative Regulation Of Cell Population Proliferation (GO:0008285),20 of 379,0.0015777732238436,0.0230372618470198,0,0,2.2074199668967744,14.24170141462496,LYN;CDKN1A;BTG1;CXCL8;PDCD5;EIF2AK2;CIB1;IFI35;SOD2;PLAAT4;IFIT3;PML;BMP5;SLC9A3R1;FTH1;IRF1;JAK2;B2M;S100A11;PTPN2
2429,GO_Biological_Process_2023,T Cell Chemotaxis (GO:0010818),3 of 10,0.001663115791958,0.0237816593289272,0,0,16.705714285714286,106.90090903355524,CXCL10;CXCL11;CXCL16
2430,GO_Biological_Process_2023,T-helper Cell Lineage Commitment (GO:0002295),3 of 10,0.001663115791958,0.0237816593289272,0,0,16.705714285714286,106.90090903355524,SOCS3;STAT3;JAK1
2431,GO_Biological_Process_2023,Regulation Of Programmed Necrotic Cell Death (GO:0062098),3 of 10,0.001663115791958,0.0237816593289272,0,0,16.705714285714286,106.90090903355524,CYLD;CFLAR;BIRC3
2432,GO_Biological_Process_2023,Negative Regulation Of Neuron Death (GO:1901215),8 of 88,0.0016737359654505,0.0237816593289272,0,0,3.922626262626263,25.07616132199445,CHGA;CSF1;MDK;IL6ST;SOD2;FBXO7;SNX6;LGMN
2433,GO_Biological_Process_2023,Regulation Of Lipid Storage (GO:0010883),4 of 21,0.0016836572976231,0.0237816593289272,0,0,9.185429682895204,58.66538186713483,NFKBIA;ZC3H12A;NFKB1;PTPN2
2434,GO_Biological_Process_2023,Modulation By Symbiont Of Entry Into Host (GO:0052372),4 of 21,0.0016836572976231,0.0237816593289272,0,0,9.185429682895204,58.66538186713483,CXCL8;TRIM38;TRIM21;TRIM22
2435,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),6 of 51,0.0016953341621847,0.023817153986584,0,0,5.21851106639839,33.2934504384537,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
2436,GO_Biological_Process_2023,Regulation Of Cardiac Muscle Contraction (GO:0055117),5 of 35,0.0017168155397278,0.0239892666008207,0,0,6.515060240963855,41.48323970801261,CHGA;ZC3H12A;CALM3;ATP1B1;CALM2
2437,GO_Biological_Process_2023,Protein-Containing Complex Assembly (GO:0065003),18 of 328,0.0017345247227027,0.0241071109855855,0,0,2.297080146325241,14.602588654174951,GSDMD;CD74;CD40;HSP90AA1;STXBP1;TRAPPC4;CX3CL1;HOPX;PML;CD2AP;TAPBP;VAMP8;NT5C3A;SLC9A3R1;ZC3H12A;CASP4;FAS;GBP1
2438,GO_Biological_Process_2023,Positive Regulation Of Protein Modification Process (GO:0031401),14 of 225,0.0017484792735309,0.0241717959143983,0,0,2.6168503280706346,16.614405906145876,LYN;CD74;CD40;CDKN1A;HSP90AA1;NNMT;CIB1;TXN;FLOT1;FAS;CAMTA1;CALM3;CALM2;PPIA
2439,GO_Biological_Process_2023,Cellular Response To Chemical Stress (GO:0062197),8 of 89,0.0017994869558763,0.0247453259170514,0,0,3.873999251777029,24.484658024340632,CHCHD2;ZC3H12A;FAS;SOD2;TRIM21;PPIA;RBX1;NFE2L2
2440,GO_Biological_Process_2023,Protein Polyubiquitination (GO:0000209),14 of 226,0.0018222516019287,0.0249264837548042,0,0,2.604371647953081,16.427549203228665,DTX3L;MYCBP2;UBE2D3;RNF19B;UBE2L6;RBX1;RNF114;RNF213;RBCK1;TRIM38;FBXO7;TRIM21;TRIM22;TRIM56
2441,GO_Biological_Process_2023,Regulation Of Erythrocyte Differentiation (GO:0045646),5 of 36,0.0019530914648467,0.0264379412350868,0,0,6.304573131234616,39.33008206538368,LYN;ZFP36;STAT1;STAT3;HIF1A
2442,GO_Biological_Process_2023,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),5 of 36,0.0019530914648467,0.0264379412350868,0,0,6.304573131234616,39.33008206538368,STAT1;STAT2;STAT3;JAK2;JAK1
2443,GO_Biological_Process_2023,Regulation Of Mononuclear Cell Migration (GO:0071675),4 of 22,0.0020173091677359,0.0268871103945931,0,0,8.674682698730795,53.83500059424647,LYN;CSF1;MDK;BMP5
2444,GO_Biological_Process_2023,Regulation Of Regulatory T Cell Differentiation (GO:0045589),4 of 22,0.0020173091677359,0.0268871103945931,0,0,8.674682698730795,53.83500059424647,SOCS1;BCL6;MDK;IRF1
2445,GO_Biological_Process_2023,Dendritic Cell Differentiation (GO:0097028),4 of 22,0.0020173091677359,0.0268871103945931,0,0,8.674682698730795,53.83500059424647,LYN;BATF2;BATF3;UBD
2446,GO_Biological_Process_2023,Negative Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051280),3 of 11,0.0022442799782903,0.0294590084019027,0,0,14.61675,89.15297421769729,GSTO1;CALM3;CALM2
2447,GO_Biological_Process_2023,Negative Regulation Of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060315),3 of 11,0.0022442799782903,0.0294590084019027,0,0,14.61675,89.15297421769729,GSTO1;CALM3;CALM2
2448,GO_Biological_Process_2023,Regulation Of T-helper 17 Cell Differentiation (GO:2000319),3 of 11,0.0022442799782903,0.0294590084019027,0,0,14.61675,89.15297421769729,NFKBIZ;ZC3H12A;JUNB
2449,GO_Biological_Process_2023,Ubiquitin-Dependent ERAD Pathway (GO:0030433),7 of 73,0.0023767278652314,0.031040782521289,0,0,4.154967008797654,25.104437741872047,HSPA5;DERL1;ERLIN1;FBXO6;CALR;UBXN4;HSP90B1
2450,GO_Biological_Process_2023,Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),4 of 23,0.0023939935876958,0.0311099466721078,0,0,8.217698555004747,49.59210437713905,STAT3;BTN3A3;BTN3A2;IL18BP
2451,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon Production (GO:0032480),5 of 38,0.0024956180653682,0.0321094621380799,0,0,5.921869295363272,35.49105874071121,CYLD;DHX58;XAF1;RELB;RBX1
2452,GO_Biological_Process_2023,Positive Regulation Of Cation Channel Activity (GO:2001259),5 of 38,0.0024956180653682,0.0321094621380799,0,0,5.921869295363272,35.49105874071121,GSTO1;TMSB4X;CALM3;CALM2;CTSS
2453,GO_Biological_Process_2023,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),7 of 74,0.0025694075977067,0.0328960115588169,0,0,4.092741935483871,24.40943996804548,MDK;IL6ST;SOD2;HIF1A;CX3CL1;SNX6;LGMN
2454,GO_Biological_Process_2023,T Cell Receptor Signaling Pathway (GO:0050852),8 of 95,0.0027186742213207,0.0346364426530029,0,0,3.605712295367468,21.301145388663468,BTN3A1;RIPK2;NFKBIZ;ZC3H12A;BTN3A3;BTN3A2;HLA-A;RBCK1
2455,GO_Biological_Process_2023,Cellular Response To Peptide (GO:1901653),6 of 56,0.0027508444133176,0.0348753396595729,0,0,4.695452716297787,27.683672478139705,RIPK2;CASP4;ICAM1;CHMP5;SNX6;LGMN
2456,GO_Biological_Process_2023,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),4 of 24,0.002816360536347,0.0353609711785795,0,0,7.806412825651303,45.84167467559578,NUB1;UBB;PSME1;PSME2
2457,GO_Biological_Process_2023,Response To Copper Ion (GO:0046688),4 of 24,0.002816360536347,0.0353609711785795,0,0,7.806412825651303,45.84167467559578,MT2A;MT1F;MT1X;MT1E
2458,GO_Biological_Process_2023,Negative Regulation Of Alcohol Biosynthetic Process (GO:1902931),3 of 12,0.0029368250987252,0.0361744475430665,0,0,12.992,75.7488969245148,ERLIN1;NFKB1;BMP5
2459,GO_Biological_Process_2023,Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),3 of 12,0.0029368250987252,0.0361744475430665,0,0,12.992,75.7488969245148,CD74;P4HB;TRIM38
2460,GO_Biological_Process_2023,Positive Regulation Of Cellular Extravasation (GO:0002693),3 of 12,0.0029368250987252,0.0361744475430665,0,0,12.992,75.7488969245148,MDK;CD47;ICAM1
2461,GO_Biological_Process_2023,Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),3 of 12,0.0029368250987252,0.0361744475430665,0,0,12.992,75.7488969245148,CD74;P4HB;TRIM38
2462,GO_Biological_Process_2023,Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),5 of 40,0.0031398860927363,0.0383125068310881,0,0,5.582903040734366,32.17744553289947,CD74;PTPN1;CYLD;SPPL2A;PTPN2
2463,GO_Biological_Process_2023,Negative Regulation Of Secretion By Cell (GO:1903531),5 of 40,0.0031398860927363,0.0383125068310881,0,0,5.582903040734366,32.17744553289947,CHGA;VAMP8;RSAD2;RHBDF2;TNFRSF1A
2464,GO_Biological_Process_2023,Response To Zinc Ion (GO:0010043),4 of 25,0.0032870079937342,0.0397463221404375,0,0,7.434297165760092,42.50765745209775,MT2A;MT1F;MT1X;MT1E
2465,GO_Biological_Process_2023,Regulation Of Phagocytosis (GO:0050764),6 of 58,0.0032879797076545,0.0397463221404375,0,0,4.5143940566475775,25.81096663991054,PLSCR1;LMAN2;RAB27A;CD47;CALR;TGM2
2466,GO_Biological_Process_2023,Positive Regulation Of Response To Biotic Stimulus (GO:0002833),5 of 41,0.00350334887549,0.0421537209601788,0,0,5.427543507362785,30.687526091171424,AKIRIN2;GBP5;PLSCR1;IFI35;TRIM56
2467,GO_Biological_Process_2023,Antimicrobial Humoral Response (GO:0019730),8 of 100,0.0037346642574007,0.0434762961584205,0,0,3.4088713219148,19.055922561402834,CXCL10;CXCL11;CXCL9;CXCL8;HLA-A;CXCL3;CXCL2;HLA-E
2468,GO_Biological_Process_2023,Acute-Phase Response (GO:0006953),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,CEBPB;PLSCR1;APOL2
2469,GO_Biological_Process_2023,Regulation Of Myoblast Fusion (GO:1901739),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,EHD1;FLOT1;CFLAR
2470,GO_Biological_Process_2023,Cellular Response To Arsenic-Containing Substance (GO:0071243),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,GSTO1;DHX36;ZC3H12A
2471,GO_Biological_Process_2023,Membrane Protein Intracellular Domain Proteolysis (GO:0031293),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,PSENEN;HM13;SPPL2A
2472,GO_Biological_Process_2023,Myeloid Dendritic Cell Activation (GO:0001773),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,BATF2;BATF3;UBD
2473,GO_Biological_Process_2023,Negative Regulation Of Viral Transcription (GO:0032897),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,IFITM3;ZFP36;TRIM21
2474,GO_Biological_Process_2023,Regulation Of ERBB Signaling Pathway (GO:1901184),3 of 13,0.0037470913195406,0.0434762961584205,0,0,11.6922,65.3216951926604,RHBDF2;IFI6;LGMN
2475,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),6 of 60,0.0038995643257848,0.0450443008120664,0,0,4.346747149564051,24.11093022389699,CYLD;SP100;TNFRSF12A;TNFSF10;CFLAR;PML
2476,GO_Biological_Process_2023,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),14 of 246,0.0039336489405667,0.0452369628165175,0,0,2.377388759607926,13.166425424960774,CD40;RIPK2;STAT3;EIF2AK2;ARID5B;CIB1;CFLAR;CX3CL1;FLOT1;RBCK1;TRIM38;TRIM21;PPIA;TRIM22
2477,GO_Biological_Process_2023,Negative Regulation Of Growth (GO:0045926),9 of 124,0.0041422054028104,0.0474255147220458,0,0,3.070550959338145,16.846660519102223,BST2;MT2A;CDKN1A;BTG1;BCL6;MT1F;MT1X;PML;MT1E
2478,GO_Biological_Process_2023,Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),4 of 27,0.004383231678782,0.0499649961980459,0,0,6.787139496384072,36.853957067080295,CYLD;TMSB4X;ZC3H12A;IFI35
